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Abstract 
Chapter 1 reviews the background of nucleic acid structures and drug targeting to 
nucleic acids. The concept of molecular recognition between drugs and nucleic acids is 
also discussed. Besides, being a drug target, DNA can be used as material for 
constructing beautiful architectures. Examples of these DNA nanostructures are 
presented.  
In Chapter 2, three way junction recognition by a metallocylinder is shown to 
occur not only in DNA but also in RNA. The recognition of RNA three way junctions by 
the metallosupramolecular cylinder, its enantiomers and its analogues are explored. It 
shows that the cylinders have the ability to bind preferentially to RNA three way 
junctions and to RNA-DNA hybrids. In addition, a competition assay of nucleic acids to 
the iron cylinder is examined. It indicates that the iron cylinder may prefer to bind to 
RNA three way junctions rather than DNA.  
In Chapter 3, to elucidate the crucial features of the metallosupramolecular 
cylinder for recognition of the DNA three way junction, an array of cylinder derivatives 
are screened. The results indicate that the geometry of the cylinder is the key trait for the 
recognition. Moreover, the electrostatic interaction from the cylinder can enhance the 
affinity of the recognition.   
In Chapter 4, the molecular effect of the iron cylinder on the structure of a DNA 
tetrahedron nanostructure is examined. Several biophysical techniques confirm that the 
cylinder binds strongly with the nanostructure, thus leading to the unusual style of a very 
rigid DNA nanostructure. 
 xiv 
In Chapter 5, to precisely determine the binding affinity of the cylinder to DNA, 
the development of SPR experiments is described. The results show that the value of the 
binding affinity obtained from SPR is less than that obtained using the conventional 
method of ethidium bromide displacement. This is due to the inaccurate measuring of the 
latter method during the experiment.  
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1.1  Introduction to DNA  
1.1.1 A brief history of DNA 
DNA is a nucleic acid which contains the genetic information that is exploited in 
the development and functioning of most living cells. The two main functions of DNA 
are to store genetic information and pass it to offspring cells on replication and to utilise 
the information through transcription into complementary RNA strands which later will 
be translated into a precise protein which will have a functional role in cell activity.  
The history of the discovery of DNA began in 1869 when Miescher, a Swiss 
physician, isolated leucocytes from pus. He first found an unknown substance which was 
fundamentally different from protein, a crude sample of DNA.1 Later, it was termed 
“nuclein”. In 1951, Chargaff reported that the base compositions were different 
depending on the species, however the ratio of total purine bases to total pyrimidine bases 
was always close to one. The amount of adenine and thymine and that of cytosine and 
guanine base were equivalent. This discovery is known as Chargaff’s rules and provided 
a valuable clue for Watson and Crick to solve the DNA structure. In 1952, an X-ray 
diffraction picture of a fibrous DNA was taken by Franklin. The picture is shown in 
Figure 1.1. The diffraction pattern illustrated a number of spots aligned in an X shape. 
Information about the size of DNA was obtained. This indicated that the DNA structure 
must be simple with a regular repeating structure. The conclusion drawn from the 
experiment was that DNA was a helix.  
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Figure 1.1 Franklin’s X-ray picture of DNA.2 
 
The three dimensional structure of DNA was unveiled in 1953 when Watson and Crick 
combined the information achieved from Chargaff’s rule and Franklin’s X-ray picture 
(Figure 1.2). They proposed that DNA was a double helix with a sugar-phosphate 
backbone on the outside and bases on the inside. Moreover, the bases must be paired with 
a purine in one strand always across from a pyrimidine in the other strand. This way the 
helix would be uniform.3 
 
 
 
 
 
 
 
Figure 1.2 Francis Crick (left) and James Watson (right) elucidated that DNA has a double-helical 
structure.4 
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1.1.2 DNA structures 
DNA is a double helical biopolymer consisting of a series of nucleotides 
containing a phosphate group, deoxyribose sugar and nitrogenous bases (Figure 1.3). The 
deoxyribose sugars are linked together by phosphodiester bonds and the bases are 
attached to the sugar unit. The nitrogenous bases are purines (adenine (A) and guanine 
(G)) and pyrimidines (cytosine (C) and thymine (T)). The right handed double stranded 
DNA helix, discovered by Watson and Crick, is defined as the B structure. The two 
polynucleotide chains are held together by hydrogen bonding between the bases on the 
different strands. All the bases are in the centre of the double helix and the sugar-
phosphate backbones are on the outside. In each case, a purine is paired with a 
pyrimidine; adenine (A) always pairs with thymine (T) via double hydrogen bonding, and 
G with C by triple hydrogen bonding. The bases are perpendicular to the helix axis and 
are stacked in a parallel fashion upon each other via face to face π-π interactions. The 
attachment points of the bases to the sugar-phosphate backbone are offset with respect to 
the hydrogen bonds between the bases. This creates two distinct grooves in the double 
helix DNA, defined as minor and major. These two grooves are important in DNA 
recognition by synthetic and natural compounds. This topic will be discussed in Section 
1.1.4.  
 
 
 
 
 
 
 
Chapter 1 
 5 
 
 
 
Figure 1.3 Three models of DNA structure. A) Schematic drawing of DNA structure illustrating Watson 
and Crick base pairing. B) The drawing of DNA double helix whose sides represent the sugar-phosphate 
backbones of the two strands and whose rungs represent base pairs. The width of DNA and the distance 
between repeated nucleotides are 2 nm and 0.332 nm, respectively. C) Space filling model of double helix 
DNA.5 
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1.1.3 A variety of DNA conformations 
The B structure of DNA elucidated by Watson and Crick is the most common 
conformation found in the cell. However, the B form is not the only conformation 
available to double stranded DNA. A form DNA, a right handed helix, can be obtained 
when the relative humidity surrounding the fibrous DNA is reduced to 75%.5 In 1979, 
Rich and his colleagues reported that DNA does not always have a right handed twist.6 
The structure of a poly CG DNA double helix was significantly different from B form 
DNA. It was left handed with a zigzag shaped backbone when viewed from the side. This 
DNA structure is therefore called Z-DNA (Figure 1.4).   
 
 
Figure 1.4 The model of A, B and Z DNA (from left to right).5  
 
These three DNA structures are different in several respects. A summary of the helical 
parameters are shown in Table 1.1 
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Table 1.1 Geometries of DNA forms.5 
 
Geometry attribute A form B form Z form 
Helix direction Right-handed Right-handed Left-handed 
Repeating unit (bp) 1 1 2 
bp/turn 11 10.5 12 
Inclination of bp to axis +19° -1.2° -9° 
Rise/bp along axis (nm) 0.23 0.332 0.38 
Pitch/turn of helix (nm) 2.82 3.32 4.56 
Diameter (nm) 2.3 2.0 1.8 
 
Besides the double helix, DNA can form higher order structures such as DNA 
junctions which are a branched DNA structure consisting of double strand(s) converging 
at one point (Figure 1.5A, B). The DNA junction is an intermediate in several genetic 
processes in living cells. Examples include the replication fork observed during DNA 
replication,7 and the four way junction (Holliday junction) presenting homologous 
genetic recombination.8, 9 
 
 
 
 
 
Figure 1.5 Higher order DNA structures. A) DNA three way junction.10 B) DNA four way junction or 
Holliday junction.11 
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In addition to the structure of DNA four way junctions, the four way junctions can 
form in a number of different conformers. It has been reported that the folding of the 
DNA junction depends on the divalent ion such as magnesium ions. Upon addition of 
magnesium ions (≥ 100 µM Mg2+), the four way junction folds by the pairwise coaxial 
stacking of helical arms and usually adopts a right handed antiparallel structure (Figure 
1.6). A small angle of ~ 60º between helical axes is observed. This structure was probed 
and confirmed by several techniques such as comparative gel eletrophoresis12, FRET 
analysis13 and enzyme and chemical probing method.14, 15 
 
 
 
 
 
 
 
 
Figure 1.6 A) Changing folding of DNA four way junction from an extended conformation to a pairwise 
coaxial stacking structure in the presence of Mg2+. B) Possible topology of strands and helices in the 
coaxial stacking structure of the four way junction. The centre shows the junction in an extended 
conformation with four arms pointing towards the corner of a square. The arms are labeled 1-4 in a 
clockwise direction. The strands can be drawn as non-crossed or crossed, illustrating a parallel (left) or 
antiparallel (right) structures, respectively. Each of which can generate a left handed form (top) and a right 
handed form (bottom). The proposed four way junction in the presence of magnesium ions is the coaxial 
stacking with a right handed antiparallel conformation, shown in red frame. Taken from ref.11 
 
Mg
2+ 
A B 
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For DNA three way junction, it has been demonstrated that a perfect three way 
junction (3H) only adopts a fully extended structure either in the presence or absence of 
magnesium ions (Figure 1.7A).16 This is due to the rigid framework of the fully paired 
DNA three way junction removes any possibility of folding by coaxial stacking of the 
helical arms. However, the addition of a single stranded bulge at the intersection of the 
helical arms, generating a 3HSn junction, will provide the flexibility to the DNA three 
way junction structure. Therefore, in the presence of magnesium ions, coaxial stacking of 
the helical arms can be observed from bulged DNA three way junction.17, 18 The intensive 
NMR studies of DNA three way junction containing two unpaired base (3HS2 junctions) 
has revealed that in the presence of magnesium ions, two helical arms remained in 
coaxial stacking but the third helix was unstacked and pointed away from the 
intersectional point.19-21 Two alternative stacking conformers shown in Figure 1.7B can 
be generated from this bulged DNA three way junction. Surprisingly, both forms of DNA 
three way junction can exist and the stability of each forms depends on the sequences.22 
 
 
 
 
 
 
 
Figure 1.7 A) Perfect three way junction with extended structure. B) Top: Transition folding of bulged 
three way DNA junctions from extended structure to coaxial stacking structure in the presence of 
magnesium ions. Bottom: Two alternative conformers achieved from coaxial stacking of bulged DNA 
three way junction (3HS2). Taken from ref.
11 
A 
B 
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It is noteworthy that metal ions play important role in folding of DNA helical 
junctions due to the polyelectrolyte feature from phosphate backbone of nucleic acids. 
Besides, magnesium ions, other divalent ions such as calcium ions can be used instead of 
magnesium ions however monovalent metal ions are ineffective in promoting transitions 
of folding.23 
In addition to double helical DNAs and DNA junction structures, quadruplex 
DNA is another “unusual” DNA structure. It is an array of G-quartets, each of which 
comprises four guanine bases, aligned with a four-fold rotational symmetry. Hydrogen 
bonds are formed along each edge, as shown in Figure 1.8A, B.. The G-quartets stack on 
each other in a helical fashion, producing a G-quadruplex structure in the centre of which 
is often found a metal cation.24 This structure was found to be involved in the structure 
and stability of telomeres in organisms.25, 26  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 A) G-quartet with the metal ion. B) Human telomeric quadruplex DNA. Taken from ref.27 
 
 
A B 
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1.1.4 Mode of DNA recognition 
DNA contains all the genetic information which is responsible for the physical 
traits and functions of the organism. The genetic data is transcribed into RNA which is 
used as a template for synthesising protein via the translation process. Changes in DNA 
sequences may result in deficiencies in the protein function and misregulation of its 
information, leading to over- or under- stimulation of cell processes. These are the origins 
of many diseases e.g. cancer. Therefore, DNA is an attractive medical target for design of 
drugs that control gene expression.  
There are five distinct traditional DNA binding modes for drugs: intercalation 
between DNA base pairs, covalent binding or metal coordination to bases, sugar 
phosphate backbone binding, minor groove recognition and major groove recognition. 
These DNA binding modes were discovered in 1960s. Two additional new binding 
modes, junction recognition and quadruplex recognition, have been reported recently. 
These drug DNA recognition modes and their examples are presented in the following 
section. 
 
1.1.4.1 DNA intercalation 
Intercalation was first reported by Lerman in 1961 when the binding of planar 
aromatic chromophores to DNA was explored.28 Research focused on this concept has 
been ongoing ever since. In technical terms, intercalation is the insertion of planar 
aromatic ring(s) into the gap between the base pairs of DNA. This interaction can be full 
insertion or partial insertion depending on the size of the DNA intercalators. DNA-drug 
intercalation is stabilised by several interaction forces: π electron overlap, hydrophobic 
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and polar interactions and electrostatic force from positive charges on the intercalators to 
the negative charge of the DNA phosphate backbone. The insertion of intercalators can 
occur from either the major or minor groove. However, the backbone is not flexible 
enough to permit all intercalators to insert into every single gap. The maximum number 
of DNA intercalators, that can insert, is one molecule per two DNA base pairs according 
to the neighbour-exclusion principle.29 The result of intercalation is the alteration of DNA 
structure by lengthening, stiffening, and unwinding the DNA helix. These changes in the 
DNA structure are believed to prevent DNA replication, thus inhibiting the growth of 
cancers or causing cell death.  
A well known DNA intercalator, mainly used in molecular biology and 
biochemistry for DNA staining, is ethidium bromide (Figure 1.9).  
 
 
 
 
 
 
Figure 1.9 Chemical structure of ethidium bromide. 
 
An example of a DNA intercalator used in medical treatment is doxorubicin 
(Figure 1.10). It has been used in the clinic as an anticancer drug since the 1960s, 
categorised as an “anthracycline antiobiotic”.30  
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Figure 1.10 Left: Chemical structure of doxorubicin. Right: Two doxorubicins (purple spheres) inserted in 
between DNA base pairs. Taken from ref.22 
  
Besides these organic molecules, scientists have synthesised intercalators 
containing metals, termed metallo-intercalators. An increase of positive charge is not the 
only benefit from incorporating metal into the design of intercalators: other features such 
as shape of the complex may be also controlled by changing the metal used.  
An early example of a metallo-intercalator was Lippard’s use of platinum metal to 
create a planar platinum (II) terpyridine intercalator (Figure 1.11).31  
 
 
 
 
 
 
 
Figure 1.11 Chemical structure of Lippard’s metallo-intercalator. 
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Building on this basic concept, Barton et al. synthesised rhodium based metal 
intercalators with large chrysi and phyzi ligands (Figure 1.12). These intercalators are 
too big to insert into normal Watson and Crick base pairing but are able to insert into a 
mismatch base pair. The application of these intercalators is to detect the mismatches of 
DNA base pairs by fluorescence.32, 33  
 
 
 
Figure 1.12 Chemical structures of Barton’s rhodium (II) intercalators.  
 
Besides mononuclear metallo-interacalators, bis-intercalators containing 
molecules with two interacalators linked together have been prepared. The flexibility and 
length of linking chain is important to allow the molecule to wrap and intercalate into the 
two sites on the same DNA duplex. However, using a rigid linking chain creates agents 
that might bind to targets where two duplex are in close proximity (Figure 1.13A).34 This 
approach was exemplified by Lowe’s platinum terpyridyl intercalators35 (Figure 1.13D) 
or two acridine intercalators, used to probe the spatial organisation of DNA.36 
Pikramenou et al. reported a hairpin style of bis-intercalator.37 In this molecule, two 
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platinum-terpyridyl moieties are attached onto aromatic thiolates, attached to a neodinium 
aminocarboxylate complex (Figure 1.13B). With the design of this hairpin intercalator, it 
binds to the same double stranded DNA with the intercalation about 10.5Å (i.e. a two bp 
gap between the intercalation sites). 
 
Figure 1.13 A) Intercalating fashions of bis-intercalators with flexible linkers (top) and rigid linkers 
(bottom). B) Pikramenou’s bisintercalator. C) Threading intercalator. D) Lowe’s platinum terpyridyl 
intercalators.  
 
Interestingly, this luminescent compound binds strongly to ct-DNA and is capable of 
harvesting light energy which is used to drive the NIR emission of the neodinium by the 
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platinum-terpyridyl units. Another bis-intercalator [D,D-µ-(bidppz)-(phen)4Ru2]
4+ 
(Figure 1.13C), known as threading intercalator, was synthesised by Lincoln and 
Norden.38 In this complex, two [Ru(phen)2(dppz)]
2+ units are linked together to form the 
semirigid binuclear ruthenium complex. DNA binding studies revealed that this complex 
slowly rearranges from an initial groove-bound, non-luminescent state to form a final 
intercalated emissive state by threading one of its Ru(phen)2 units through the DNA base 
stack. 
 
1.1.4.2 Alkylation or covalent binding  
Another DNA binding mode is observed when drugs bind directly to the DNA 
bases, usually to the N7 position of G or A bases in the DNA major groove. The nitrogen 
mustards such as chlorambucil (Figure 1.14), are the example of this DNA binding 
mode.39, 40 This organic compound covalently binds to DNA bases by alkylation of the 
nitrogen via substitution of the chlorine, and is used in the clinic for the treatment of 
lymphocytic leukemia, ovarian and breast carcinomas and Hodgkin’s disease.41  
 
 
 
 
 
 
Figure 1.14 Chemical structure of the nitrogen mustard, chlorambucil. 
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One of the most successful of the clinical “alkylating” agents for cancer treatment 
is cis-platin, a platinum-based drug. It binds to DNA with displacement of two chlorides 
ligands and formation of two metal-coordination bonds to the N7 of two adjacent purine 
DNA bases on the same strand (Figure 1.15) This type of DNA binding causes a kink in 
the DNA of around 45 degrees at the platination site.42 This kink is recognised by HMG 
proteins and this is believed to protect the lesion from DNA repair.43 
 
 
 
 
 
 
 
Figure 1.15 Left: Chemical structure of cis-platin. Right: Cisplatin-DNA adduct bound to HMGB1. 
Cisplatin is shown as red and white spheres. DNA is shown in blue, HMGB1 shown as grey cartoon with 
intercalated phenylalanine shown as yellow spheres. Taken from ref.44 
 
 Although cisplatin is an effective antineoplastic agent, its clinical use is limited 
because of its severe side effects including nephrotoxicity, gastrointestinal toxicity, 
neurotoxicity, ototoxicity, hematologic and hyperuricemia. To overcome these problems, 
scientists designed and developed a range of cisplatin derivatives, which are more 
effective and less toxic (Figure 1.16). These are carboplatin and oxaliplatin which have 
been approved for worldwide use. Other cisplatin derivatives have been clinically 
approved for some countries such as nedaplatin (Japan), lobaplatin (China) and 
heptaplatin (South Korea).  
Pt
Cl
Cl
H3N
H3N
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Figure 1.16 Cisplatin and its derivatives 
 
The toxicity of platinum drugs is directly related to how easily the leaving groups 
leave and the complex is aquated. Platinum complexes with highly labile ligands are very 
toxic whereas ligands which aquate very slowly are much less toxic.45 In carboplatin, the 
dichloride ligands of cisplatin were substituted by a bidentate 1, 1-cyclobutanedicar 
boxylic acid ligand (Figure 1.16). It was found that the side effects associated with 
cisplatin treatment were reduced with no significant renal or neural toxicity. In addition, 
carboplatin is believed to form the same DNA adduct as cisplatin due to the presence of 
the same carrier ligand (NH3). Nedaplatin is a square planar platinum (II) complex with a 
glycolic acid bidentate ligand with one carboxyl and one hydroxyl donor (Figure 1.16). 
Its solubility is ten times greater than that of cisplatin. It has shown higher antitumor 
activity than carboplatin but equivalent to that of cisplatin with less nephrotoxicity, 
neurotoxicity and gastrointestinal toxicity than cisplatin.46-48 Oxaliplatin is a squar planar 
platinum (II) complex containing 1,2 diaminocyclohexane (DACH) and oxalic acid as a 
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carrying group and leaving group, repectively (Figure 1.16). This oxalate ligand 
dramatically reduces the severe side effects of the drug compared with cisplatin.49 
Oxaliplatin was the first drug approved that was capable to overcome cisplatin resistance 
due to the different adducts forming with DNA. In combination with the other anticancer 
agents including 5-fluorouracil (5-FU) and folinic acid, oxaliplatin is used to treat 
colorectal cancer.50 Lobaplatin is a disastereomeric mixture (50:50) of the carrier ligand, 
1,2- diaminomethylcyclobutane (Figure 1.16). The leaving group of this drug is lactic 
acid. Lobaplatin is currently approved for the treatment of leukaemia, breast cancer and 
small cell lung cancer.45 Heptaplatin was approved to use in Korea (Figure 1.16). Its 
cytotoxicity can be equal to or greater than cisplatin in various cell lines.51, 52  It had a 
high stability in solution, no remarkable toxicity and ability to overcome cisplatin- 
resistant cells. It is currently used in clinic for the treatment of gastric cancer.45  
 
1.1.4.3 Sugar phosphate backbone binding 
Farrell synthesised a cationic trinuclear Pt(II) complex (TriplatinNC, Figure 
1.17B) which can bind to the DNA phosphate backbone.53 This agent is related to the 
trinuclear trans-platinum drug BBR3464 (Figure 1.17A) but lacks the reactive Pt-Cl 
groups. It can non-covalently bind to DNA through hydrogen bonding and electrostatic 
interactions.  Recently the crystal structure of a double-stranded B-DNA dodecamer with 
TriplatinNC has indicated that this compound can form multiple hydrogen bonds with the 
phosphate oxygen and can track along the phosphate backbone, described as “Backbone 
tracking”.54 It can also span the minor groove making a bridge between the phosphate 
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backbones on each strand. TriplatinNC shows micromolar activity against human ovarian 
cancer cell lines.55  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17 A) BBR3464. B) Crystal structure of backbone tracking of the trinuclear platinum(II) 
compound, TriplatinNC which was cocrystallised with DNA.54 
 
 
 
A 
B 
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1.1.4.4 Minor groove recognition 
Several organic agents such as diarylamides (DAPI, berenil and pentamidine) and 
bis-benzimidazoles (Hoechst 33258 and their derivatives) target the DNA minor groove 
(Figure 1.18). These are used as anticancer, antiparasite, antiviral and antibacterial 
agents. Some, such as DAPI and Hoechst, show attractive fluorescent properties when 
bound to DNA, and are therefore widely used as DNA stains for biological imaging.56, 57 
The common structural features shared by most minor groove binders are a positive 
charge, linked aromatic or heteroaromatic rings and a crescent shape.58 Most minor 
groove binders have a preference for AT sequences over CG sequences as the AT 
sequence has a narrower and more flexible minor groove, resulting in a snug fit.34 
 
 
                                          
  
 
 
 
 
 
 
 
 
Figure 1.18 A) Chemical structures of DNA minor groove binders. B) Binding of DAPI (left) and berenil 
(right) in the minor groove of DNA.34 
B 
A 
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Another well known example of minor groove binder is an array of polyamides 
which are known as sequence specific DNA binding agents. Dervan et al. have 
established a combination of code, by which synthetic agents relied on modified 
distamycin-type structures, can recognise the DNA sequence via the minor groove (Table 
1.2).  
 
Table 1.2 Pairing code for minor groove recognition. Taken from ref.59 
 C•G G•C A•T T•A 
Py/Im + - - - 
Im/Py - + - - 
Py/Hp - - + - 
Hp/Py - - - + 
 
Note:  Py = pyrrole, Im = imidazole, Hp = hydroxypyrrole. (+) = favored, (-) = disfavoured. 
 
At the first step of Dervan’s study, a methylpyrrole of distamycin was substituted 
by a methylimidazole group (Figure 1.19A, B).34 As expected, the formation of hydrogen 
bonding was observed between the new nitrogen in the ring system and the NH2 of the 
guanine base in the minor groove (Figure 1.19C). At high drug loading, it is interesting 
that two strands of two pyrrole/imidazole peptide could bind side by side in the minor 
groove (Figure 1.19D). This is different from the other minor groove binders such as 
DAPI and berenil which are formed 1:1 ratio of drug to DNA strand. The two polyamide 
strands align head-to-tail in the groove therefore the cationic guanadinium ends are 
placed away from each other (Figure 1.19E).  
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Figure 1.19 A) Chemical structure of distamycin A. B) Structure of polyamide strand (ImPyHpPy). C) 
Schematic diagram of hydrogen bonding interaction of polyamide strand (ImPyHpPy) with the 5′-
AGATCT-3′. Hydrogen bonds are shown in dash line and numbers indicate distance between non hydrogen 
atoms. D) Two polyamide strands (pink and orange) aligning side by side in the DNA minor groove (blue 
and cyan) E) Relative orientations of two polyamide strands. Taken from ref.34, 60 
 
In addition, each polyamide strand interacts with the bases of one strand of the 
DNA. Subsequently, two polyamide strands forming π-π stacking between the 
pyrrole/imidazole rings of one strand and the amide carbonyls of the other strand can 
recognise a base pair of DNA in the minor groove. Based on this concept, a hairpin linker 
 
C 
A 
B 
E 
D 
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was introduced to incorporate two antiparallel polyamide strands into one molecule. The 
biological studies demonstrate that these polyamides can inhibit the transcription of 
specific genes.61 Furthermore, a series of conjugated hairpin polyamides with DNA 
binding agents was synthesised. It was reported that the polyamide with DNA alkylator 
(chlorambucil) conjugate is able to cause cell arrest in the G2/M stage in the cell cycle. 
The conjugate is also active against a wide range of cancer cells without animal 
toxicity.62 Moreover, hairpin polyamide-fluorescent dye conjugate was created.63 The aim 
of synthesising this compound is to probe and quantify the uptake of the polyamide to 
nucleus of live cells. 
 
1.1.4.5 Major groove recognition 
The DNA major groove provides a large variety in size and shape and a greater 
variety in pattern of hydrogen bond donor and acceptor units than the minor groove. 
Therefore, it is a common target for proteins.34 Major groove recognition by proteins 
usually involves cylindrical binding units based on alpha helices. This unit has the perfect 
size and shape to fit tightly into the major groove but is too large for the minor groove. 
The principle recognition motifs found in DNA binding proteins are α-helix-turn-α-helix, 
zinc-finger and leucine zippers.58 Besides proteins, oligonucleotides can recognise the 
DNA major groove by forming triplex DNA via Hoogsteen or reverse Hoogsteen base 
pairing (Figure 1.20). This sequence specific binding has been used in an application for 
genetic manipulations.64, 65 
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Figure 1.20 Hydrogen bonding in the major groove involving triplex formation. A) Hoogsten base pairing. 
B) Reverse-Hoogsteen base pairing. C) Structural representation of triple helix forming oligonucleotide 
(TFO, green) bond in the major groove of double stranded DNA.66  
 
 Based on this triplex DNA formed from oligonucleotides, Nielsen et al. invented 
peptide nucleic acid (PNA) in which the sugar backbone of conventional DNA was 
replaced by a polyamide (Figure 1.21).67 The benefit from this replacement is the 
reduced negative charge resulting in greater binding of PNA to DNA than 
oligonucleotide to DNA. Thus, PNAs are capable to form (DNA)2(PNA) triplex with 
double stranded DNA. However in practice, these agents frequently displace one of the 
DNA strands forming a (PNA)2(DNA)1 triplex. This occurs when the DNA double helix 
is opened up and two PNA strands invade. One of those PNAs binds to one of the DNA 
strands with respect to Watson and Crick base pairing and another strand binds to the 
major groove of that PNA-DNA double helix. 
C 
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Figure 1.21 Chemical structure of PNA. 
 
Not only proteins, oligonucleotides and PNA can target the major groove DNA 
but also a synthetic agent, called a metallosupramolecular cylinder (Figure 1.22). This 
compound was initially synthesised by Hannon et al.68 It was first reported as a synthetic 
agent that targets the major groove by fitting snugly into the DNA major groove across 
five base pairs.69, 70 The nucleic acid binding is more complex than this though and this 
cylinder and its derivatives are the subject of detailed studies herein. The review of the 
cylinder and its derivatives will be shown in Section 1.1.4.5.1.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.22 Synthetic scheme of the iron metallosupramolecular cylinder.69 
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1.1.4.5.1 Metallosupramolecular iron (II) cylinders 
 
The first metallosupramolecular iron cylinder was synthesised by Hannon et al.68 
This complex contains two metal iron (II) centres wrapped by three pyridylimine ligand 
forming triple stranded helicate (Figure 1.23).  
 
 
 
 
 
 
 
 
Figure 1.23 Synthetic scheme of a metallosupramolecular iron (II) cylinder (Fe2(C25H20N4)3Cl4).  
 
This tetracationic iron helicate compound ([Fe2L3]
4+) has a cylindrical shape with ∼2 nm 
in length and ∼1 nm in width therefore sometimes it is called a iron cylinder. The 
synthetic approach of this iron cylinder is inexpensive and easy. The iron cylinder is a 
helical molecule containing two enantiomers: left handed helicate (M enantiomer) and 
right handed helicate (P enantiomer) (Figure 1.24). These enantiomers are easily 
separated by using cellulose as a stationary phase and 20 mM NaCl solution as eluent.71, 
72 Interestingly, the dimensions of the iron cylinder are similar to protein DNA-
recognition motif therefore this cylinder should have the same target as DNA recognition 
proteins which are mainly at the major groove.  
Chapter 1 
 28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.24 Enantiomers of the iron cylinder. A) Separation of the iron cylinder by cellulose paper and 
NaCl solution. B) CD spectrum of enantiomerically pure M and P of the iron cylinder. Taken from ref.71 
 
DNA binding studies of the iron cylinder to DNA were probed by several 
biophysical techniques such as CD, LD and AFM (Figure 1.25). The results show that 
the iron cylinder targets the major groove of B-DNA by binding across five base pairs70 
and induces intramolecular DNA coiling.69 It has been shown that two enantiomers of the 
iron cylinder bind differently to the major groove. The M enantiomer dramatically 
induces the intramolecular ct-DNA coiling, bending more than that of the P enantiomer. 
It has been also reported that the two enantiomers of the iron cylinder clearly show a 
different in DNA binding modes. The M enantiomer preferentially binds to the major 
groove while the P enantiomer is believed to bind along the minor groove spanning the 
two phosphate backbones.73 
 
 
 
A 
(-) M enantiomer 
(+) P enantiomer 
B 
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Figure 1.25 DNA binding studies of the iron cylinder to DNA. A) CD and LD showing that the iron 
cylinder binds to B-DNA and it does not change the conformation of B-DNA. B) AFM image representing 
intramolecular coiling of the iron cylinder to ct-DNA. C) X-ray structure of the iron cylinder locating at the 
core cavity of DNA three way junction. Taken from ref.69 
 
One interesting biophysical parameter for evaluating the ability of the compound 
to interact with DNA is unwinding angle. It is the number representing the degrees by 
which the DNA is unwound about its helical axis per the molecule bound.74 The result 
shows that the M enantiomer is more effective than the P enantiomer at unwinding DNA  
(Table 1.3).75 The high efficacy of the iron cylinder at unwinding DNA, compared to the 
other synthetically non-covalent DNA binding agents, may reveal a potential to affect 
cellular processes involving DNA strand separation, such as DNA replication, 
transcription or repair. Moreover, both enantiomers exhibited the lower binding affinity 
B 
A 
 
 
a) 
b) 
C 
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of ct-DNA than poly(dA-dT)2 and poly(dG-dC)2 (Table 1.3). This suggests that the 
enantiomers has a preferential binding for regular purine-pyrimidine tracts rather than a 
random DNA sequence. The result also demonstrates that repetitive AT sequences is 
preferred by both enantiomers over GC sequences.  
 
 
Table 1.3 Summary of value achieved from biochemical and molecular biological studies of DNA-complex 
interaction. Taken from ref.75, 76 
 
Kapp (x 10
6
 M
-1
)  Compound Unwinding angle 
(degree)  ct-DNA poly (dA-dT)2 poly (dG-dC)2 
rac-[Fe2L3]
4+ 27±3º 60 ND ND 
M-[Fe2L3]
4+ 32±3º 46 106 77 
P-[Fe2L3]
4+ 22±3º 76 142 89 
 
ND = not determined 
 
 
 
Besides the major groove recognition, the iron cylinder has an additional 
unprecedented DNA binding mode which is three way junction recognition. An X-ray 
crystal structure, which was obtained from a solution containing a palindromic 
hexanucleotide DNA and the iron cylinder, shows that the iron cylinder is perfectly 
located at the heart cavity of the DNA three way junction.77 This is interesting because a 
palindromic oligonucleotide used for preparing crystal structure can usually form a 
double stranded DNA rather the other possible structures such as three way junction, four 
way junction, etc. In the presence of the iron cylinder, the helicate has chosen three way 
junction to which it binds most effectively, therefore the crystal structure in the form of 
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the cylinder locating at the core cavity of three way junction is obtained (Figure 1.26). 
The binding of the iron cylinder to three way junction were confirmed again by other 
techniques including NMR and gel electrophoresis to ensure that the obtained X-ray 
structure is not solely the artefact from the crystallisation. The X-ray study suggests that 
several non-covalent interactions are contributed in this stabilisation including 
electrostatic interactions, face to face π-π stacking interactions, sandwiching interactions 
in the minor groove, hydrogen bonding interactions and hydrophobic interactions.77  
 
 
 
 
 
 
 
 
 
Figure 1.26 DNA junction recognition by a metallosupramolecular tetracationic cylinder. The stick 
represents hexanucleotide DNA and space filling demonstrates the cylinder. Taken from ref.77 
 
Three way junctions can be found in DNA and RNA. In RNA, they are involved 
in splicing78 and translation processes.79 In DNA, they are known as replication fork, 
forming transiently during DNA replication.7 They also form as intermediated structures 
during triplet repeat expansions which are associated with several human genetic diseases 
such as myotonic dystrophy type1 and Huntington’s diseases.80 A drug designed to 
recognise DNA three way junction could be a promising strategy for a potential 
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anticancer drug as it could selectively bind to the DNA target. This could possibly 
overcome the unpleasant side effect of current anticancer drug used in clinic such as 
cisplatin.  
Recently, it is reported that the iron cylinder can stabilise G-quadruplex structure 
and its chiral cylinders can distinguish G-quadruplex DNA. The P enantiomer has a 
stronger selectivity to G-quadruplex than the M enantiomer. Moreover, only the P 
enantiomer can convert antiparallel G-quadruplex to hybrid structure.81 The conversion of 
G-quadruplex structure by the P enantiomer was probed by several techniques such as 
CD, UV melting curve and gel electrophoresis.81 Due to a hydrophobic surface, 
compatible size of the cylinder (length ~ 18 Å, diameter ~ 8 Å)68 to the G-quartet (length 
~ 14 Å, diameter ~ 11 Å)82 and electrostatic interactions between positive charge of the 
complex (4+) and negative charge from phosphate backbone of the DNA, the cylinder 
has a potential to interact with the two lateral loops and grooves of G-quadruplex via 
external stacking.  
Biological studies demonstrate that the supramolecular cylinder inhibits the 
proliferation in a number of cancer cell lines and induces cytostasis at the G0/G1 phase 
and apoptosis in myeloid leukaemia cell line HL-60.83 Moreover, this anticancer activity 
is not associated with genotoxicity or mutagenicity confirming by COMET assays and 
AMES tests, respectively. This is important because those are the major drawbacks of 
cisplatin which can lead to an increased risk of secondary cancers such as leukaemias. 
Recently, it has been reported that the enantiomers of the cylinder can inhibit a 
telomerase activity and influence telomere shortening, β-galactosidase activity which are 
associated with cell senescence and upregulation of cyclin-dependent kinase (CDK) 
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inhibitors p16 and p21 in chronic myelogenous leukemia known as K562 cell lines. In 
addition, the P enantiomer is more effective than the M enantiomer.81 This work provides 
new insights into elucidating chiral complex and G-quadruplex.  
Furthermore, the cylinder also exhibits antimicrobial activity against B. subtilis 
and E. coli representing of gram positive and gram negative bacteria through a 
bactericidal manner.84 Due to the extremely fast rate of killing, it is believed that DNA 
binding may not the only mechanism of bactericidal activity. Interestingly, the structure 
and the mode of action of the cylinder are different from all known antimicrobial agents. 
Consequently, it may effectively act against bacterial resistant strains to other antibiotics.  
Since the metallosupramolecular cylinder was synthesised, much effort has been 
put on the modification of the parent cylinder in order to enhance its selectivity to DNA 
and improve a physical feature of the modified compound such as fluorescent property. 
All modified cylinders which were synthesized in Hannon group, will be reviewed 
herein. Firstly, Uerpmann et al. synthesised an extended triple stranded 
metallosupramolecular cylinder.85 The modified iron cylinder is longer and slightly wider 
than the parent iron cylinder. The DNA binding studies showed that the compound binds 
in the same fashion as the parent cylinder does however a DNA coiling effect of the 
modified cylinder is much less than the parent cylinder. Later, Peberdy and co-workers 
showed that increasing the width of the parent cylinder by adding methyl group (CH3) on 
the parent ligand at the 3 position of the pyridyl ring adjacent to the metal binding site 
unit (Figure 3.3C, F in Chapter 3) weakens the DNA binding strength, reduces the 
bending and coiling effect.76 Interestingly, lengthening the cylinder by introducing 
methyl group on the parent ligand at the 5 position of the pyridyl ring shows a similar 
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DNA interaction to those of the parent cylinder.76 This indicates that the dimensions of 
the cylinder are crucial for its binding ability to DNA. Furthermore, Pascu et al. 
combined the DNA binding features of the parent cylinder with the photoactive 
properties of ruthenium by synthesising a metallosurpramolecular triple stranded 
ruthenium cylinder ([Ru2L3]
4+).86  Using ruthenium instead of iron metal will increase the 
stability of the compound as well as the fluorescent property. DNA binding studies of the 
ruthenium cylinder show that the ruthenium cylinder binds and coils ct-DNA in a similar 
fashion as the parent cylinder does. It is because both cylinders have the same size, shape 
and charge. Surprisingly, the unwinding angel of the ruthenium cylinder, shown in Table 
1.4, was noticeably less than the parent cylinder ([Fe2L3]
4+).  
 
Table 1.4 Comparison of bending angel and binding constant of the iron and ruthenium cylinder. Taken 
from ref.74-76  
 
Compound Unwinding angel (degree) Kapp (x 10
6
 M
-1
) 
[Fe2L3]
4+ 27±3º 60 
[Ru2L3]
4+ 13±2º 58 
 
This may be the effects emerging from differences in the extent of polarization of 
the protons on the exterior of [Ru2L3]
4+.74 Moreover, [Ru2L3]
4+ exhibits a highly effective 
DNA-photocleavage ability via singlet oxygen (1O2) mechanism. Therefore, this 
compound could be used as specific photoreagents in photodynamic therapy due to a low 
toxicity of the compound in the absence of light and its localized effects.74 Furthermore, 
the cytotoxicity of [Ru2L3]
4+ is drastically different from that of [Fe2L3]
4+. [Fe2L3]
4+ is 
active against an ovarian cancer cell line but [Ru2L3]
4+ is not. This indicates that the 
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mechanism of action of [Ru2L3]
4+and DNA interaction could be different from that of 
[Fe2L3]
4+.83, 86 Another promising strategy for enhancing the specificity of the parent 
cylinder is to attach short amino acids to the end of [Fe2L3]
4+. By this approach, the 
conjugated cylinder will combine the DNA binding properties of the parent cylinder and 
a selectivity property from attached amino acids. The first conjugated cylinder was 
synthesised by Cardo et al.87 Several biophysical experiments were carried out to probe 
DNA-complex interactions. It is shown that the conjugated cylinders are able to coil 
DNA but less effective than that of the parent cylinder (see Section 3.5.2.3 in Chapter 
3). In addition, the stability of conjugated complexes is less stable than that of the parent 
cylinder. The instability of the conjugate complex increases when a long peptide is 
anchored to the parent cylinder. Interestingly, the conjugated compounds also show the 
cytotoxicity to cancer cell lines.88 
 
1.1.4.6 Recognition of DNA junction structure 
Nucleic acid junctions, in RNA and DNA, are unique branched structure 
containing double strand(s) emerging at one point. They can be a perfect junction which 
has Watson and Crick base pairing or with mismatched base pairs.89 Recently, a new 
DNA binding mode defined as DNA junction recognition was reported by Hannon et al. 
Crystallographic studies of a palindromic hexanucleotide DNA and a dinuclear 
tetracationic triple stranded helicate, the iron cylinder, were performed.69 Surprisingly the 
cylinder was found to be located in the hollow cavity of a DNA Y-shaped junction rather 
than simply binding to duplex DNA (Figure 1.27).77  This new binding mode does not 
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cause any changes in the structure of the DNA three way junction or the cylinder, rather 
they seem to be a perfect fit.  
 
 
 
 
 
 
 
Figure 1.27 A) Recognition of DNA three way junction by iron cylinder. B) Face to Face π stacking of 
phenyl rings of the ligand of complex and DNA bases. Taken from ref.34 
 
Several interactions contribute to this recognition:77 electrostatic forces from the 
positive charge of the cylinder to the negative charge of phosphate backbone, and face-
face π stacking interaction from the aromatic surfaces of the cylinder to DNA bases. In 
addition, a hydrogen bond, CH…X formation, between the imine hydrogen and N3 of an 
adenine base occurred. Moreover, the pyrimidine rings are sandwiched in the minor 
groove as seen with minor groove binders. This unprecedented binding mode is of 
particular interest for gene regulation as the replication fork, occurring during the DNA 
replication process, is a Y-shaped junction and the cylinders might therefore be used to 
stop the growth of cancer cells. Indeed, experiments have confirmed that they are active 
against cancer cell lines.83  
 
 
A 
B 
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1.1.4.7 Recognition of quadruplex DNA structure 
Quadruplex DNAs are secondary DNA structures which are assembled from 
guanine-rich sequences usually presented in telomeres.90 Telomeres usually contain 
tandem repeated guanine rich sequences at the 3′ overhang of single stranded DNA, 
present at the end of chromosomes. Telomeres shorten in every cell cycle due to 
incomplete DNA replication of telomeric termini, thus resulting in cell senescence. 
Several studies reveal that a large number of human cancers maintain the elongation of 
telomeres by exploiting the enzyme telomerase, a kind of reverse transcriptase, so the 
cancer cells become immortal.  Aside from telomeres, G-rich sequences that have the 
potential to form quadruplex structures also exist in promoter regions of certain 
oncogenes. This suggests that quadruplex structures may be involved in the regulation of 
gene expression.91 For these reasons, quadruplex structures have been proposed as 
potential new targets for anticancer agents.92, 93 The conventional agents targeted to 
quadruplex structures are mostly organic based compounds. Recently, metal based 
complexes have been considered as synthetic agents due to the fulfillment of the basic 
requirements of designing quadruplex DNA binders. Several advantages can be obtained 
from using metal complexes.94 The quadruplex binding affinity and specificity can be 
easily optimised by changing the geometries and orientation of the complex by changing 
the metal used. The π interaction of the metal to the G-quartet can be increased via the 
electron withdrawing properties of the metal. The presence of positive charge on the 
metal facilitates the stablilisation of a G-quartet by substituting the alkali cation. An 
example of the metal based complex as quadruplex DNA binder is shown Figure 1.28.  
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Figure 1.28 Left: Chemical structure of platinum molecular square. Right: Model of the platinum square 
binding to quadruplex DNA. Platinum complex is shown in blue and grey. Hydrogen bonding to phosphate 
backbone is illustrated as blue dotted line. Taken from ref.95 
 
 
1.2 Introduction to RNA 
1.2.1 The fundamental structure of RNA 
Ribonucleic acid (RNA) is an important biological molecule, consisting of a long 
chain of nucleotides. As mentioned in the previous section, deoxyribonucleic acid (DNA) 
is also made up of nucleotides however RNA is different from DNA in two key chemical 
aspects. The first chemical aspect that renders RNA different from DNA is the bases 
present. Thymine bases (T), present in DNA, are replaced by uracils (U), which have the 
same hydrogen bonding but do not have a methyl group at the 5′ position (Figure 1.29A). 
Secondly, the sugar of RNA has a hydroxyl group (OH) attached at the 2′ position, 
known as ribose sugar while in DNA, it is deoxyribose sugar. The effect of an additional 
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hydroxyl group on the sugar has an effect on the conformation and stability of RNA. 
RNA sugars are much more rigid than DNA sugars, and only adopt the C3′-endo pucker 
conformation as the hydroxyl group at the 2′ position would clash with C8 of purine or 
C6 of pyrimidine attached (Figure 1.29B). Therefore, RNA adopts an A-form geometry 
rather than the B-form which is usually observed in DNA. The A-RNA conformation has 
a narrow and deep major groove and a wide, shallow minor groove (Figure 1.29C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.29 A) Uracil base (U) found only in RNA while Thymine (T) is present only in DNA. B) Sugar 
conformation of nucleic acid: C2 endo Sugar pucker is usually found in DNA while C3 endo sugar pucker 
is found in RNA.96 C) Comparison of the groove of nucleic acids.97  
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C 
Chapter 1 
 40 
The presence of an extra hydroxyl group on the ribose sugar also affects to the 
stability of RNA. RNA is much more susceptible to nucleophilic attack in the presence of 
OH‾ on the 5’-phosphorous atom, thus resulting in breakage of the phosphodiester bond 
on the backbone.  
 
1.2.2 Secondary structures of RNA 
While DNA usually dimerises to form a double stranded structure, RNA 
frequently (but not exclusively) folds up , like a protein, to form a folded but single 
stranded structure. The examples of the secondary structures of RNA that have been 
elucidated are RNA duplexes, hairpins, bulges, loops, mismatches, and RNA junctions 
such as three way junctions and four way junctions.98 These structures are defined with 
respect to the specific hydrogen bonding interaction located in the strands as shown in 
Figure 1.30. In addition some of these secondary structures, partially found in tertiary 
RNA structures, are crucial sites for ligand recognition.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.30 RNA secondary structures: A) Duplex. B) Hairpin loop. C) Single-base bulge. D) Multiple 
base bulge. E) Symmetric internal loop (2:2). F) Asymmetric internal loop (3:2). G) Mismatch loop. H) 
Three way junction. I) Four way junction. Taken from ref.98 
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1.2.2.1 Hairpin loop  
Big hairpin loops (more than four bases) (Figure 1.30B) are found as a 
composition of tRNA while smaller hairpins with four-base loops, termed as tetraloops, 
are usually observed in ribosomal RNAs (rRNAs). Interestingly, unusual base pairing and 
hydrogen bonding can be observed in some tetraloops. For example, the GAAA loop has 
a G-A base pair 99 and the UUYG loop (Y = pyrimidine) has a U-G base pair.100, 101 
Notably, the different tetraloops will provide different structures, therefore offering 
significant unique binding site for targeting by small molecules.  
 
1.2.2.2 Bulges 
The formation of bulges occurs when there is one or more consecutive unopposed 
nucleotide on a strand of a duplex.23 Bulges can have one unpaired nucleotides, called 
single base bulges (Figure 1.30C), or more than one unpaired nucleotide, termed as 
multiple-base bulges (Figure 1.30D). The unpaired bases of the bulge can either point 
into the duplex or out towards the solution, depending on the base category. Furthermore, 
the effect of unpaired nucleotides on RNA structures, for instance a distortion of base 
stacking in the duplex, bending of the helix or the reduction of the duplex’s stability, can 
also differ. This depends on having the appropriate number and composition of bases in 
the bulge.102, 103 Such bulges can open the major groove leading to an easily accessible 
binding site for proteins or small molecules.104 
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1.2.2.3 Internal loops 
An internal loop differs from a bulge by the presence of opposing 
noncomplementary bases. These internal loops can have either symmetric or asymmetric 
loops (defined as X:Y, where X and Y correspond to the number of nucleotides on each 
side of the loop) within the duplex. It may have one or more mismatched loops (Figure 
1.30G, E, respectively) or more unpaired loops (Figure 1.30F) on each strand of duplex 
RNA compared to a bulge. The presence of internal loops enhances the accessibility of 
the major groove of the RNA. It also induces conformational adaptation when a ligand is 
bound.105 
 
1.2.2.4 RNA junctions 
RNA junctions (Figure 1.30H, I) are found when double strand(s) are connected 
together. Three and four way junctions are commonly found however the higher order 
junctions are only observed with low frequency. The junctions can be either perfectly 
paired (rarely found) or most commonly interrupted by mismatched bulges at the point of 
strand exchange. The global structure of RNA four way junctions is different from DNA 
four way junction as well as changes of the structure due to metal ions.106 It demonstrates 
that the RNA junction adopted a 90º cross of helical stacks in the presence of 1 mM 
Mg2+. In the absence of metal ions, a parallel form was observed from the rotation of the 
RNA junctions. Increasing concentration of Mg2+ or using 0.5 mM Ca2+ can change the 
structure of RNA junction into an antiparallel form (Figure 1.31). 
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Figure 1.31 The global structures of RNA four way junction in the presence of different concentrations of 
metal ions. Taken from ref.89 
 
Obviously, the conversion of nucleic acids from DNA to RNA has a significant 
impact to the global folding of four way junction.   It is believed that some differences 
could be from the A-form helix of RNA. The most interesting difference is the structure 
of RNA four way junction in the absence of metal ion. In contrast to the DNA junctions,  
the RNA junctions tended to rotate into a parallel form instead of turning to extended 
form. This suggests that overall electrostatic repulsion in the RNA junction is lower than 
the DNA. The four way junction can be found in U1 snRNA involved in splicing of 
mRNA, hairpin ribozyme23 and tRNA.107, 108 
For RNA three way junctions, its global structure has remained unknown. The 
structures are restricted to specific examples, chosen for a particular study. Regarding to 
the basic stereochemical principle, it would suggest that the folding of RNA three way 
junctions should be similar to that of DNA three way junctions.23 The folding of the 
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perfect RNA three way junction to coaxial stacking would be difficult unless an 
additional bases are added to the point of exchange to increase the flexibility of the 
structure. In addition, most of RNA three way junctions found in 16S and 23S rRNA 
usually have an additional bases in the middle of the junction and it rarely found a perfect 
RNA three way junction. The folding of these junctions would expect to depend on 
divalent metal ions. Examples of RNA three way junction include 5S rRNA109 a 
ribosomal protein binding site in 16S rRNA110 and hammerhead ribozyme.111, 112  
 
1.2.3 Targeting of RNA by a small molecule 
The cellular function of RNA has been elucidated for nearly two decades showing 
that this biomolecule is not simply working as an intermidate between the transcription113, 
114 and translation process.115 It has been reported that RNAs are involved in many vital 
biological processes such as the replication of DNA,90, 116 genetically catalytic activity.117 
The scenario of RNA dependent gene expression process is shown in Figure 1.32. 
RNA is a promising drug target as it has a diverse array of three dimensional 
structures,118 no repair mechanism and easy to access compared to extensively packed 
chromosomal DNA.98  
 
Chapter 1 
 45 
Replication
DNA
Transcription
Processing
Translation
Primary transcript RNA
mRNA
Protein
telomeraase (maintenance of telomeric DNA ends
tRNA primer (reverse transcription of retroviral
genome
virale RNAs
RNA regulatory elements (transcription activation,
antitermination, termination
RNAaseP (5' end cleavage of precursor tRNAs)
snRNAs (splicing, maturation, transport of mRNAs)
viral RNAs (interfering with snRNA function)
self-slicing introns
gRNAs (mRNA editing in trypanosomes)
tRNAs, rRNAs
RNA regulatory elements (translation regulation,
recoding)
 
 
Figure 1.32 Overview of RNA participating in the important processes of gene expression.119 
 
1.2.3.1 Understanding the design of RNA binding molecules 
The concept of molecular recognition, used for DNA binding complexes, was 
initially applied to the study of RNA-small molecule interactions. Intercalators and 
groove binders were among the first compounds analyzed for their RNA binding 
ability.120 However, to achieve the specific RNA recognition, proteins rather than DNA 
need to be examined as it is the three dimensional structure that is the key feature of RNA 
rather than the base sequences as in DNA.119 To understand the specific association 
between small molecules and RNA, a general knowledge of how they interact with RNA 
and which interactions play an important role in the binding specificity is required. The 
major interactions facilitating small molecules and RNA binding will be described herein. 
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The first common interaction is electrostatic forces. The molecules that interact 
with nucleic acid, DNA and RNA usually have a positive charge in order to increase the 
binding affinity to nucleic acids which have a negatively charged phosphate backbone. 
Electrostatic forces can facilitate small molecules to tightly interact with RNA.119  It 
should be noted that the increase of positive charge results in the enhancement of the 
binding affinity but may not enhance the specificity. Therefore electrostatic forces are 
considered as a non-specific interaction.  
The second interaction between small molecules and RNA is hydrogen bonding. 
It has been demonstrated that the hydrogen bonding, observed between the phosphate 
group of the RNA backbone and hydrogen atoms of the small molecule, can contribute 
significantly to RNA-drug binding.119 This interaction was established from intensive 
studies on the complex aminoglycoside, an antibacterial drug used in the clinic, and 
several kinds of RNA such as aptamer RNAs and oligonucleotides derived from the 
rRNA of bacteria.121-123 From the three dimensional structure of the RNA and 
aminoglycoside complex (Figure 1.33), it can be seen that the ammonium and hydroxyl 
group of the drugs behave as hydrogen donors which interact with the oxygen of the 
phosphate backbone of RNA and with N7 and O4 atom of purine and uridine, 
repectively.124, 125 In addition, the hydrogen bonding of a variety of substitution sites on 
the ammonium and hydroxyl groups in aminoglycosides and RNA are distinct in terms of 
strength of interactions. This shows that the hydrogen bonding is a specific interaction 
which can enhance or regulate the binding of the drug to DNA.  
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Figure 1.33 The formation of a hydrogen bond, shown by a dashed line, between donor and acceptor group 
in 16S A site RNA-paromomycin complex. Taken from ref.123, 126 
 
 Another interaction to be considered is shape complementarity and 
conformational adaptation. Shape complementarity, how well a ligand and receptor 
electrostatically and sterically fit together, provides a high binding affinity and high 
specificity for the formation of RNA and small molecule complexes. An example of this 
is the three dimensional structures of RNA aptamer complexes.127, 128  
Conformational adaptation is the changes induced from the binding of small 
molecules to RNA. The changes in conformation of RNA when bound to small molecules 
can be small, such as the binding of A site in rRNA and aminoglycoside, 124 or larger for 
the interaction of HIV TAR RNA  and argininamide.129 Once this molecular interaction is 
understood a small molecule that can prevent the folding of RNA can be designed, in 
which the conformational change is crucial for the biological function of the RNA 
target.130 This is an intriguing strategy for a therapeutic agent.  
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1.2.3.2 RNA binding molecules 
By combining the known functions of RNA and the knowledge of molecular 
interactions between small molecules and RNA, a small molecule that specifically targets 
RNA can be developed. In this section aminoglycosides, well known clinically used 
antibiotics that target RNA, will be reviewed along with examples of RNA binding metal 
complexes.  
 
1.2.3.2.1 Aminoglycoside 
Aminoglycoside antibiotics consist of amino sugars linked at the 4,5 and 4,6 
position of a non-sugar, 2-deoxystreptamine ring (DOS).131 The structures of these 
aminoglycosides are illustrated in Figure 1.34. 
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Figure 1.34 Chemical structures of aminoglycoside antibiotics. The 2-deoxystreptamine ring (DOS) is 
represented in blue. Modified from ref.132 
 
The mechanism of action of aminoglycoside antibiotics involves binding to the 16S 
rRNA of a bacterial ribosome and interfering with its translational fidelity. This was 
discovered almost three decades ago.133 The prokaryotic ribosome, consisting of 
ribosomal RNA and ribosomal proteins, has two subunits which are 30S (small)79 and 
50S (large). The responsibility of the 30S in translation is to ensure that the right amino 
acid from tRNA is incorporated into the peptide chain while the peptide bond formation 
is controlled by the 50S subunit.5 The binding of a cognate tRNA to 16S rRNA, part of 
30S rRNA subuit, induces two residues of adenine, A1492 and A1493 to adopt a 
conformational change while no conformational change is induced by miscognate tRNA 
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(Figure 1.35).134 However, binding of aminoglycoside, the 4, 5 and 4, 6 substituted to 2 
DOS to 16s rRNA i.e. neomycin and paranomycin for 4, 5 substituted and gentamycin, 
tobramycin, amikacin and kanamycin for 4,6 substituted, induces a conformational 
change in the same fashion as cognate tRNA, thus resulting in incorporating the 
noncognate tRNA to the peptide chain.135, 136 The accumulations of error proteins, that 
may not correctly function, leads ultimately to bacteria cell death.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.35 Left: Bacterial decoding site in 16S rRNA. The box shows the aminoglycoside binding site. 
Right: Overlay of the crystal structures of three aminoglycosides with the decoding site RNA. The 
conformational change of 16S rRNA induced by binding of the 2-DOS in aminoglycosides, is depicted. 
Taken from ref.132 
 
Besides ribosomal RNA, aminoglycosides also bind to non-ribosomal RNA.97, 137 
It has been reported that aminoglycoside antibiotics bind to tRNA by displacing the 
divalent metal ion thus resulting in conformational change and inhibition of amino 
acylation.138, 139 Ribozymes including the self-splicing group I intron140, hammer head 
motif141 and ribonuclease P (RNase P)142, 143 are also the target of aminoglycoside 
antibiotics in addition to 16S rRNA. Interestingly, aminoglycoside antibiotics also exhibit 
anti-HIV activity by inhibiting the binding of the HIV-1 Tat protein, essential for 
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promoting transcriptional efficiency, to the bulged region, known as TAR (trans-
activating response element) in RNA.144 Neomycin, one of the aminoglycoside 
antibiotics, has the most potential to prevent the Tat-TAR interaction with an IC50 of 0.92 
µM.145 Moreover, the studies from Green and co-workers in 1993 shows that 
aminoglycoside antibiotics, especially neomycin, has the ability to interrupt the 
interaction of RRE-Rev by binding to RRE with a KD = 100 nM.
146 The inhibition of 
RRE-Rev binding is believed to be one strategy to prevent the viral replication and 
maturation.147  
 
1.2.3.2.2 Metal complexes 
The use of inorganic metal complexes to target RNA has several advantages. 
They are relatively easy to synthesise and the ligands or metal can be altered allowing 
control of the shape, RNA recognition properties and reactivity of the complex.98 Due to 
the benefits that can be attained from metal complexes, many researchers have currently 
been focused on synthesising metal complexes that target RNA. Some of these metal 
complexes will be exemplified.  
A metal complex binding to naturally structured RNA was initially synthesised by 
Barton et al. in 1990. In this study, tris (1,10-phenantroline)ruthenium (II) [Ru(phen)3]
2+ 
and tris (3,4,7,8-tetramethylphenantholine)ruthenium (II) [Ru(TMP)3]
2+ (Figure 1.36) 
were exploited for the recognition of tRNAPhe as photocleavagers. [Ru(phen)3]
2+ and 
[Ru(TMP)3]
2+ were shown to cleave tRNA preferentially at guanine residues. In addition, 
two different patterns of cleavage were observed for the two ruthenium complexes. This 
shows that different selectivities for a different site can be obtained by the different 
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binding characteristics resulting from different molecular shapes.148 In addition, these 
complex also bind to DNA.  
 
Figure 1.36 Chemical structures of rhodium and ruthenium polypyridal complexes.  
 
Utilising rhodium metal instead of ruthenium provides the ability of direct strand 
scission by the complex rather than cleavage by diffusible reactive species. Additionally, 
Barton and co-workers studied photocleavage of yeast tRNAPhe by the rhodium 
complexes ([Rh(DIP)3]
3+ and [Rh(phen)2phi]
3+ (Figure 1.36). The studies of 
[Rh(DIP)3]
3+ and tRNAphe show that the addition of the phenyl group substituents to the 
phenanthroline ring of the rhodium complex enhances the specificity of RNA binding. 
Also it has two major recognition sites which are pseudouracil 55 residue (ψ55) in the 
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pocket between two loop areas of the tRNA. This is similar to the cleavage site of this 
compound on DNA cruciforms.149 The second site is 3’side of a wobble-paired U residue 
(G-U mismatch) within the double helix region of RNA (Figure 1.37).  
 
 
 
 
 
 
 
Figure 1.37 Map of cleavage sites of ruthenium and rhodium complexes on the three dimensional structure 
of tRNAphe. Left: Cleavage by [Ru(phen)3]
2+ and [Ru(TMP)3]
2+. Black circles represent guanine residue cut 
by both complexes. Half black and white circles depict the guanine residue cut by [Ru(phen)3]
2+. White 
circles illustrate the guanine residue which is not cleaved by both complexes. Right: Cleavage by 
[Rh(phen)2phi]
3+ (black circles) and [Rh(DIP)3]
3+ (white circles). Taken from ref.148 
 
For [Rh(phen)2phi]
3+, the interesting results show that in the presence of a 
denaturing agent no cleavage is observed at the specific site. This indicates that the 
natural structure of RNA is required for the recognition of the complex and RNA. 
Moreover, [Rh(phen)2phi]
3+ demonstrates that it can target a unique region, the triple 
bonded sites in tRNA. It can also recognise 5S rRNA of Xenopus oocyte which is crucial 
for binding by the transcription factor IIIA (TFIIIA).150 This might lead to a gene 
regulation application. Moreover, another example of an octahedral metal complex, 
believed to be the first example with sequence specificity for simple duplex RNAs due to 
the chirality of complexes, is the eilatin-containing Ru (II) complex ([Ru(bpy)2Eilatin]
2+) 
(Figure 1.38).151 Eilatin is a bifacial metal chelator, consisting of a fused heptacyclic. In 
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vitro studies show that [Ru(bpy)2Eilatin]
2+ has remarkable anti-HIV activity by inhibiting 
Rev-RRE activity, which is an important mechanism for viral replication. 
 
 
 
 
 
 
 
 
 
 
Figure 1.38 Top: Chemical structure of Λ-[Ru(bpy)2Eilatin]
2+ and ∆-[Ru(bpy)2Eilatin]
2+. Bottom: RNA 
target of both complexes: RRE and TAR. Modified from ref.151  
 
Interestingly, [Ru(bpy)2Eilatin]
2+ shows enantiomeric selectivity to its RNA 
target, RRE and TAR, providing a promising strategy for antiviral activity. It has been 
demonstrated that Λ-[Ru(bpy)2Eilatin]
2+ prefers to bind to RRE (Rev Response Element) 
while TAR (Transactivation response Region) is the target for ∆-[Ru(bpy)2Eilatin]
2+ 
(Figure 1.38). The planarity of the eilatin moiety is crucial for the recognition of anti-
HIV activity and affinity of these complexes.   
Besides therapeutic agent, metal complex can be used as a probe to detect the 
localisation of RNA in cells. Turro et al. reported a RNA imaging probe, RuEth.152 It 
consists of a phenanthridine moiety covalently linked to a ruthenium(II) isothiocyanate 
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modified complex, RuITC (Figure 1.39). RuEth was obtained by the reaction of RuITC 
with an amine functionalised ethidium derivative. This compound combines several 
attractive advantages including RNA binding property, the ability to enhance 
fluorescence intensity and lifetimes from phenanthridine unit and ruthenium bipyridine 
complexes, repectively.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.39 A) Chemical structures of ruthenium isothiocyanate (RuITC; left) and the RNA probe RuEth 
(right). B) Optical (a) and fluorescence (b) microscope images of RuEth uptake into mammalian cells. 
Taken from ref. 152 
 
In addition, uptake experiment of this compound into mammalian cells showed that the 
compound give a great signal in regions of cells where RNA localise. An image from a 
fluorescence microscope indicated that a maximum fluorescence intensity of the 
compound was detected in the nucleous, a dense region of RNA, and cytoplasm where 
mRNA is present but less detected in the nucleus where DNA is located.  
A 
B 
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 Cisplatin (cis-diammine-dichloroplatinum (II), cis-[Pt(NH3)2Cl2]) is a well known 
metal complex, used in the clinic as an anticancer drug against a variety of tumors such as 
testicular, ovarian, esophageal, head and neck and lung cancer, see Section 1.1.4.2.153 It 
is known to bind to the N7 position of adjacent purine (guanine and adenine) bases of 
genomic DNA, causing intrastrand crosslinking on the DNA.154 This binding fashion has 
been significantly linked to the induction of apoptosis and antitumor activity. Several 
studies have intensively focused on the interaction of cisplatin and DNA however studies 
with RNA have been only recently been considered. These investigations show that 
cisplatin has the ability to interfere with the transcription process of RNA by blocking 
RNA polymerase.155, 156 Cisplatin can also inhibit splicing157 and translation at the initial 
step by preventing the association of the 60S ribosomal to the 48 S preinitiation 
subunit.158 Moreover, Elmroth and co-workers demonstrated that cisplatin is able to bind 
to the site near a G-U wobble pair at the stem of tRNAAla.159, 160 Cisplatin also has the 
ability to inhibit the self splicing activity of ribozyme.161 Recently, Chow et al. revealed 
that cisplatin can be used as a structural probe to identify accessible purine bases in 16S 
rRNA of bacteria both in vitro and in vivo.162 The accessibility of ribosomes may provide 
a new target sites for novel antibacterial agents.162 Furthermore, the studies from 
Hostetter and co-workers indicated that cisplatin is capable of crosslinking at internal 
loop of complex RNA.163 Very recently, Chapman and colleagues showed that the 
platination of RNA can alter the function of RNA processing enzymes including 
exonuclease, endoribonuclease (RNase) and reverse transcriptase, in a sequence specific 
pattern. It is assumed that this in vitro investigation may also occur in vivo which may 
explain the antitumor activity of the platinum drug at the cellular level.164  
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1.3 DNA nanotechnology 
1.3.1 Background 
Technology to manipulate and control a substance at nanometer (nm) level (1 nm 
= one billionth of a meter) using atoms and molecules to create new materials and devices 
with intriguing functions is known as “Nanotechnology”.165 This topic is a highly 
multidisciplinary field involving areas such as biology, chemistry, physics and computer 
science.  
There are two main approaches employed in nanotechnology165: one is the “top-
down” approach where nano-devices are built from larger entities without atomic-level 
control. Nano-lithography is a good example of this approach. Another is the “bottom-
up” approach where materials and objects are constructed from molecular components 
which assemble themselves by using principles of molecular recognition. One interesting 
example of this second approach is DNA nanotechnology, in which DNA is utilised as a 
component to precisely construct desired objects. This shows that DNA is not only 
considered as a genetic material for storing and transmitting the blue prints of life but also 
a tool for programmable architectures due to its reliable base pairing. In this section, 
structural DNA nanostructures will be presented. 
 
1.3.2 Considering DNA as a material for construction 
DNA has several attractive properties for use as a material for nanotechnological 
construction.166-169 Firstly, it provides a programmable and reliable construction from the 
recognition of purine and pyrimidine, known as Watson and Crick base pairing. A binds 
to T while C binds to G with double and triple hydrogen bonding, respectively. Secondly, 
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with phosphoramidite chemistry, any arbitrary sequence of DNA can be synthesised and 
modified by attaching biotin or a fluorescent dye to the DNA. Thirdly, since the 
geometries and properties of DNA have been intensively studied, the stiffness and 
flexibility of the DNA can be easily adjusted by controlling the number of bases. This 
property of DNA is one of the key successes in controlling the DNA nanostructure to 
achieve a desired architecture. As mentioned in the literature, double stranded DNA can 
behave as a rigid rod with a persistence length of 50 nm (approximately 150 bps) while 
the flexibility of the desired structure can be increased by the single stranded DNA with a 
persistence length of 1-2 nm. Therefore, the flexibility and rigidity of the nanostructure 
can be adapted by changing the length of the DNA. Finally, the commercial availability 
of a number of enzymes used in biotechnology such as restriction enzyme, DNA ligase 
and kinase can be used as a tool for either probing and confirming the formation of the 
desired DNA construction or modifying the structure.  
 
1.3.3 DNA nanotechnology architectures 
1.3.3.1 Two dimensional DNA structures.  
The initial work of structural DNA nanotechnology was firstly carried out by 
Seeman and co workers in the early 1980s. Inspired by nature, Seeman et al. exploited 
the branched junction motif, found as intermediates in DNA replication and 
recombination, i.e., four way junction or Holliday junction, as a building block to 
construct a DNA structure.170 The junction was well designed to avoid the migration of 
the branched point, which can cause instability of the junction, by eliminating the 
symmetry which can occur in the sequences.171 The first study for constructing higher 
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order DNA nanostructures was begun by ligating the sticky end of a four way junction to 
achieve quadrilateral lattices (Figure 1.40). However it was not possible to assemble this 
branched junction into defined 2D and 3D structures due to the flexibility of the junction 
arm. Later, the same group created a well defined double cross over motif (DX), 
considered as the first DNA building block for self assembly of 2D structures (Figure 
1.40). This motif contains two double DNA strands connected at two crossover points by 
sticky end ligation in a parallel and antiparallel arrangement.172 This approach 
subsequently generated three and four double helix cross overs.173  The benefit obtained 
from this motif is the increase of the double stranded DNA rigidity in the structure.  
 
Figure 1.40 Primary DNA building blocks for DNA nanostructure constructions. A) Branched point DNA 
with four helical arms, four way junction. B) The formation of 2D lattice from four way junction with 
sticky end cohesion approach. C) Double cross over tile. D) Triple cross over tile. Taken from ref.172, 174 
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These simple foundations have been amended and developed to generate other building 
blocks, providing various highly controllable 2D structures such as hexagonal,175 
square176, 177 and triangular-shaped DNA lattice178 and helix bundle (Figure 1.41).179 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.41 Building block units and their 2D DNA nanostructure. A) 3, 4 and 6 arm junctions, assembling 
from cross over tile, as a unit for generating 2D hexagonal, square and compound lattice. B) Triangular 
DNA building block flanked with sticky end to build triangular shaped DNA lattice. C) 6 and 8 membered 
helix bundle for helical tube assembly. Modified from ref.180 
 
Recently, Rethemund et al. presented a novel approach to generate a defined DNA 
nanostructure, known as DNA origami (Figure 1.42). In this strategy, a long single strand 
of DNA is folded into a large number of different desirable shapes facilitated by short 
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complementary DNA strands termed staple strands. These short strands hold the DNA 
assembly via strand exchange crossover. Examples of 2D DNA nanostructures made 
using this method are squares, rectangles, stars, smiley faces, and triangles with 
rectangular domains.  
 
 
 
 
 
 
Figure 1.42 DNA origami. Left: The folding of DNA origami from a continuous single strand of DNA 
(black line) to a desired structure. Shape of DNA was maintained by a stappling strands (shown in several 
colours). Right: 2D architectures generated from DNA origami approach including a star, a smiling face 
and a triangle. Taken from ref.180 
 
1.3.3.2 Three dimensional DNA objects 
The first three dimensional DNA nanostructure was a cube-like object, 
constructed by Seeman et al. This structure was assembled from 6 interconnected cylic 
DNA strands by ligation strategy, however with a yield lower than 1%.181 Consequently, 
the same group used a stepwise solid phase synthesis for constructing a truncated DNA 
octahedron, to avoid the difficult purification step in the synthetic procedure.182 Recently, 
Turberfield and co-workers synthesised tetrahedral and bipyramid shaped DNA 
nanostructures by hybridising multiple strands of DNA in one step.183-185 This DNA 
nanostructure was later used as a cage to encapsulate a protein molecule.186 Sleiman and 
co-workers introduced a new strategy in which the rigid organic molecules used as the 
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vertices can modulate the discrete formation of 3D DNA objects such as a triangular 
prism, cube, pentameric prism, hexameric prism, heteroprism and biprism in a reasonable 
yield.187, 188 Very recently, Andersen et al. generated a nanobox from the DNA origami 
strategy. This nanobox has a controllable lid responding to a specific key. This nanobox 
can be a promising vehicle for drug delivery due to its internal cavity, and the lid for 
loading and releasing a drug at the target.189 All three dimensional DNA nanostructures 
are shown in Figure 1.43  
 
 
 
Figure 1.43 3D DNA nanostructures. A) DNA cube.169 B) DNA truncated octahedron.182 C) DNA 
tetrahedron and their AFM images.185 D) DNA bipyramid.183 E) 3D DNA constructions of triangular prism, 
cube, pentaprism, heptaprism, heteroprism and biprism.188 F) DNA nanobox with their AFM images.189  
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1.4 Overview of thesis 
The goal of this thesis is to explore how the metallosupramolecular cylinders 
interact with a range of different nucleic acid structures including DNAs, RNAs, DNA-
RNA hybrids and DNA nanostructure. This PhD thesis will be divided into four 
experimental chapters as described below.  
In Chapter 2, the recognition by the metallosupramolecular cylinder and its 
enantiomers and the stabilisation of RNA three way junctions will be investigated. As 
previously mentioned in Chapter 1 (Section 1.1.4.6) that the cylinder can also bind to the 
core cavity of DNA three way junctions, the competition assay of nucleic acid to the 
cylinder is also carried out.  
In Chapter 3, exploring the appropriate size and shape of the cylinder for the 
enhancement of the recognition to a DNA three way junction will be discussed.  
In Chapter 4, the effect of the cylinder on the structural alteration of a very rigid 
DNA tetrahedron will be shown. 
In Chapter 5, the establishment of using SPR technique for precisely determining 
the binding affinity of the cylinder to DNA will be presented.  
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2.1 Introduction 
The recognition of DNA three way junctions by the metallosupramolecular 
cylinder has been demonstrated and confirmed by several experiments such as X-ray 
crystal structure
1
, NMR study
2
 and gel electrophoresis.
3
 However, a three way 
junction can occur not only in DNA but also in RNA (see Section 1.2.2.4).  
RNA is involved in many steps of gene replication and expression
4
 however it 
has been focused on as a drug target only recently.
5-7
 RNA is an attractive drug target 
and has intriguing features such as offering a high accessibility compared to 
extensively compact chromosomal DNA, no RNA repair mechanisms and the 
diversity of three dimensional folds.
8
 The latter plays a crucial role in RNA’s  
biological functions and allows rational design of therapeutic compounds which bind 
specially to RNA folds. To achieve specific RNA recognition, there are several 
molecular interactions that can contribute and need to be considered, such as 
electrostatic forces
9
, H-bond formation
10
 and interactions such as π-π stacking.
11
 The 
shape complementarity (how well a ligand and receptor fit together) and 
conformational changes (binding induced changes in both the ligand and effector) in 
RNA also provide a key driving force for specific binding. The complexes should 
ideally bind only in a specific site rather than unspecific sites. In addition, design of a 
therapeutic agent that inhibits the conformational change required for the biological 
functions of the target, is a promising strategy in the search for therapeutic 
compounds.
12
 
In this chapter the recognition between the supramolecular cylinder, 
[Fe2L3]Cl4, and the RNA three way junction mainly by gel electrophoresis is 
investigated. Initially, the binding of the cylinder to the RNA three way junction is 
confirmed by circular dichroism. Then the stabilisations of the RNA three way 
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junction, bulged RNA three way junction and RNA-DNA hybrid by the iron cylinder, 
are probed by gel electrophoresis. Furthermore, a competition assay is established to 
investigate the preferential binding of the iron cylinder to nucleic acid, the DNA and 
RNA three way junction. 
 
2.2 Results and discussion 
2.2.1 Circular dichroism  
To initially confirm the binding of the iron triple stranded helicate to an RNA 
three way junction, a CD experiment was carried out. The sequences used in this 
chapter were adapted from the DNA three way junction.
3
 The same length and 
sequences are used however uracil is used instead of thymine as shown below (Figure 
2.1). 
 
Figure 2.1 The schematic drawing of the oligonucleotide sequences used to assemble a three way 
junction. Left: DNA three way junction. Right: RNA three way junction. The numbers shown are the 
bases in each nucleic acid strand. A asterisk is the position where 32P is incorporated for labelling. 
 
Circular dichroism (CD) is a well known spectroscopic technique for detecting 
the change in structural conformation of nucleic acids induced by a synthetic agent.
13
 
A stock solution (700 µM) of the racemic mixture of the cylinder was titrated into a 
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preformed S1, S2 and S3 of RNA three way junction solution (10 µM) in which the 
RNA concentration was kept constant during the titration. It should be noted that the 
racemic mixture of the cylinder has no CD signal in the MLCT region due to the 
symmetry of the components.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 CD and UV spectra (left and right, respectively) of 10 µM RNA three way junction in 
buffers of 0.89 mM Na-cacodylate (pH 7.0) and 20 mM NaCl with increasing concentration of the iron 
cylinder (legends show increasing ratio of complex and RNA three-way junction). 
 
The CD spectra show that in the absence of the iron cylinder, an A-form RNA 
was obtained confirmed by the characteristic pattern from 220-300 nm and the 
maximum signal at 260 nm. During the titration, the CD spectra (Figure 2.2, Left) 
show that in the presence of the cylinder, the spectroscopic signature of the RNA 
(below 300 nm) is not dramatically altered demonstrating that the RNA arms have 
retained their A-conformation. The appearance of induced CD signals (ICD) in the 
region 450-650 nm corresponding to the MLCT of cylinder indicates a binding event 
of the cylinder to the RNA three way junction. The corresponding UV-Vis spectra 
(Figure 2.2, Right) show no effect on the MLCT region of the cylinder (450-650 nm) 
confirming that the cylinder retains its structure.  
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2.2.2 The RNA three way junction induced by the iron cylinder [Fe2L3]
4+
 
(L=C25H20N4) 
The first crystallographic study that demonstrated the recognition of the iron 
cylinder and a DNA three-way junction, used a palindromic hexamer; a junction with 
short arms [three base pairs (bps)].
1
 Initial gel electrophoresis studies used a DNA 
three way junction that was formed from three distinct DNA strands, each of which is 
a 14-mer non palindromic oligonucleotide.
3
  The minimum length of DNA required 
for a three way junction lacking unpaired bases to stay stable during electrophoresis 
on a native gel at 5°C is seven base pairs per arm as shown previously.
14
 Therefore, to 
begin probing recognition and stabilisation of the iron cylinder to the RNA three way 
junction by gel electrophoresis, the sequences shown in Figure 2.1, Right were 
employed. These ribonucleotides have the same length as used in DNA three way 
junction experiments.  
The autoradiogram of the electrophoresis gel run at 4 °C (Figure 2.3) shows 
the formation of the RNA three way junction from 14-mers ribonucleotide in the 
presence and absence of magnesium chloride (10 µM), which is known to stabilise 
three way junctions at low to intermediate ionic strengths.
14, 15
 This implies that the 
oligoribonucleotides have the ability to form the RNA three way junction regardless 
of whether magnesium chloride is present or not. Increasing the concentration of the 
tetracationic iron cylinders, the bands corresponding to the RNA three way junction 
became stronger. This indicates that the tetracationic iron cylinder has the ability to 
induce as well as stabilise the three way junction.  
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Figure 2.3 Autoradiogram of the gel run on nondenaturing 15% polyacrylamide gel at 4 °C. Lane 1: 
Positive control consisting of 10 nM of S1, S2 and S3 in TBN buffer with 10 µM MgCl2. Lanes 2-4: 
Control containing S1, S1+S2 and S1+S2+S3 of RNA in the buffer. Lanes 5-6: Control containing S1 
and S1+S2 of RNA in the buffer with [Fe2L3]
4+
 ratio 3:1 (RNA strand:cylinder). Lanes 7-10: Sample 
containing S1, S2 and S3 in the buffer with increasing the concentrations of the cylinder from 3:0.5, 
3:1, 3:2 and 3:10 corresponding to 5, 10, 20 and 100 nM, respectively. Lane 11: Negative control 
containing S1, S2 and S3 of RNA in the buffer with [Fe2 (L-CF3)3]
4+
 ratio 3:1 (RNA strand:cylinder).  
 
To further explore the importance of the shape and size of the cylinder, a 
bulky cylinder [Fe2(L-CF3)3]
4+
 (Figure 2.4) was introduced. The bulky cylinder was 
used as a control since it has the same electrostatic charge but can not bind at centre 
of a three way junction due to additional CF3 groups protruding from the carbon in the 
middle of the parent ligand. Interestingly in the presence of the bulky cylinder, a three 
way junction was formed. This unexpected band might be due to self formation of the 
RNA three way junction together with unspecific binding effects at low temperature. 
Therefore, the experiment was carried out again at 25 °C in order to inhibit self 
formation of the three way junction and remove any unspecific binding effects. 
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                                   A                                                                        B 
Figure 2.4 Schematic drawing of the ligands (top) and iron metallosupramolecular cylinders (bottom) 
used in this chapter. A) [Fe2L3]Cl4, L = C25H20N4. B) [Fe2 (L-CF3)3]Cl4 or bulky cylinder. 
 
The result of the gel experiment performed at 25 °C (Figure 2.5) demonstrates 
that an RNA three way junction alone is inherently less stable. Neither magnesium 
chloride nor bulky cylinder causes stabilisation of the structure. Note that a band 
corresponding to a three way junction in the presence of magnesium chloride is a 
three way junction formed from self assembly of RNA. On the other hand, the three 
way junction was formed in the presence of the iron cylinder. This implies that the 
iron cylinder does induce and stabilise the RNA three way junction during 
electrophoresis. Lane 11 shows the negative control; an RNA three way junction with 
the bulky cylinder. The result (Figure 2.5) shows that there was still a band 
corresponding to three way junction in the presence of the bulky cylinder, however it 
was weaker than the PAGE performed at 4 °C. Nevertheless, the quantification 
indicated that the intensity of the band was similar to the lane containing only three 
strands of RNA. This demonstrates that the band is not due to the bulky cylinder but 
rather from self assembly of RNA. The result also shows that no frayed duplex RNA 
was formed at 25 °C even in the present of divalent salt (10 µM MgCl2) nor the iron 
cylinder.  
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It is possible that the stabilisation of the fraying RNA three way junction by 
the iron cylinder is not as strong as the stabilisation from the perfect three way 
junction. Therefore, the interaction force stabilising the complex and the junction is 
not great enough to hold the two strands together during electrophoresis so it 
dissociates.  
 
 
Figure 2.5 Autoradiogram of the gel performed on nondenaturing 15% polyacrylamide gel at 25 °C. 
Lane 1: Positive control consisting of 10 nM S1, S2 and S3 in TBN buffer with 10 µM MgCl2. Lanes 2-
4: Control containing 10 nM S1, S1+S2 and S1+S2+S3 of RNA in the buffer. Lanes 5-6: Control 
containing S1 and S1+S2 of RNA in the buffer with [Fe2L3]
4+
 ratio 3:1 (RNA strand:cylinder). Lanes 7-
10: Sample containing S1, S2 and S3 in the buffer with increasing concentration of cylinder from 3:0.5, 
3:1, 3:2 and 3:10 corresponding to 5, 10, 20 and 100 nM, respectively. Lane 11: Negative control 
containing S1, S2 and S3 of RNA in the buffer with [Fe2 (L-CF3)3]
4+
 ratio 3:1 (RNA strand:cylinder).  
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It can be seen (Figure 2.5) that increasing the iron cylinder concentration does 
enhance the formation of the RNA three way junction. To investigate this further, the 
quantification of lanes 7-10 on the gel (Figure 2.5) were examined.  
 
Figure 2.6 Plot of percentage of RNA three-way junction carried out at 25 °C as a function of the iron 
cylinder concentration. The result represents the mean of three individual experiments ± SD (n = 3). 
 
As shown in Figure 2.6, the RNA three way junction remarkably formed 
when the concentration of the iron cylinder increased. Interestingly, the plot started to 
level off at 20 nM corresponding to the ratio of RNA to cylinder 3:2 which was more 
than the expected ratios of RNA strand to cylinder 3:1 corresponding to 10 nM. This 
implies that at high concentration of the cylinder, the specificity of the iron cylinder to 
the three way junction decreases as it can bind to the arm of the RNA three way 
junction. 
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2.2.3 The RNA three way junction assembled by the ruthenium cylinder 
[Ru2L3]
4+
 (L=C25H20N4) 
The previous section has shown that the triple stranded helicate iron cylinder 
binds to the RNA three way junction. It has also been demonstrated that the size and 
shape of the cylinder is crucial for molecular recognition. The triple stranded 
ruthenium cylinder was chosen to compare the stabilisation and recognition of RNA 
three way junction versus the iron cylinder as it has a similar size and shape but 
contains a different metal. This ruthenium complex has fluorescence properties and is 
used for visualising the nuclei in tumor cells and monitoring the changes of tumor 
cells in real time. Therefore, it is an attractive alternative for future application. 
Moreover, the ruthenium cylinder exhibits similar DNA binding properties to the iron 
cylinder, however the cytotoxicity is drastically different.  This compound has been 
indicated to be inactive against an ovarian cancer cell line compared to the parent 
cylinder.
16, 17
 Obviously, the ruthenium cylinder might have a different mode of action 
from the parent cylinder. To further explore this, experiments were carried out with 
the RNA three way junction and the ruthenium cylinder. 
 
 
 
Figure 2.7 An overlay of the crystal structure
16
 illustrations of  the iron cylinder in red ([Fe2L3]Cl4, L = 
C25H20N4) and ruthenium cylinder in yellow ([Ru2L3]Cl4, L= C25H20N4). 
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Figure 2.8 Autoradiogram of the gel carried out on nondenaturing 15% polyacrylamide gel at 4 °C. 
Lane 1: Positive control consisting of S1, S2 and S3 in TBN buffer with 10 µM MgCl2. Lanes 2-4: 
Control containing 10 nM S1, S1+S2 and S1+S2+S3 of RNA in the buffer. Lanes 5-6: Control 
containing S1 and S1+S2 of RNA in the buffer with [Ru2L3]
4+ ratio 3:1 (RNA strand:cylinder). Lanes 
7-10: Sample containing S1, S2 and S3 in the buffer with increasing the concentration of the cylinder 
from 3:0.5, 3:1, 3:2 and 3:10 corresponding to 5, 10, 20 and 100 nM, respectively. Lane 11: Negative 
control containing S1, S2 and S3 of RNA in the buffer with [Fe2 (L-CF3)3]
4+
 ratio 3:1 (RNA 
strand:cylinder). 
 
The results of the autoradiogram at 4 °C show that three way junction was 
formed in the absence and presence of the ruthenium cylinder i.e. lanes 4, 7, 8, 9 and 
10. These bands correspond to the three way junction as they are located at the same 
position as the positive control (lane 1). Unexpectedly, the three way junction was 
observed in the negative control containing the bulky cylinder, even though the size 
and shape of the cylinder is not expected to induce three way junction formation. As 
has been mentioned in the previous section, these are the effects of non specific 
binding at low temperature. Therefore, the experiment carried out at 25 °C was 
undertaken.  
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Figure 2.9 Autoradiogram of the gel run on nondenaturing 15% polyacrylamide gel at 25 °C. Lane 1: 
Positive control consisting of S1, S2 and S3 in TBN buffer with 10 µM MgCl2. Lanes 2-4: Control 
containing 10 nM S1, S1+S2 and S1+S2+S3 of RNA in the buffer. Lane 5-6: Control containing S1 
and S1+S2 of RNA in the buffer with [Ru2L3]
4+
 ratio 3:1 (RNA strand:cylinder). Lanes 7-10: Sample 
containing S1, S2 and S3 in the buffer with increasing the concentration of the cylinder from 3:0.5, 3:1, 
3:2 and 3:10 corresponding to 5, 10, 20 and 100 nM, respectively. Lane 11: Negative control 
containing S1, S2 and S3 of RNA in the buffer with [Fe2 (L-CF3)3]
4+
 ratio 3:1 (RNA strand:cylinder).  
 
The results of the experiment at 25 °C (Figure 2.9) shows that only bands 
corresponding to single strand RNA and three way junction were detected. As with 
the iron cylinder, none of the fraying Y-shaped junction and duplex RNA was 
observed. A possible explanation for this is that the running temperature is higher than 
the melting temperature of the duplex (11.5 °C), thus the cylinder is not capable of 
stabilising Y-shaped junction. Eventually, it dissociates and is not detected on the 
autoradiogram.  
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The RNA three way junction was observed with various intensities, which increase 
with increasing concentration of cylinder (from 3:0.5, 3:1, 3:2 to 3:10 (RNA 
strand:cylinder) corresponding to 5, 10, 20 and 100 nM, respectively). The bands 
were quantified and a graph was plotted to compare the RNA three way junction 
induced from the ruthenium cylinder and those from the iron cylinder (Figure 2.10). 
 
Figure 2.10 Plot of percentage of RNA 3WJ formed at 25 °C versus the concentration of iron and 
ruthenium cylinder. The result represents the mean of three individual experiments ± SD (n = 3). 
 
The plot shows that the ability of the ruthenium cylinder to induce three way 
junction formation is greater than the iron cylinder. Considering the size and shape are 
the same, perhaps the metal plays an important role in the binding and stabilisation of 
the RNA three way junction. It would be interesting in the future to explore further 
about the effect of different metals coordinated to the ligand (C25H20N4) on the 
stabilisation of the RNA three way junction. 
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2.2.4 The effect of enantiomers of the iron cylinder [Fe2L3]
4+
 (L=C25H20N4) on the 
stabilisation of the RNA three way junction 
The iron cylinder is a helical molecule, thus has two enantiomers, termed 
M and P  for the left and the right handed helicate, respectively. Both enantiomers are 
easily separated by a cellulose column as stationary phase and 20 mM NaCl as 
eluent.
18
 Both enantiomers have different DNA binding properties. The M enantiomer 
has a stronger binding affinity to DNA than the P enantiomer.
19
 Moreover, the crystal 
structure of the DNA three way junction demonstrates that only the M enantiomer is 
located in the heart of the DNA three way junction, although the racemic mixture was 
used in the crystallisation approach.
1
 Furthermore, the recent gel electrophoresis 
studies demonstrate that the M enantiomer has a higher ability to stabilise a DNA 
three way junction than the P enantiomer.
3
  
To further investigate this, the binding of the enantiomerically pure iron 
cylinder to the RNA three way junction was carried out at 4 °C and 25 °C on a 15% 
polyacrylamide gel electrophoresis. It should be noted that following experiments and 
the discussion in this section will mainly focus on the results at 25 °C rather than 4 
°C, due to the non-specific binding and self assembly of RNA at 4 °C. (see Section 
2.2.2 and 2.2.3) 
The different effect of the two enantiomers on the gel results at 25 °C (Figure 
2.12B) were not readily apparent by eye. In addition, the quantification results 
(Figure 2.12C) reveal that there was not significantly different between the binding 
of M enantiomer and P enantiomer to the RNA three way junction at the range of 0.1 -
 0.4 µM. Recently, the crystal structure of the RNA three way junction and the iron 
cylinder has been achieved by Joachim Schnabl and Dr. Eva Freisinger, our 
collaborator working with Professor Roland K.O. Sigel from The University of 
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Zurich, Switzerland (unpublished result). The crystal structure reveals that the M 
enantiomer is located at the heart of the RNA three way junction as shown in Figure 
2.11. Interestingly, the crystal was grown from the racemic mixture of the iron 
cylinder. Unexpectedly, the result achieved from the gels was conflicted to the 
crystallographic result that M and P enantiomer has no preferent binding to the RNA 
three way junction. It could be possible that in crystallographic approach, the 
concentration of the cylinder and RNA are much higher (mM) than that used for gel 
experiment (nM). This might affect to the recognition in term of thermodynamic. The 
further results and discussion about the concentration of RNA and cylinder will be 
discussed in Section 2.2.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 Crystal of the RNA-[Fe2L3]
4+
 complex. A) The diffraction pattern of the RNA three way 
junction and the iron cylinder complex. B) RNA three-way junction (grey ribbon) formed around a 
[Fe2L3]
4+
 cylinder (magenta) with additional terminal cylinder molecules (green). C) Three RNA three-
way junctions arranged around the additional cylinder molecule (green). D) X-ray structure of DNA 
three way junction with [Fe2L3]
4+
. 
1
  E) Crystal structure of RNA three way junction with [Fe2L3]
4+
.
20
D 
E 
A 
B 
C 
C
h
ap
te
r 
2
 
 
9
3
 
A
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
             
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
F
ig
u
re
 2
.1
2
 
A
u
to
ra
d
io
g
ra
m
 o
f 
th
e 
R
N
A
 t
h
re
e 
w
ay
 j
u
n
ct
io
n
s 
an
d
 e
n
an
ti
o
m
er
s 
o
f 
th
e 
ir
o
n
 c
y
li
n
d
er
 
p
er
fo
rm
ed
 o
n
 a
 1
5
%
 p
o
ly
ac
ry
la
m
id
e 
g
el
 a
t 
4
 °
C
 (
A
) 
an
d
 a
t 
2
5
 °
C
 (
B
),
 r
es
p
ec
ti
v
el
y
. 
L
an
es
 1
-3
: 
C
o
n
tr
o
l 
co
n
ta
in
in
g
 S
1
, 
S
1
+
S
2
 a
n
d
 S
1
+
S
2
+
S
3
 o
f 
R
N
A
 i
n
 T
B
N
 b
u
ff
er
. 
L
an
e 
4
: 
P
o
si
ti
v
e 
co
n
tr
o
l 
co
n
si
st
in
g
 o
f 
1
0
 
n
M
 S
1
, 
S
2
 a
n
d
 S
3
 i
n
 t
h
e 
b
u
ff
er
 w
it
h
 1
0
 µ
M
 M
g
C
l 2
. 
 L
an
es
 5
-6
: 
C
o
n
tr
o
l 
co
n
ta
in
in
g
 S
1
 a
n
d
 S
1
+
S
2
 o
f 
R
N
A
 i
n
 t
h
e 
b
u
ff
er
 w
it
h
 M
 e
n
an
ti
o
m
er
 r
at
io
 3
:1
 (
R
N
A
 s
tr
an
d
:c
y
li
n
d
er
).
 L
an
es
 7
-1
0
: 
S
am
p
le
 c
o
n
ta
in
in
g
 
S
1
, 
S
2
 a
n
d
 S
3
 i
n
 t
h
e 
b
u
ff
er
 w
it
h
 i
n
cr
ea
si
n
g
 r
at
io
s 
o
f 
M
 e
n
an
ti
o
m
er
 f
ro
m
 3
:0
.5
, 
3
:1
, 
3
:2
 a
n
d
 3
:1
0
 
co
rr
es
p
o
n
d
in
g
 t
o
 5
, 
1
0
, 
2
0
 a
n
d
 1
0
0
 n
M
, 
re
sp
ec
ti
v
el
y
. 
L
an
es
 1
1
-1
2
: 
C
o
n
tr
o
l 
co
n
ta
in
in
g
 S
1
 a
n
d
 S
1
+
S
2
 
o
f 
R
N
A
 
in
 
th
e 
b
u
ff
er
 
w
it
h
 
P
 
en
an
ti
o
m
er
 
ra
ti
o
 
3
:1
 
(R
N
A
 
st
ra
n
d
:c
yl
in
d
er
).
 
L
an
es
 
1
3
-1
6
: 
S
am
p
le
 
co
n
ta
in
in
g
 1
0
 n
M
 S
1
, 
S
2
 a
n
d
 S
3
 i
n
 t
h
e 
b
u
ff
er
 w
it
h
 e
n
h
an
ci
n
g
 r
at
io
s 
o
f 
P
 e
n
an
ti
o
m
er
 f
ro
m
 3
:0
.5
, 
3
:1
, 
3
:2
 
an
d
 
3
:1
0
 
co
rr
es
p
o
n
d
in
g
 
to
 
5
, 
1
0
, 
2
0
 
an
d
 
1
0
0
 
n
M
, 
re
sp
ec
ti
v
el
y
. 
L
an
e 
1
1
: 
N
eg
at
iv
e 
co
n
tr
o
l 
co
n
ta
in
in
g
 S
1
, 
S
2
 a
n
d
 S
3
 o
f 
R
N
A
 i
n
 t
h
e 
b
u
ff
er
 w
it
h
 [
F
e 2
(L
-C
F
3
) 3
]4
+
).
 C
) 
P
lo
t 
o
f 
p
er
ce
n
ta
g
e 
o
f 
R
N
A
 
3
W
J 
fo
rm
ed
 a
t 
2
5
 °
C
 v
er
su
s 
th
e 
co
n
ce
n
tr
at
io
n
 o
f 
en
an
ti
o
m
er
s.
 T
h
e 
re
su
lt
 r
ep
re
se
n
ts
 t
h
e 
m
ea
n
 o
f 
th
re
e 
in
d
iv
id
u
al
 e
x
p
er
im
en
ts
 ±
 S
D
 (
n
 =
 3
).
 
 B
 
C
 
Chapter 2 
 94 
2.2.5 The iron cylinder [Fe2L3]
4+
 (L=C25H20N4) also binds to bulged RNA three 
way junction 
In the previous experiment, the results show that the iron cylinder recognises 
and binds to the perfect RNA three way junction. This RNA three way junction is not 
the only possible structure that can be found in nature. Most naturally occurring RNA 
three way junctions contain unpaired bases, bulges, and internal loops. Interestingly, it 
has been shown that these types of structure are crucial for specific protein binding 
such as the binding of the HIV transactivator protein Tat to the three pyrimidine bulge 
in the trans–activation response elements (TAR).
12, 21, 22 
To investigate the recognition 
ability of the iron cylinder to bulged RNA three way junctions, gel electrophoresis 
was carried out. 
 
 
 
Figure 2.13 A) Structures of the unbound TAR RNA and Tat protein obtained from NMR.  Important 
regions for intermolecular recognition are highlighted. Nucleotides of TAR RNA involved in Tat 
binding are shown in green. B) Proposed model for Tat protein-TAR interactions.  The yellow and red 
are represented the structure of TAR RNA and nucleotide respectively. The structure of the Tat peptide 
drawn from Tat protein structure is shown in cyan. Taken from ref. 23 
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The sequences used to form the bulged RNA three way junctions were designed by 
adding one or two uracils (U) into the middle of either S2 or S3 (Figure 2.14).  
 
 
 
Figure 2.14 Schematic drawing of RNA three way junctions. A) A Fully matched RNA three way 
junction containing seven nucleotides on each arm. B), C), D) and E) Bulged RNA three way 
junctions. Additonal uracils were added onto a fully matched RNA in different position at the centre of 
the RNA three way junction. 
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Figure 2.15 Autoradiogram of bulged RNA three way junctions performed on non-denaturing 15% 
polyacrylamide gel at 4 °C (A) and 25 °C (B), respectively. Lanes 1-5: Control comprising of the fully 
matched RNA three way junctions. Lanes 6-9, 10-13, 14-19, 17-19: A set of bulged RNA three way 
junctions containing additional uracil at the center of three way junction in various RNA strands treated 
with 10 µM MgCl2 and the iron cylinder at the ratio 3:1 (RNA strand:complex) corresponding to 10 
nM.  
 
A 
B 
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The results in Figure 2.15A show that at 4 °C, all bands were clearly 
illustrated. Apparently, a self assembly of the fully matched and bulged three way 
junctions occurred. Interestingly, two bands corresponding to duplex RNA were 
observed in lanes 7-9 and lanes 11-13. In lanes 7-9, the lower band corresponds to 
S1*+S3 which has the same molecular weight as S1*+S2. Consequently, both 
components had the same mobility through the gel electrophoresis. The presence of 
the upper band corresponding to S1*+S2(U) in lanes 7-9 and S1*+S2(UU) in lanes 
11-13 were observed. The gel shows that the increasing molecular weight caused by 
adding one or two uracil to S2 retarded the mobility of the bulged duplex compared to 
the original duplex. In lanes 17-19, the duplex formation of S1*+S2(U) and 
S1*+S3(U) have the same molecular weight thus the migration ability is the same, 
resulting in only a duplex band.  
The gel experiment was carried out again at 25 °C to compare the result with 
the experiment carried out at 4 °C. Figure 2.15B shows that the fully matched and 
bulged three way junction formation were increased in the presence of the iron 
cylinder even if self formation occurred. To compare the three way junctions obtained 
from each sequence, the bands on the gel were quantified by ImageQuant. The 
quantified analysis is represented in a bar graph (Figure 2.6). 
The bar graph (Figure 2.16) demonstrates that the percentage of three way 
junctions from both bulged and fully matched sequences was increased in the 
presence of the iron cylinders even if self formation of the three way junction has 
occurred. Furthermore, the effect of the iron cylinder on the three way junction 
stabilisation was greater than the effect of the divalent ion, magnesium chloride. 
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Figure 2.16 Bar graph depicting the percentage of RNA three way junction at 25 °C and the sequences 
used. The result represents the mean of three individual experiments ± SD (n = 3). 
 
It can be concluded that the iron cylinder is capable of recognising and binding 
to the bulged junctions, although the stabilisation of the iron cylinder to the bulged 
three way junction was not greater than the perfect three way junction. 
 
2.2.6 Increasing RNA concentration enhances the formation of the three way 
junction induced by the iron cylinder  
It has been demonstrated from the previous section that the iron cylinder has 
the ability to bind to the RNA three way junction. However, the concentration of 
oligoribonucleotide used in the experiments was incredibly low, 10 nM. The low yield 
from the RNA labelling of S1 was the main reason for using this concentration for the 
experiments. In addition, the problem of achieving low yield in RNA labelling could 
be from the use of high concentration of RNA in the labelling step so the radioactivity 
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is not enough to label all RNA strands in the solution. Practically, the problem could 
be solved by reducing the stock concentration of RNA from 100 µM to 2.5 µM. The 
radioactivity in the labelling solution will be excess thus resulting in an increase of the 
labelling efficiency.  
Considering the concentration of RNA used in the section 2.2.2-2.2.5, it was 
very low. This will affect the concentration of the cylinder which is depended on the 
concentration of RNA. Consequently, the amount of the cylinder added into the 
solution was also low even at excess amount of the cylinder which is at 3:10 
corresponding to 100 nM. Apparently, this concentration is much lower than the 
dissociation constant of the cylinder and DNA (See Chapter 5). This is important 
issue as the concentration of the cylinder used in the experiment should be higher than 
the dissociation constant. Therefore, the experiments mentioned previously were 
carried out again under new condition in which the concentration of the RNA three 
way junction was increased from 10 nM to 0.20 µM by adding the non-labelled S1, 
called cold strand, to boost the concentration of S1. In addition, it is known that salt in 
the buffer, NaCl, facilitates the stabilisation of the three way junction by reducing the 
repulsion of the negative charge from the phosphate backbone. Thus, the 
concentration of NaCl was increased from 100µM to 100 mM corresponding to the 
increasing concentration of the RNA three way junctions. Consequently, all the 
experiments shown above were carried out again using 0.20 µM of the RNA three 
way junction and TBN buffer containing 100 mM NaCl.  
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The results of the native gel electrophoresis performed at high RNA 
concentration (Figure 2.17) show that the stabilisation and recognition of the iron 
cylinder to a three way junction is similar to the one performed at low RNA 
concentration at both temperatures. In addition, in the presence of the iron cylinder at 
4 and 25 ºC, doublet bands corresponding to a three way junction band were 
observed. It could be possible that the top band of the doublet could be a three way 
junction-cylinder adduct as the migration rate was slower than the bottom doublet 
which could be a three way junction alone. Furthermore, the quantification 
information is intriguing. The percentage of three way junction obtained from the gel 
undertaken at high concentration of RNA is remarkably higher than the one carried 
out at low RNA concentration. The plot of gel carried out in both conditions is shown 
below. These results were compared at the same ratio of RNA strand to the complex. 
 
Figure 2.18 Bar graph illustrating the percentage of the RNA three way junction versus the ratios of 
RNA to complex at 25 °C under low and high RNA concentration conditions. The result represents the 
mean of three individual experiments ± SD (n = 3). 
 
The plot (Figure 2.18) shows that in the absence of the iron cylinder, the 
starting amount of the RNA three way junction in both conditions, low and high RNA 
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concentration, was the same. Interestingly, the percentages of the RNA three way 
junction obtained from high RNA concentration were distinctively more than those at 
low RNA concentration. This result is interesting as the same percentages of the three 
way junction was assumed to achieve even if the RNA concentration was increased. 
The theory of thermodynamic equilibrium may explain this result as illustrated in 
Figure 2.19. 
 
 
 
 
Figure 2.19 Schematic of the formation of the RNA three way junction in the presence of the iron 
cylinder 
 
In the steady state, the rate of the RNA three way junction formation in the 
presence of the iron cylinder, forward reaction, is equal to the rate of breakdown of 
the three way junction, backward reaction. At high RNA concentration, the RNA 
added disturbs the equilibrium. To remain in equilibrium, the formation of the three 
way junction induced by the cylinder has to increase.  
A gel experiment to probe the preferential binding effect of both enantiomers 
of the iron cylinder on the RNA three way junction was also performed at 4 °C and 25 
°C. The gel results are represented in Figure 2.20. The gel quantification at 25 °C is 
shown in Figure 2.21. The results show that the three way junction induced by both 
enantiomers at  high RNA concentration is dramatically increased when compared to 
the gel experiments carried out at low RNA concentration at both temperatures. In 
addition, at high RNA concentration, the M enantiomer has a higher binding affinity 
to the RNA three way junction than the P enantiomer.  
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Figure 2.21 Bar graph comparing percentage of RNA three way junction obtained from each 
enantiomer at low and high RNA concentration versus the ratio of RNA per strand to the complex. The 
result represents the mean of three individual experiments ± SD (n = 3). 
 
The bulged RNA three way junctions were also treated with high RNA 
concentration (Figure 2.22). The increase of the bulged RNA three way junctions was 
monitored at 4 °C and 25 °C respectively.  Surprisingly, the result at 4 °C at high 
RNA concentration did not give as good a resolution as the one at low RNA 
concentration. For example, lane 6 showed two bands of fraying Y-shaped RNA i.e. 
S1+S2(U) and S1+S3 at low RNA concentration, however only a single band of 
duplex RNA correlated to S1+S3 was observed at high RNA concentration.  
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Quantification reveals that at high RNA concentration, more bulged RNA 
three way junction is formed than at low RNA concentration as shown in Figure 2.23. 
A bar graph demonstrates that in the absence of the iron cylinder either at low or high 
RNA concentration, the self formation of bulged RNA three way junctions was 
always detected. However, the enhancement of the bulged RNA three way junction 
was observed in the presence of the iron cylinder indicating that the iron cylinder 
recognises and stabilises to bulged RNA three way junctions.  
 
Figure 2.23 Bar graph showing the comparison percentage of each bulged RNA three way junction 
obtained in the absence and presence of iron cylinder at high and low RNA concentration. LRNA(-), 
HRNA(-) are low RNA and high RNA concentration, repectively, in the absence of the iron cylinder. 
LRNA(+), HRNA(+) are low RNA and high RNA concentration, repectively, in the presence of the 
iron cylinder. The result represents the mean of three individual experiments ± SD (n = 3). 
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2.2.7 A competition experiment between the DNA and RNA three way junction  
Previous studies have elucidated the binding of the iron cylinder to the DNA 
three way junction by X-ray crystallography
1
, gel electrophoresis
3
 and NMR 
spectroscopy
2
.
 
The results above show that the cylinder also binds to the RNA three 
way junction. The question that arises is that to which nucleic acid junction the iron 
cylinder preferentially binds. Therefore, an assay was established in which 
competition between the DNA and the RNA three way junction was induced. 
Consequently, a preferential binding of the cylinder to a nucleic acid is assumed. 
 
Figure 2.24 The competition assay of the iron cylinder to nucleic acid (DNA and RNA) performed on 
20% native polyacrylamide gel electrophoresis at 25 °C. Lanes 1-3 and 10-12: Control containing 0.2 
µM S1, S1+S2, S1+S2+S3 of DNA and RNA respectively. Lanes 4, 13: Control containing 0.2 µM 
S1+S2+S3 of DNA (4) and RNA (13) in the presence of 0.2 µM iron cylinder. Lanes 5-9: 0.2 µM DNA 
three way junction and 0.2 µM iron cylinder in the presence of increasing RNA three way junction 
concentration (40, 100, 200, 400 and 1000 nM, respectively). Lanes 14-18: 0.2 µM RNA three way 
junction and 0.2 µM iron cylinder in the presence of increasing DNA three way junction concentration 
(40, 100, 200, 400 and 1000 nM, respectively). 
 
It was found that the competition of the nucleic acids with the cylinder could 
be followed on the same native gel although RNA strands are identical to DNA in 
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term of length and sequence. However, DNA strands run faster on the gel due to the 
absence of the hydroxyl group on the pentose ring in the 2′position in DNA which 
results in a lower molecular weight. Therefore, the DNA three way junction and the 
RNA three way junction can be distinguished from each other. The assay was 
performed as follows. To a constant concentration of DNA three way junction and 
cylinder, increasing amounts of the RNA three way junction were added. A second 
experiment was performed where the concentration of RNA three way junction and 
cylinder were fixed and the concentration of DNA three way junction added into the 
solution was increased.  
The results (Figure 2.24) show that competition between the nucleic acids for 
the iron cylinder occurred. An increase of the RNA three way junction results in a 
decrease of the DNA three way junction and a simultaneous rise of single stranded 
DNA. The single strand detected on the gel was from the dissociation of the three way 
junction, caused by the removal of iron cylinder from the three way junction by the 
competitor. The result demonstrates that the dissociated single stranded DNA from 
the DNA three way junction when the RNA three way junction was added does 
increase compare to dissociated single stranded RNA when the DNA three way 
junction was added. The latter shows the constant intensity of the single strand RNA. 
This illustrates that the iron cylinder is hardly taken from the RNA three way junction 
in the other word the iron cylinder prefers to bind to RNA three way junction rather 
than DNA three way junction. However, care must be taken when interpreting the 
results, as the equilibrium being studied is not the simple competition between a RNA 
three way junction and a DNA three way junction that would be most desirable. 
Rather the equilibrium is between cylinder bound DNA three way junction plus single 
stranded RNA versus cylinder bound RNA three way junction and single strand DNA 
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(Figure 2.25). It has been known (since some unbound RNA three way junction is 
present in the absence of cylinder) that the energy required to form an RNA three way 
junction from a single stranded RNA is lower than that needed to form a DNA three 
way junction from a single strand of DNA and this will influence the position of the 
equilibrium. 
 
Figure 2.25 Schematic drawing of proposed equilibrium for a competition assay between DNA and 
RNA three way junction to the iron cylinder.   
 
In addition, the competition assay could alternatively have been performed in 
by labelling one of nucleic acid three way junction. Then, the non-labelled competitor 
will be added to a solution containing a constant concentration of labelled nucleic acid 
and the cylinder. This alternative experiment may aid the interpretation of the 
experiment by reducing a number of bands on the gel. 
 
2.2.8 DNA-RNA hybrid three way junctions 
Targeting nucleic acids using small molecules usually exploits the material 
involving in the gene expression pathway, for instance DNA, RNA and protein. 
However, the intermediate processes, DNA-RNA, have not often been considered. 
The DNA-RNA hybrid formation offers a specific target for manipulating the transfer 
of genetic information through binding by small molecules. Due to the different 
conformation of the DNA-RNA hybrid, compared to entirely DNA or RNA, and also 
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the low occurrence within biological systems, it would be interesting to further 
explore their therapeutic potential.  
The aim of this experiment was to examine the recognition of the iron cylinder 
to a DNA-RNA hybrid three way junction. A set of DNA-RNA hybrid three way 
junction combinations was created as shown in Figure 2.26. Note that in this 
experiment strand 3 of DNA and RNA were labelled. In fact, it does not matter which 
strand is labelled as long as it is one of the three strands. The autoradiogram of the 
hybridisation experiment is shown in Figure 2.27. 
 
 
 
 
 
Figure 2.26 Schematic drawing of DNA-RNA hybrid three way junctions. Note that S3 of DNA and 
RNA were labelled. The black letters represents DNA strand and the blue letters represent RNA strand. 
 
The result (Figure 2.27) shows that the formation of the three way junctions 
was observed only in the presence of the iron cylinder. This indicates that the iron 
cylinder recognises and binds to the DNA-RNA hybrid three way junctions. The 
migration distances of the hybrids are different from the three way junctions 
composed of entire DNA or RNA and even among the hybrids. According to 
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electrophoresis principles, the nucleic acid will migrate differently depending on its 
charge, Y-shaped configuration and molecular weight. Since the charge and 
conformation of the hybrid are assumed to be the same, the difference in migration 
comes from the component of the hybrid. Note that in the same length of 
oligonucleotide, RNA has a higher molecular weight than DNA due to the hydroxyl 
group on C3 position in the ribose sugar. Therefore, the components that have less 
RNA strands will run faster than the ones that have more RNA strands.  
 
Figure 2.27 The autoradiogram of DNA-RNA hybrid three way junction carried out on 20% native 
polyacrylamide gel at 25 °C. Lanes 1, 9: Control containing 0.2 µM DNA and RNA three way junction 
respectively. Lanes 2, 10: Control containing 0.2 µM DNA and RNA three way junction, respectively 
in the presence of 0.2 µM iron cylinder. Lanes 3, 5, 7: 0.2 µM DNA-RNA hybrid three way junctions 
consisting of various DNA and RNA components as shown in the figure and S3 of DNA was labelled. 
Lanes 4, 6, 8: Containing 0.2 µM DNA-RNA hybrid three way junctions in the presence of 0.2 µM iron 
cylinder. Lanes 11, 13, 15: Sample containing different components of DNA-RNA hybrid three way 
junctions in which S3 of RNA was labelled. Lanes 12, 14, 16: Sample containing 0.2 µM DNA-RNA 
hybrid three way junction in the presence of 0.2 µM iron cylinder. The black letters represent DNA 
strand while the blue one represent RNA strand.  
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Furthermore, the result indicates that the iron cylinder prefers to bind to each DNA-
RNA hybrid three way junction combination differently. Among the hybrid 
combinations, lane 12, containing S1 (DNA), S2 (DNA), S3 (RNA), was remarkably 
not stable at all even in the presence of the iron cylinder. Lane 14, consisting of S1 
(DNA), S2 (RNA), S3 (RNA) in the presence of the cylinder was less stable but 
slightly better than lane 12. The two hybrids share a similar feature in which both 
contain S1 (DNA) and S3 (RNA). This might be a key point for the recognition and 
stabilisation of the iron cylinder to DNA-RNA hybrid. On the other hand, the great 
stability of the hybrid achieved in lane 4, 8 containing S1 (RNA), S2 (RNA), S3 
(DNA) and S1 (DNA), S2 (RNA), S3 (DNA) respectively in the presence of the iron 
cylinder. It is noticed that S2 (RNA), S3 (DNA) play important role in the recognition 
of the cylinder to the DNA-RNA hybrid.  
 
2.3 Conclusions 
The results herein demonstrate that the iron cylinder [Fe2L3]
4+
 binds and 
stablilises RNA three way junctions. The results also show that the effect of the iron 
cylinder on stabilising the three way junction structure is greater than the effect of the 
divalent cations. The expected interactions underpinning the stabilisation are 
electrostatic interactions between the highly positively charged (4+) complex and the 
negatively charged RNA phosphate backbone. Also, the hydrophobic interaction of 
the aromatic exterior of the iron cylinder which prefers to be accommodated in the 
hydrophobic cavity of an RNA three way junction. The perfect size and shape of the 
iron cylinder also plays a major role in the stabilisation, since the bulky cylinder 
possess the same charge, but is not capable of stabilising the RNA Y-shaped junction. 
A similar result but with a slightly higher stabilisation efficiency has been achieved 
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with the ruthenium cylinder, which has the same size and shape as the iron cylinder. 
The difference in the stabilisation of the two cylinders to the RNA three way junction 
could be one of the factors involved in the difference in cytotoxicity of the cylinders: 
the ruthenium cylinder is inactive in ovarian cancer cell lines while the iron cylinder 
is active.
16, 17
 The binding of the iron cylinder to the RNA three way junction without 
perturbing the A-form structure of the arms is confirmed by circular dichroism. 
Furthermore, the results indicate that both M and P enantiomers can stabilise the three 
way junction but the M is apparently more effective than the P at high RNA 
concentration. This is also confirmed again by crystal structure achieved from 
Joachim Schnabl and Dr. Eva Freisinger, our collaborator, in Univeristy of Zurich, 
Switzerland. This crystal structure obtained from the solution of RNA three way 
junction and the racemic mixture demonstrates that only the M is located at the heart 
of the RNA three way junction. This result is similar to the binding of the two 
enantiomers to the DNA three way junction, in which the M enantiomer is more 
effective than the P enantiomer.  Interestingly the iron cylinder also recognises bulged 
RNA three way junctions. This is important since the majority of RNA three way 
junctions present in nature consisting of bulged and looped structures, involving the 
specific protein binding such as HIV protein (Tat) to TAR. By this discovery, the 
binding of the iron cylinder to the specific region of the bulged RNA is possible to 
block the binding of the specific protein involving in the gene expression resulting in 
gene suppression. Beside, RNA conformation, in nature, the DNA-RNA hybrid could 
occur during transcription and there are only a few studies about this.
24
 The iron 
cylinder shows the preferential binding to a specific combination of the DNA-RNA 
hybrid three way junction. Thus, RNA three way junctions might be an intriguing 
alternative target for this kind of supramolecular cylinder drug which is specifically 
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capable of inhibiting gene expression in translation level. Moreover, the competition 
assay has revealed that the iron cylinder prefers to bind to RNA three way junctions 
rather than DNA three way junctions however I am not completely convinced for this 
as the equilibrium being studied is not the simple competition between a RNA three 
way junction and a DNA three way junction as shown in Figure 2.25. Increasing 
RNA concentration in all experiments, as shown in this chapter, does lead to more 
three way junction formation. The studies are continuing in our group and 
collaborators to confirm the binding of the iron cylinder to RNA three way junctions 
and characterising by NMR and crystallography. 
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2.4 Experimental 
RNA purification: All synthetic HPLC grade oligonucleotides (DNA; S1: 
CGGAACGGCACTCG, S2: CGAGTGCAGCGTGG, S3: CCACGCTCGTTCCG) 
and RNA (S1: CGGAACGGCACUCG, S2: CGAGUGCAGCGUGG, S3: 
CCACGCUCGUUCCG, S2(U): CGAGUGCUAGCGUGG, S2(UU): CGAGUGC 
UUAGCGUGG, S3(U): CCACGCUUCGUUCCG) used in this chapter were 
purchased from Microsynth, Switzerland. The purification is described as following. 
The oligonucletides were run on 18% denaturing polyacrylamide gel (42g urea, 10 ml 
of 10x TBE buffer (Geneflow), 45 ml of 40% acrylamide (29:1) (Geneflow)). The gel 
was run slowly at 5 watts, room temperature until the oligonucleotide had migrated 
approximately two thirds of the length of the gel. The gel was placed on Saran Wrap. 
It was then laid on fluorescent thin-layer chromatographic plate where the 
oligonucleotide is predicted to be. Then, a hand-held UV lamp was used to examine 
the oligonucleotide by illumination from above at 260 nm. The desired 
oligonucleotide, which should be the slowest-migrating band, was recovered by 
cutting the oligonucleotide band with a sharp and clean scalpel. The gel pieces were 
put in the electroelution machine (Bio-rad) applying 200 volt for 3 hours. 1 ml of 
solution containing oligonucleotide was collected from the machine every hour. To 
obtain the DNA pellet, the 3 ml DNA was precipitated with a solution containing 9 ml 
of absolute ethanol and 125 µl of 5 M NaCl and left at -20°C overnight. The solution 
was centrifuged at 9,500 rpm at 4 °C for 30 minutes. The supernatant was discarded 
then the DNA was dried in vacuum centrifuge (eppendorf) at 45 °C for 3 hours.  
Radiolabelling RNA at 5´terminus: A reaction mixture of 10 µl in 1.5 ml Eppendorf 
containing 4.8 µl of MilliQ water, 1 µl of 10x bacteriophage T4 polynucleotide kinase 
buffer, 1.2 µl of 100 µM oligonucleotide, 1µl of bacteriophage T4 polynucleotide 
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kinase (Promega, UK) and 2 µl of γ-
32
P ATP (6000 Ci/mmol, 10 mCi/ml) from Perkin 
Elmer were well mixed and incubated for 40 min at 37 °C. In addition to the reaction 
mixture, an excess of radioactivity is usually required for the labelling of nucleic 
acids. Considering the reaction mixture shown above, it suggests that the reaction 
mixture may either needs more γ-
32
P ATP or needs less oligonucleotide by 40 times 
from the initial reaction mixture. Reducing the concentration of oligonucleotide will 
be more practical for a new radiolabelling recipe. To purify the labelled 
oligonucleotide the sample was mixed with 10 µl of formamide loading buffer and 
loaded into 18 % denaturing polyacrylamide gel running at 15 watts for 2.50 hours. 
The gel was taken out then wrapped with Saran and exposed to a phosphor imager 
plate for 10 minutes for visualisation. The band corresponding to labelled RNA was 
cut and crushed with a spatula in a 1.5 ml eppendorf. After adding 4 times volume of 
elution buffer (10 mM MOPS pH 6, 1 mM EDTA, 250 mM NaCl) to a volume of cut 
gel pieces, the eppendorf was placed on a shaker at 4 °C for 2 hours. The mixture was 
centrifuged at 13,000 rpm for 5 min to separate gel pieces from the solution. To 
precipitate RNA three volumes of cold ethanol were added to supernant and left at -
20°C overnight. The solution was centrifuged at 13,000 rpm for 5 minutes and the 
supernatant was discarded. The eppendorf was placed under vacuum to dry off the 
ethanol residual. Finally a pellet was dissolved in 50 µl of milliQ water. The 
concentration of the labelled strand was measured by a scintillator machine from the 
mixture of 1 µl of labelled strand and 5 ml of scintillator solution. The calculation is 
shown in the Appendix. 
Gel electrophoresis experiment 
Polyacrylamide gel preparation: 15% native polyacrylamide gel solution containing 
20 ml of 10x TB buffer pH 8.3 (890 mM tris(hydroxymethy) amino methane, 890 
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mM boric acid), 75 ml of 40% acrylamide (29:1) from Geneflow, 105 ml of milliQ 
water, 1ml of 10%(w/v) ammonium persulfate and 100 µl TEMED, was poured onto 
a set of glass plates. The wells of the polymerised gel were thoroughly washed with a 
running buffer (TB buffer) before use. Note that prerunning of the gel at 200 volts for 
5 minutes is required before the experiment is performed. 
Gel electrophoresis experiment: 10 µl of the samples in 1.5 ml eppendorf tubes 
were prepared by mixing equal amounts of three strands of oligonucleotides (10 nM 
as final concentration for low RNA concentration and 0.2 µM as final concentration 
for high RNA concentration) with the metal complex in TBN buffer (100 µM or 100 
mM NaCl in case of low and high salt concentration respectively.). Ratios of RNA per 
strand to complex were 3:0.5, 3:1, 3:2 and 3:10 respectively.  The samples were then 
incubated at room temperature for 1 hour and on ice for 20 min. 5 µl of 30% glycerol 
was added to each sample to increase the density of the sample to be able to sink into 
a well. All samples then were loaded into 15% native polyacrylamide gel. Note that 
loading dye (5x GelPilot DNA Loading Dye, QIAGEN) was separately loaded into 
the first and the last well to mark where the RNA migrates to. The gel was run at 5 
watts for 4 hours then the gel was placed in between a sheet of 3MM whatman paper 
and Saran wrap. The gel was dried on a Maxi gel dryer (Thermo Scientifc) at 85°C for 
20 minutes. The dried gel was cooled to room temperature. A phosphorimaging plate 
(Amersham, GE health care) was exposed to the gel overnight. The bands were 
visualised by scanning the phosphorimaging plate on typhoon storm (GE healthcare). 
The ImageQuant TL from Amersham Bioscience was used for the quantification. 
Circular Dichroism (CD) Measurements: A spectropolarimeter (JASCO)  was used 
for CD measurements. The experiments were performed at 20 °C with 0.1 and 1 cm 
path length cuvettes (Strana) for measuring at 200-400 nm and 400-750 nm 
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respectively. Before the measurement, the RNA samples were heated to 95 °C for 5 
min then gently cooled down by thermal block. 30 µM total strand concentration of 
RNA in buffers of 0.89 mM Na-cacodylate ( pH 7.0 ) and 20 mM NaCl were titrated 
with stock solution 700 µM complex various from stochiometry of RNA 3WJ and 
complex from 1:0.5 to 1:10. During the titration UV-Vis spectra (Cary 5000) were 
recorded. 
DNA and RNA three way junction hybridisation: 10 µl of the samples in 1.5 ml 
eppendorf tubes were prepared by mixing the combination of RNA, DNA and DNA-
RNA hybrid three way junctions in equal amounts of three strands of oligonucleotides 
(0.2 µM as final concentration) with the metal complex in TBN buffer (100 mM). 
Ratios of nucleic acid three way junction per strand to complex was 3:1. The samples 
were then incubated at room temperature for 1 hour and on ice for 20 min. 5 µl of 
30% glycerol was added into each sample to increase the density of the samples to be 
able to sink into a well. All samples then were loaded into 15% polyacrylamide gel. 
Note that loading dye (5x GelPilot DNA Loading Dye, QIAGEN) was separately 
loaded into the first and the last well to mark where the RNA migrates to. The gel was 
run at 5 watts for 4 hours then the gel was placed in between a sheet of 3MM 
whatman paper and Saran wrap. The gel was dried on a Maxi gel dryer (Thermo 
Scientifc) at 85°C for 20 minutes. The dried gel was cooled to room temperature. A 
phosphorimaging plate (Amersham, GE health care) was exposed on the gel 
overnight. The bands were visualised by scanning the phosphorimaging plate on 
typhoon storm (GE healthcare). The ImageQuant TL from Amersham Bioscience was 
used for the quantification. 
Competition assay between the DNA and RNA three way junction to the iron 
cylinder: The stock solutions of the DNA and RNA three way junction (0.4, 1.0, 2.0 
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and 5.0 µM) were prepared by combining equimolar quantities of preformed 
oligonucleotides (DNA and RNA) in TBN buffer. It should be noted that strand 1 of 
DNA and RNA were labelled. Five samples containing 0.2 µM of the DNA three way 
junction as a final concentration and the iron cylinder (0.2 µM) were mixed in each 
tube. The solutions were incubated at room temperature for an hour. The RNA three 
way junction from the stock solution was added to obtain the final concentration 40 
nM, 100 nM, 200 nM, 400 nM and 1000 nM. The same experiment was carried out 
again but the DNA three way junction was added to constant concentration of RNA 
three way junction and the iron cylinder. All samples were incubated again at room 
temperature for an hour. 5 µl of 30% glycerol was added to each sample. Then, the 
samples were loaded onto 20% non-denaturing polyacrylamide gel. The gel was run 
for 4 hours at 5 watts. The gel was dried and exposed on phosphorimaging machine 
overnight in the film cassette. The autoradiogram was developed by scanning the plate 
on the scanner. The quantification was performed by ImageQuant. 
The triple stranded helicate [Fe2(L-CF3)3]Cl4 synthesis:
25
  
Ligand (L-CF3; C27H18N4F6) synthesis: 4, 4´-(Hexafluoroisopropylidene)-dianiline 
(0.55g, 1.65 mmol) and 2-pyridinecarboxaldehyde (0.35g, 3.28 mmol) were added to 
methanol (25 cm
3
). Then, five drops of acetic acid were added to the solution. The 
mixture was heated to reflux for 5 hours. The solvent was removed by rotary 
evaporation to produce green oil (0.71g, 84%) and used without further purification.  
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Mass spectrum (ESI): m/z 513 {M+H}. 
1
H NMR (300 MHz, CDCl3, 298K):δ 8.75 (2H, d, J = 3.4 Hz, H6), δ  8.64 (2H, s, 
Him), δ 8.23 (2H, dt, J = 7.9,1.2 Hz, H3), δ 7.86 (2H, td, J = 7.6, 1.7 Hz, H5), δ 7.50 
(4H, d, J = 8.5 Hz, Ha/b), δ  7.42 (2H, ddd, J = 7.9, 4.9, 1.3 Hz, H4), δ 7.30 (4H, d, J = 
8.5 Hz, Ha/b). 
Coordination of L-CF3 to iron (II)  
The ligand (L-CF3) (0.60g, 1.17 mmol) and iron (II) chloride tetrahydrate (0.16g, 0.78 
mmol) were added to methanol (25 cm
3
). After 2 hours of stirring, the deep purple 
solution was obtained. The iron (II) triple stranded helicate was precipitated upon the 
addition of diethylether and following with the filtration. Then, it was allowed to dry 
in a vacuum dessicator. The purple solid was obtained (0.62g, 89%). 
Mass spectrum (ESI): m/z 561{[Fe2(L-CF3)]Cl}
3+
, 412 [Fe2(L-CF3)]
4+
                             
1
H NMR (300 MHz, CD3OD, 298K): δ 9.21 (2H, s, Him), δ 8.72 (2H, d, J = 6.8 Hz, 
H3), δ 8.52 (2H, t, J = 6.8 Hz, H4), δ 7.90 (4H, m, Ha/b & 5), δ 7.44 (2H, d, J = 4.5 Hz, 
H6), δ 6.83 (4H, d, J = 8.2 Hz, Ha/b), δ 6.05 (4H, d, J = 7.7 Hz, Ha/b), δ 5.11 (4H, d, 
CH2, J = 7.9 Hz, Ha/b) 
Elemental analysis calculated (%) for [Fe2(L-CF3)3]Cl4.9.5H2O: C: 49.61, H: 3.76, N: 
8.58; found: C: 49.58, H: 3.74, N: 8.58. 
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The triple stranded helicate [Fe2L3]Cl4 synthesis
25
:  
Ligand (L; C25H20N4) synthesis: 4, 4’−Methylenedianiline (1.0g, 5.04 mmol) was 
combined with 2-pyridinecarboxaldehyde (1.08g, 10.08 mmol)  in ethanol (50 cm
3
) 
and the solution was allowed to stir overnight. The yellow precipitate was filtered off 
and dried in vacuo (1.57g, 82.6 %). 
 
 
 
Mass spectrum (ESI): m/z 377 {M+H}. 
1
H NMR (300 MHz, CDCl3, 298K): δ 8.72 (2H, d, J = 3.9 Hz, H6), δ 8.62 (2H, s, 
Him), δ 8.23 (2H, d, J = 7.0 Hz, H3), δ 7.83 (2H, td, J = 8.3, 1.9, 0.6 Hz, H4), δ 7.41 
(2H, ddd, J = 7.6, 4.9, 1.2 Hz, H5), δ 7.30 (8H, m, Ha/b), δ 4.09 (2H, s, CH2) 
Coordination of L to Iron (II) 
 The iron triple helicate [Fe2L3]Cl4 was synthesised by simply mixing of the ligand (L; 
0.3 g, 0.797 mmol) with iron(II) chloride tetrahydrate (0.106 g, 0.533 mmol) in 
methanol (25 cm
3
) at room temperature. The purple solution, characteristic of iron(II) 
tris-pyridylimine compounds, was stirred for 3 hours. The purple compound was 
precipitated by diethylether. The purple precipitate was filtered off and dried in vacuo 
(0.33 g, 87 %). 
Mass spectrum (ESI): m/z = 425 {[Fe2L3]Cl3}
+
, 310 [Fe2L3]
4+ 
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1
H NMR (300 MHz, CD3OD, 298K): δ 9.17 (2H, s, Him), δ 8.70 (2H, d, J = 7.2 Hz, 
H3), δ 8.49 (2H, td, J = 7.7, 1.1 Hz, H4), δ 7.86 (2H, ddd, J = 5.6, 1.1 Hz, H5), δ 7.46 
(2H, d, J = 5.2 Hz, H6), δ 7.04 (4H, broad, Ha/b), δ 5.61 (4H, broad, Ha/b), δ 4.07 (2H, 
s, CH2) 
Elemental analysis calculated (%) for [Fe2L3]Cl4.7H2O: C: 59.74, H: 4.95, N: 11.16; 
found: C: 59.22, H: 4.95, N: 11.05. 
Separation of the iron cylinder [Fe2L3]Cl4 enantiomers 
A cellulose column was prepared by pouring a suspension containing 6 g of cellulose 
and 40 ml of 20 mM aqueous sodium chloride into a 2 x 30 cm sintered column. 25 
mg of Fe2L3Cl4 diluted in 100 µl of 20 mM sodium chloride was loaded onto the 
column (approximately 5 mg/ml).   The fractions were collected by visual separation 
of two bands, one from each purple band. Each fraction was desalted by using 
Sephadex G10: Sephadex G10 was swelled in methanol for 3 hours and was packed 
into a 1 x 30 cm sintered column by pouring the slurry into the column taking care not 
to trap air bubbles. The compound was loaded and eluted with methanol. The purple 
fraction was collected and dried using a freeze dryer. The UV-Vis absorbance and CD 
of each fraction were recorded to check the purity of obtained enantiomers. 
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3.1 Introduction 
In the postgenomic era, more information about how DNA sequence is 
responsible for gene function has been unveiled. This information is useful in many 
aspects. One example is that gene expression, which can cause disease either from over 
expression or decreased expression, can now start to be controlled. This can be achieved 
by creating a synthetic agent which can recognise either the sequences or the structure of 
DNA and bind selectively to DNA. In principle, this might be used to normalise the gene 
expression, stopping the disease.
1
  
One strategy for designing these agents is to imitate the traits, such as size or 
shape, of a natural DNA recognition protein i.e. alpha helix or zinc finger protein. The 
synthetic agent designed may be able to interact in a similar way to natural DNA 
recognising biomolecules. By exploiting supramolecular chemistry as an approach to 
design and synthesise a DNA binding agent, Hannon et al. created a tetracationic triple 
stranded helicate ([Fe2L3]
4+
, L = C25H20N4). The synthesis involves only one step, 
offering a high yield with cheap starting materials.
2
 This helicate, a iron cylinder, has a 
cylindrical shape. The dimensions of this cylinder, obtained from its crystal structure, are 
~1.8 nm in length and ~1 nm in diameter. DNA binding studies of the helicate show that 
it binds to natural polymeric DNA like ct-DNA in the DNA major groove and causes 
dramatic intramolecular DNA coiling. This effect is reminiscent of DNA coiling induced 
by histones in the nucleus of living cells.
3
 Biological testing with several cancer cell lines 
indicates that the iron cylinder has cytotoxicity to cancer cells without exhibiting 
genotoxicity.
4
 Interestingly, an unprecedented DNA binding mode for the iron cylinder 
was revealed when a palindromic hexaoligonucleotide sequence of DNA was used in a 
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crystallographic approach. Surprisingly, rather than duplex DNA binding, the three 
strands of palindromic DNA formed a Y-shaped DNA three way junction with the iron 
cylinder sitting in the middle as shown in Figure 3.1.
5
 Although this is mentioned in 
Section 1.1.4.6, it is worth considering this structure in more detail since it is the key to 
the work in this chapter.  
 
 
 
Figure 3.1 The crystal structure of [Fe2L3]
4+
 and palindromic hexaoligonucleotide. A) Top view of 
[Fe2L3]
4+
 binding to DNA
 
major groove. B) Lateral view of the iron cylinder interacting with DNA three 
way junction. Taken from ref.
5
 
 
This unprecedented DNA structure, in which the supramolecular helicate 
[Fe2L3]
4+ 
located at the heart of a DNA Y-shaped junction, is supported by several non 
covalent interactions.
5
 The cylinder has a high positive charge (4+) and interacts with the 
negatively charged phosphate backbone of DNA through electrostatic interactions 
(Figure 3.2A). Moreover, the three bis-pyridylimine ligands provide a large hydrophobic 
surface allowing the helicate to be accommodated in the hollow hydrophobic cavity of 
the DNA three way junction. The information gained from the crystal structure shows 
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that the spacer unit of the ligand, consisting of two phenyl rings, can form π-π stacking 
interaction with the thymine and adenine bases of the junction (Figure 3.2B).  
 
 
 
Figure 3.2 A) View from the minor groove illustrating threefold axis of the iron interacting with the 
phosphate backbone of DNA via electrostatic interactions. B) π-π stacking interaction between the phenyl 
ring (labeled as C and B) and base A and T. C) Interaction between terminal phenyl ring of the cylinder and 
the minor groove DNA. Taken from ref.
5
  
 
Sandwiching interactions in the minor grooves from the pyridine rings at the end of the 
cylinder were also observed (Figure 3.2C). In addition, hydrogen bonding was also 
detected from the imine hydrogen adjacent to the minor groove end of the cylinder 
forming a C-H
…
X hydrogen bond with N3 nitrogen of adenine. The interactions 
mentioned above allow such a structure to be formed and eventually stabilised. Further 
studies were carried out by NMR
6
 and radioactive polyacrylamide gel electrophoresis.
7
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These studies confirm this unprecedented binding mode is not solely an artifact from the 
crystal structure but rather a real structure seen in both the solid state and solution.  
Three way junction and related structures are involved in many biological 
functions in both RNA and DNA. The splicing process
8
 and translation
9-11
 are examples 
of the function of RNA three way junctions while a DNA three way junction known as a 
replication fork is present as the intermediate structure during DNA replication.
9
 The 
DNA three way junction is also believed to be associated with several human genetic 
diseases such as myotonic dystrophy type1 and Huntingtons disease.
10
 The relevance to 
the replication fork means that the DNA three way junction can be proposed as a new 
target for anticancer agents. Binding to a replication fork should inhibit cancer cell’s 
growth and eventually lead to apoptosis, programmed cell death. The crystallographic 
studies show that the dimensions of the cylinder are crucial to the DNA recognition. 
Changing the dimensions of the cylinder will alter the DNA binding properties: 
Uerpmann et al. probed the effect of dimensional change on the dimetallo supramolecular 
cylinder by inserting a ketimine spacer unit between the pyridylimime and diphenyl 
methane of the parent ligand, the bispyrimidylimine ligand (Figure 3.3B).
11
 The new 
tetracationic supramolecular helicate was longer and wider than the parent cylinder 
(Figure 3.3E) but the cylindrical shape was retained. DNA binding studies of the 
complex with ct-DNA showed that the modified cylinder retained its DNA binding. 
However, the DNA coiling effect of the new cylinder was much less than the parent 
cylinder. Peberdy et al.  have introduced a methyl group on the parent ligand at the 3 and 
5 positions on the pyridyl ring adjacent to the metal binding site unit as shown in Figure 
3.3C; L
3
 and L
5
, repectively.
12
 The 3 methyl group points directly out of the sides of the 
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cylinder (Figure 3.3F) while the 5 methyl group is located at the ends of the cylinders 
and does not dramatically affect the cylindrical surface itself (Figure 3.3G). Investigation 
of the DNA binding behavior of the two compounds showed that the DNA binding of the 
position 3 methyl substituted cylinder was weaker than the parent cylinder, as was the 
coiling effect. For the position 5 methyl substituted cylinder, the DNA binding was found 
to be comparable to that of the parent compound. These previous two studies indicate that 
the dimensions of the tetracationic dimetallo supramolecular iron cylinder are the key 
feature of its DNA binding ability to the major groove of ct-DNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 The chemical structures of ligand modification to form tetracationic supramolecular iron 
cylinders. A) Parent ligand. B) Uerpmann’s ligand.
11
 The ketimine group (labled as red letter) was inserted 
between the diphenylmethane spacer and pyridylimine metal binding site units. C) Peberdy’s ligand.
12
 The 
methyl group is substituted at the position as labelled. D) Crystal structure of the parent cylinder. E) 
Overlay of crystal structure of parent cylinder (black) and Uerpmann’s cylinder (grey). F), G) Crystal 
structure of Peberdy’s iron cylinder with L
3
 and L
5
 ligand, repectively. Taken from ref.
11, 12
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The focus of this chapter is to explore the effect of the size, shape and coordinated 
metal centre of the cylinders on the recognition of a DNA three way junction. Gel 
electrophoresis proves to be a powerful way to probe this and a competition assay of the 
DNA three way junction and other DNA structures is also presented.  
 
3.2 Results and discussion 
3.2.1 Overview 
In order to achieve more information about this unprecedented DNA binding 
mode, the recognition of three way junction by metallo-supramolecular cylinders are 
investigated with the aid of polyacrylamide gel electrophoresis (PAGE). The sensitivity 
of this technique can be increased by the use of radioactivity labeling on a DNA strand 
instead of ethidium bromide staining. In this technique, it requires very low concentration 
of the cylinders and DNA (in µM concentration) compared to that used for 
crystallographic approach (in mM concentration). Therefore, an artifact arising from 
crystal packing from X-ray study can be excluded from the experiment.  
DNA sequences used in this experiment were designed to employ a 14-mer 
nonpalindromic oligonucleotide (Figure 3.4A) as it has been shown in literature to be the 
minimum length of DNA required for a three way junction lacking unpaired bases to stay 
stable during electrophoresis on a native gel at 5 °C but not stable at higher temperature 
i.e. at room temperature.
13
 The idea of this experiment is that in the absence of the 
cylinder, the pre-formed single stranded DNAs will appear as single stranded DNAs at 
room temperature since the DNA three way junction can not form. 
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Figure 3.4  A) Sequences used to form fully paired DNA three way junction.
7
 B) Idea of PAGE experiment 
to probe the recognition and stabilisation of three way junction DNA by the cylinder. 
 
However in the presence of the iron cylinder, the formation of three way junction DNA 
will be observed as the result of the recognition and stabilisation of the DNA by the 
complex (Figure 3.4B). It should be noted that this study was carried out in the lab of 
Professor Viktor Brabec at Institute of Biophysics Academy of Sciences, Brno, Czech 
Republic.
7
 The conditions and apparatus used to perform the experiments, mentioned in 
the publication, were however different from what we have in Birmingham therefore the 
gel experiments were established again in the group of Professor Kevin Chipman, School 
of Bioscience, University of Birmingham. 
 
 
 
 
 
A B 
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3.2.2 Establishing purity of labelled strand 
When using radioactive polyacrylamide gel electrophoresis the labelling of a 
DNA strand is required. In this experiment, oligonucleotide (strand 3) was labelled with 
γ-phosphate of ATP at the 5’ terminus by catalysing of bacteriophage T4 polynucleotide 
kinase.
14
 The forward reaction in which the γ-phosphate is transferred to the 5’ terminus 
of dephosphorylated DNA is employed. As the electrophoresis experiment to be 
conducted is a high sensitivity method, the purity of the labelled strand must be 
determined. This is because any contamination from oligonucleotide (n-1) will be 
detected and subsequently will affect the experiment. Therefore, it is important to check 
the purity of the labelled strand and this is achieved by running the labelled 
oligonucleotide on denaturing polyacrylamide gel.  
 
 
 
 
 
 
Figure 3.5 The autoradiogram of labelled oligonucleotide run on 18% denaturing polyacrylamide gel 
electrophoresis. 
 
The result (Figure 3.5) shows that the labelled oligonucleotide produces a single 
band indicating that the oligonucleotide is pure. Therefore this labelled oligonucleotide 
(strand 3) was used for further experiments. 
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3.2.3 Recognition and stabilisation of the iron cylinder [Fe2L3]
4+
to DNA three way 
junction 
As mentioned in Section 3.2.1, these PAGE studies were carried out and 
published in the lab of Professor Brabec.
7
 To establish the same experiment in the lab of 
Professor Chipman, our collaboration from School of Bioscience, University of 
Birmingham, a control experiment is needed to carry out to ensure that the changed 
condition of the experiment will produce the same result.  
 
 
 
 
 
 
 
 
 
Figure 3.6 Left: The autoradiogram of 15% PAGE running at room temperature. Lane 1: S3*+S2+S1 in 
TBN buffer. The concentration of oligonucleotide was 0.2 µM per strand. Lane 2: S3*+S2+S1 with 10 mM 
MgCl2. Lane 3-7: S3*+S2+S1 with [Fe2L3]
4+  
increasing the ratio of DNA per strand to complex from 
3:0.25, 3:0.5, 3:1, 3:2 and 3:10, corresponding to 0.05, 0.1, 0.2, 0.4 and 2 µM of the complex, respectively. 
Right: the graphical plot of concentration of iron cylinder (µM) as a function of % DNA three way 
junction. The red asterisk represents labeled strand. The plot represents the means of three individual 
experiments ± SD (n = 3). 
 
The results (Figure 3.6) shows that a band corresponding to the DNA three way 
junction was observed in the presence of the iron cylinder and three oligonucleotides 
(lane 3-7) while the control containing three oligonucleotides and no cylinder produced 
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only a band corresponding to single stranded DNA (lane 1). This indicates that three way 
junction formation can occur only in the presence of the iron cylinder. The iron cylinder 
not only binds to the DNA three way junction but also stabilises the structure. 
Surprisingly, the three way junction band was not formed in the presence of magnesium 
chloride which was used as a positive control at room temperature (Lane 2). It could be 
possible that the stabilisation of magnesium chloride to DNA three way junction was less 
than that of the iron cylinder therefore only a band corresponding to single strand was 
detected. However, it has been shown that magnesium chloride can promote three way 
junction formation at 5°C.
7
 Furthermore, increasing the concentration of iron cylinder 
results in enhanced formation of DNA three way junction. At the point where the iron 
cylinder is in excess, the graph levels off. In addition, this PAGE experiment for 
investigating the recognition and stabilisation of three way junction DNA by the iron 
cylinder was successfully established as achieved results are similar to the publication.
7
 
 
3.2.4 Recognition and stabilisation of the ruthenium cylinder [Ru2L3]
4+ 
and its 
enantiomers to DNA three way junction: effect of the metal on three way junction 
formation 
Next, the effect of changing the metal in the cylinder on three way junction 
stabilisation was probed using a ruthenium cylinder. Ruthenium has been highlighted as 
an advantageous metal for metal based anticancer drugs due to several attractive features. 
The advantages of utilising ruthenium are described as follows.
15-18
 First, ruthenium 
provides a variety of oxidation states e.g. Ru
II
, Ru
III 
and Ru
IV 
which can be accessed 
under physiological conditions resulting in remarkably good anticancer activity. Second, 
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ruthenium compounds are less toxic when compared to platinum compounds due to the 
ability of ruthenium to mimic iron in the binding to the significant biological molecules 
such as serum, transferrin and other proteins. In addition, the novel mechanism of 
ruthenium based anticancer drug is obtained from the octahedral coordination geometry 
of the metal, which is completely different from the square planar geometry of platinum 
(II). This is also believed to overcome drug resistance which was one of the main 
disadvantages of platinum based drug.  
To combine the intriguing features of ruthenium and the unprecendent DNA 
binding mode of the iron cylinder, a dinuclear ruthenium(II) triple stranded helicate 
[Ru2L3]
4+ 
was synthesised.
19
 The size and shape of the ruthenium complex (Figure 3.7), 
[Ru2L3]
4+
, is similar to the iron cylinder, [Fe2L3]
4+
, with a cylindrical shape with ~1.8 nm 
in length and ~1 nm in width.  
 
 
 
 
 
 
 
 
Figure 3.7 X-ray crystal structure of [Ru2L3]
4+
. The red, blue and yellow spheres represent Ru, N and C, 
respectively. 
19 
 
Interestingly, this ruthenium cylinder is fluorescent which may enable its application as a 
probe. The visualisation of the DNA binding of this compound in the nuclei of tumor 
cells and the proliferation of these tumor cells in real time could be achieved. Moreover, 
the ruthenium triple stranded helicate it is shown to bind to DNA and coil DNA in a 
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similar way to the parent cylinder.
20
 However, the cytotoxicity of the ruthenium cylinder 
is different from that of the iron cylinder. The iron cylinder is active against an ovarian 
cancer cell line while the ruthenium cylinder is not.
4, 22
 This indicates that the mechanism 
of action of the ruthenium cylinder interaction with DNA could be different from that of 
the iron cylinder. One interesting DNA binding property of the iron cylinder is the 
unprecedented DNA three way junction binding mode. However, the three way junction 
binding ability of the ruthenium cylinder has not yet to be explored. To investigate this 
unusual DNA binding mode with the ruthenium cylinder, a radioactive gel experiment 
was carried out. The ruthenium cylinder was kindly provided by Anna Leczkowska from 
our group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Autoradiogram of ruthenium triple stranded helicate binding to DNA. Lane 1-4: control 
containing S3*, S3*+S2, S3*+S2+S1 and S3*+S2+S1 with 50 mM MgCl2 respectively in Tris-borate 
containing 100 mM NaCl buffer. The concentration of the oligonucleotide is 0.2 µM per strand.  Lane 5-8: 
containing S3*+S2+S1 with [Fe2L3]
4+
, [Ru2L3]
4+
and their enantiomers e.g. M and P enantiomers at ratio 3 
to 1 (DNA per strand : complex). 
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The results (Figure 3.8) demonstrate that in the presence of the ruthenium triple 
stranded helicate, the three way junction was formed. This reveals that the ruthenium 
cylinder and its enantiomers can recognise and stabilise the DNA three way junction.  
The [Ru2L3]
4+
 helicate has two enantiomers, which are the M enantiomer or left 
handed helicate and the P enantiomer or right handed helicate. Both enantiomers were 
separated easily using a cellulose column and NaCl solution as eluent (work of Anna 
Leczkowska). This separation method is again similar to that of the iron cylinder.
21
 To 
probe the stabilisation ability of the enantiomers of the ruthenium cylinder with a DNA 
three way junction, a gel experiment was carried out. The experiment was performed by 
treating a constant concentration of oligonucleotide (S1, S2 and S3) with increasing ratio 
of DNA (per strand) and ruthenium complex from 3:0, 3:0.5, 3;1 to 3:2 corresponding to 
0, 0.2, 0.4 and 0.8 µM of the complex. The effect of each enantiomer on the stabilisation 
of DNA three way junction is compared by plotting the percentage of three way junction 
obtained as a function of complex concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Plot of percentage of DNA three way junction formation as a function of concentration of 
complex. Left: comparison of [Fe2L3]
4+
 and [Ru2L3]
4+
. Right: comparison of M and P enantiomer of 
[Ru2L3]
4+
. The plot represents the means of three individual experiments ± SD (n = 3). 
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 The results (Figure 3.9, Left) demonstrate that the amount of DNA three way 
junction formed in the presence of the iron cylinder was not significantly different from 
that in the presence of the ruthenium cylinder. Considering the similarity in the size, 
shape and structure of the ligand of both the ruthenium and iron cylinders, ([Ru2L3]
4+
) 
and ([Fe2L3]
4+
), it is not surprising that the amount of DNA three way junction formed is 
the same. This is because the main interaction forces; electrostatic, hydrophobic and 
sandwiching in minor groove between the cylinder and DNA three way junction are 
similar for both the iron and ruthenium cylinders.  
The effect of the enantiomers of the ruthenium cylinder ([Ru2L3]
4+
) on DNA three 
way junction formation and stabilisation was also investigated. The results (Figure 3.9, 
Right) show that the affinity of M and P enantiomers of the ruthenium cylinder to DNA 
three way junction was not dramatically different.  
 
 
 
 
 
 
 
 
 
Figure 3.10   Plots of the formation of DNA three way junction by the iron cylinder and its enantiomers as 
a function of cylinder concentrations. Taken from ref.
7
 
 
Chapter 3 
 140 
It could be possible that the twist from the helicate does not have much effect as the same 
amount of DNA three way junction was formed for both enantiomers. Interestingly, the 
three way junction formation in the presence of the P enantiomer of the ruthenium 
cylinder ([Ru2L3]
4+
) was remarkably greater than that for the P enantiomer of the iron 
cylinder ([Fe2L3]
4+
) (Figure 3.10).
7
 However, a direct comparison between two 
experiments would be difficult because these results came from different sets of 
experiment. To gain more understanding of the effect of [Ru2L3]
4+
 on the DNA three way 
junction, study of the crystal structure may be needed in the future. Perhaps, if the crystal 
structure of the DNA three way junction with both enantiomers of [Ru2L3]
4+
 is obtained it 
may shed light on the gel electrophoresis results.  
 
3.2.5 Effect of size and shape of the metallosupramolecular cylinder on a DNA three 
way junction formation 
There are several factors contributing to the binding of the iron cylinder [Fe2L3]
4+
 
to the DNA three way junction. The size and shape of the metallosupramolecular cylinder 
are crucial for the binding of the complex to the cavity of the three way junction. Malina 
et al. demonstrated that a bulkier cylinder [Fe2(L-CF3)3]
4+
 (Figure 3.11) does not 
stabilise the three way junction formation.
7
 This compound is identical to the parent 
cylinder [Fe2L3]
4+
 apart from an additional CF3 group attached to the carbon in the middle 
of the ligand, resulting in a huge enlargement of the diameter of the cylinder. Therefore, 
it is unlikely to fit into the core cavity of the junction.  
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Figure 3.11 Schematic drawing of ligands. Top: Parent ligand (C25H20N4). Bottom: Ligand to form bulky 
cylinder (C27H18N4F6). 
 
To further explore the importance of the size and shape of the cylinder, gel 
electrophoresis on a range of substituted cylinder, with phenyl and pyridine substituents, 
peptide conjugates and a triangular platinum compound were carried out.  
 
3.2.5.1 The effect of a substitution adjacent to imine bond on three way junction 
formation 
It has been shown that the spacer unit is important for the helicate to bind to the 
core cavity of the three way junction. To probe the effect of the substitution group of the 
ligand on the DNA binding, it was decided that the substitution position to be 
investigated would be the imine bond, which is adjacent to the metal coordination site. 
The substitutions performed on the parent ligand are shown in Figure 3.12. 
 
NN
NN
F3C CF3
NN
NN
L
L-CF3
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Figure 3.12 Left: The chemical structure of a parental ligand (L). Right: The substitution on imine bond 
on the hydrogen position with phenyl ring (L-Ph), on the second position of pyridine ring (L-Py2) and on 
the fourth position of pyridine ring (L-Py4) respectively. 
 
A CD experiment investigating the binding of the compounds (chloride form) to 
calf thymus DNA was carried out by Natalia Calle Alonso from the Hannon group. The 
results show that the substituted compounds ( [Fe2(L-Ph)3]
4+
, Fe2(L-Py2)3]
4+
 and Fe2(L-
Py4)3]
4+
) bind and coil polymeric ct-DNA, however the coiling effect is far less than for 
that of the parent cylinder, [Fe2L3]
4+
. To probe the effect of the substitution group on 
DNA three way junction formation, PAGE was carried out. The substituted iron 
compounds, as the chloride salt, were synthesised and kindly provided by Natalia Calle 
Alonso from Hannon group. 
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Figure 3.13 Autoradiogram of a substituted helicate and the three strands of oligonucleotides. Lane 1-3: the 
controls; S3*, S3*+S2, S3*+S2+S1 respectively. Lane 4-7: S3*+S2+S1 in presence of parent cylinder 
,[Fe2(L)3]
4+
, which used as a control (4), [Fe2(L-Ph)3]
4+
 (5), [Fe2(L-Py2)3]
4+ 
(6), [Fe2(L-Py4)3]
4+ 
(7). All the 
loaded samples contained 0.4 µM of oligonucleotide to have a DNA:complex ratio of 3:1.   
 
The results (Figure 3.13) show that the three way junction was prominently 
observed in the presence of the parent cylinder (lane 4). Out of the three substituted 
cylinders tested, the phenyl substituted was the only compound which allowed formation 
of three way junction, obtained in lane 5, containing [Fe2(L-Ph)3]
4+
. However, it was 
much less effective at stabilising three way junction than the parent complex. The 
mobility of this band is less than that of the parent cylinder due to its higher molecular 
weight. This is an interesting result as an analogous carried out by Malina et al. (2007) 
testing the three way junction formation of the phenyl substituted compound ([Fe2(L-
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Ph)3]
4+
) to a palindromic DNA sequence, showed that no DNA three way junction was 
detected.
7
 It is unclear whether this is a difference between the relative ease of stabilising 
a nonpalindromic three way junction versus a palindromic three way junction or whether 
[Fe2(L-Ph)3]
4+
 has some preference for the DNA sequence at the junction point. The 
difference in three way junction forming ability of the three substituted compounds gives 
evidence that the substitution group on the parent ligand does influence three way 
junction formation.  
 
3.2.5.2 The effect of non metallo helicate on the recognition and stabilisation of DNA 
three way junction 
It has previously been mentioned that the size and shape of the cylinder is crucial 
for the recognition and stabilisation of the DNA three way junction. Beside these 
helicates, the other structures e.g. non helicate, having the potential to stabilise DNA 
three way junction were also investigated
7
 to elucidate the best structure of metal based 
compound for DNA three way junction recognition in order to design a novel 
metallosupramolecular complex for targeting selectively to higher order DNA structure, 
DNA three way junction. One interesting compound is a trinuclear Pt (II) complex 
containing 2, 2'-bipyrazine ligands (bpz) as shown in Figure 3.14.  
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Figure 3.14 Schematic drawing (left) and crystal structure
22
 (right) of [{(en)Pt(bpz)}3]
6+
 where en = 
ethylenediamine. 
 
Unlike the helicates investigated, this compound has a cyclic structure containing 
three platinum atoms bridged by a pyrazine ligand thus resulting in an approximate 
equilateral triangle formation. Considering this compound in terms of DNA three way 
junction recognition, it posses several advantages. It has a high positive charge (6+) and a 
triangular shape, which should allow good recognition. Moreover, the length between Pt-
Pt is approximately 1 nm
22
 which is comparable to that of the iron cylinder (1 nm in 
width). Therefore, a gel experiment was carried out to probe the DNA three way junction 
recognition of this triangular platinum compound. This compound, which has a nitrate 
(NO3
-
) counter ion, was kindly provided by Philipp von Grebe, a PhD student working 
with Professor Bernhard Lippert at the University of Dortmund.  
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Figure 3.15 Autoradiogram of the recognition and stabilisation of [{(en)Pt(bpz)}3]
6+
 to DNA three way 
junction. Lane 1: S3*+S2+S1. The concentration of DNA per strand was 0.4 µM. Lane 2-6: S3*+S2+S1 
with [{(en)Pt(bpz)}3]
6+
. The ratios of DNA (strand) to complex
 
increased from 3:0.25, 3:0.5, 3:1, 3:2 to 
3:10. Lane 7: control containing S3*+S2+S1 with [Fe2L3]
4+
 at 3:1 ratio. The samples were incubated for 24 
hours. 
 
Initially, the experiment was carried out following the protocol in which the 
solution containing DNA and the complex were incubated for an hour before PAGE was 
run. However, the band corresponding to DNA three way junction was not observed. 
Since increasing the time the compound and DNA were able to interact could possibly 
promote the formation of the DNA three way junction therefore the experiment was 
repeated with an increased incubation time of 24 hours. The result shown in Figure 3.15 
demonstrates that the platinum compound ([{(en)Pt(bpz)}3]
6+
) was not able to recognise 
and stabilise DNA three way junction. This could be due to the molecule. It could be 
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possible that the ethylenediamine coordinated to platinum is not in the right orientation. 
Also the ligand contains a rigid bond between the two pyrazines which may not be as 
flexible as the CH2 spacer of [Fe2L3]
4+
 therefore the π-π stacking of the complex to the 
bases at the core cavity may be absent.  
This result again confirms that the complex’s size and shape are the key features 
for the recognition of a DNA three way junction. Interestingly, the higher positive charge 
(6+) from the platinum complex (4+ for the iron cylinder) did not simply electrostatically 
aid the three way junction formation confirming that the size and shape of the complex 
are a key requirement of binding in the junction.   
 
3.2.5.3 The effect of the peptide conjugated iron cylinder on the recognition and 
stabilisation of a DNA three way junction 
Recently, many researchers have focused on enhancing the specificity of metal 
complexes to DNA sequences by conjugating short amino acids to these metal 
complexes. This is because amino acids play a crucial role in the recognition of specific 
DNA base sequences in natural systems.
23-25
 Therefore, combining the DNA binding 
properties of the iron cylinder and specificity from short amino acids would be the most 
promising strategy to create cylinders with unprecedented DNA binding properties that 
selectively recognise DNA sequences. Based on this concept, the iron cylinder-peptide 
conjugates (Figure 3.16) were synthesised by Lucia Cardo, colleague from the Hannon 
group.
26
 In order to retain the efficiency of their DNA recognition properties, the peptides 
were designed to attach at the end of the cylinder at the 5-position of the pyridine ring. 
This attachment site was thought to be the best site for conjugation as the peptides are 
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kept far away from the key DNA binding motif of the cylinder. They should not interfere 
with the coordination sphere of the octahedral metal ions of the complex. 
 
 
 
Figure 3.16 A) Illustrating the chemical structure of the parent ligand (L) and the ligand-peptide 
conjugated used to form the iron triple stranded helicate. Note that X is the amino acids that conjugate to 
the ligand (Lp). It consists of D-Serine (Lp1), L-Serine(Lp2), D-Arginine(Lp3), L-Arginine(Lp4) and 
tripeptide, Glycine-Glycine-Serine (Lp5). B) Amino acids used to attach to the iron cylinder. 
 
DNA binding experiments using circular and linear dichroism techniques confirm 
the binding and reveal that all conjugated cylinders are capable of coiling and bending ct-
DNA differently.
26
 However, the binding of the conjugated cylinder to a DNA three way 
junction has not yet been investigated. An experiment to explore the effect of the 
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conjugated amino acid on the recognition of a DNA three way junction, compared to the 
parent cylinder, was carried out. In this experiment all the conjugated iron cylinders, with 
chloride counter ions, were kindly provided by Lucia Cardo (Hannon group) who 
designed and synthesised the conjugated cylinders.  
 
Figure 3.17 The autoradiogram shown the recognition of the conjugated iron cylinder to a DNA three way 
junction on 15% PAGE at room temperature. Lane 1-3: Controls including S3*, S3*+S2, S3*+S2+S1 
respectively. Lane 4-9: S3*+S2+S3 in the presence of the parent cylinder, [Fe2L3]
4+
, [Fe2(Lp1)3]
4+
, 
[Fe2(Lp2)3]
4+
, [Fe2(Lp3)3]
4+
, [Fe2(Lp4)3]
4+
 and [Fe2(Lp5)3]
4+
, respectively where Lp1, Lp2, Lp3, Lp4 and 
Lp5 are D-serine, L-serine, D-arginine, L-arginine and tripeptide (glycine-glycine-L-serine). The 
concentration of DNA (per stand) was 0.4 µM and the ratio of DNA (per strand) to complex was 3:1 
corresponding to 0.4 µM of the complexes. 
 
The result shown in Figure 3.17 demonstrates that all conjugated iron cylinders, 
[Fe2(Lp1)3]
4+
, [Fe2(Lp2)3]
4+
, [Fe2(Lp3)3]
n+
, [Fe2(Lp4)3]
n+
 and [Fe2(Lp5)3]
4+
 in lane 5, 6, 7, 
8 and 9 respectively, show the ability to promote DNA three way junction formation. 
Furthermore, the different migration distances among the conjugated iron cylinders and a 
DNA three way junction adduct were observed. The gel reveals that the D and L serine 
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(lanes 5 and 6) conjugates migrated slightly slower than the iron cylinder due to the 
increased molecular weight from the serine attachment. Moreover, the migration of the D 
and L arginine conjugates (lanes 7 and 8) was the slowest among all of the conjugated 
helicates. This is because the D and L-arginine conjugated cylinder ([Fe2(Lp3)3]
n+
 and 
[Fe2(Lp4)3]
n+
) adducts have a high positive charge so they run slower than the adducts 
that are less positively charged, i.e. [Fe2L3]
4+
 (lane 4), [Fe2(Lp1)3]
4+
 (lane 5), 
[Fe2(Lp2)3]
4+
 (lane 6) and [Fe2(Lp5)3]
4+
 (lane 9). Precipitation of DNA on the well was 
observed in lane 7 and 8 containing D and L- arginine due to the high positive charge 
(10+) arising from the metal and amino acid. The tripeptide conjugated iron cylinder 
adduct ([Fe2(Lp5)3]
4+
) in lane 9 migrated slower than the D and L-serine conjugates due 
to its the higher molecular weight. However, the tripeptide conjugate ran faster than the D 
and L arginine conjugated cylinders. This is because the effect of the charge (potentially 
as high as 10+) from the D and L arginine is greater on the migration than the molecular 
weight of the tripeptide conjugate. Although the mobility shift of each compound-three 
way junction adduct was different, the result will be more obvious if the gel 
electrophoresis is run longer than 4 hours or the concentration of polyacrylamide gel is 
increased up to 20%. In addition, the quantification of the distance migration of each 
adduct could be used to calculate a Rf value (distance of 3WJ over distance of ssDNA) 
and therefore the migration of each adduct could be accurately compared. 
To compare DNA three way junction formation due to each conjugated complex, 
quantification of the band intensity from Figure 3.17 was performed. It should be noted 
that the experiments were carried out only in duplicate as in the other experiments herein 
as the amount of each compound was limited.  
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Figure 3.18 A Bar graph depicting the comparison percentage of 3WJ treated with the peptide conjugated 
iron cylinders. Each conjugating units of the complex has been labelled in x-axis. PC = parent cylinder 
([Fe2L3]
4+
). The graph represents the means of two individual experiments ± SD (n = 2). 
 
 
The percentage of DNA three way junction formed, illustrated in the graph 
Figure 3.18, shows that the arginine conjugates, both D and L configurations, cause the 
highest three way junction formation among all conjugates. In addition, the D-arginine 
conjugate has a higher ability to induce three way junction formation than the L-arginine 
conjugate. This indicates that the chirality of the conjugated compounds contributes to 
the recognition of a DNA three way junction. Interestingly, DNA binding studies by CD 
showed that the M enantiomer conformation of the triple stranded helicate, remarkably 
induced by the anchored D-arginine, is more effective in DNA recognition than the P 
enantiomer promoted by the anchored L-arginine.
27
 The parent cylinder (PC), the serine 
conjugates, in D and L configuration, and the tripeptide conjugate show a comparable 
activity to promote DNA three way junction formation. This experiment shows that 
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conjugation of an appropriate amino acid to the iron cylinder does enhance DNA three 
way junction formation. 
 
3.2.6 Competitive assay of DNA three way junction and the other DNA structures to 
[Fe2L3]
4+ 
It is known that cisplatin and its analogs have great efficacy in the treatment of 
certain types of cancers such as testicular, ovarian, bladder, cervical, head, neck and lung 
cancer.
28
 This anticancer drug binds all along the DNA to a guanine base at the N7 
position and kinks the DNA. One result of this widespread DNA platination is unpleasant 
side effects.
29
 One strategy for drug design is to focus on a very specific DNA sequence. 
However to explore the effective sequence selectivity, many bases have to be recognised 
and high throughput screening is required. Recently, an alternative approach to anticancer 
drug design has been to seek to recognise higher order DNA structures such as targeting 
DNA three way junctions or G-quadruplex DNA.
33, 34
 
It has been shown that the iron cylinder [Fe2L3]
4+
 binds in the DNA major groove 
and causes dramatic intramolecular coiling. Additionally, it also recognises and promotes 
DNA three way junction formation. Recently, Yu et al. reported results from several 
biophysical experiment.
30
 It was proposed that the P enantiomer of the iron cylinder 
[Fe2L3]
4+
 selectively recognised and stabilised human telomeric G-quadruplex DNA with 
a stronger efficiency than the M enantiomer. Corresponding results from several 
biological tests, including telomerase inhibition, telomere shortening, β-galactosidase 
activity and up-regulation of CDK inhibitors p16 and p21, appeared to confirm that the P 
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enantiomer exhibited a stronger preference to G-quadruplex DNA than the M 
enantiomer.
31
 
The preference of the iron cylinder for different DNA structures was therefore 
investigated. A competition assay between several DNA structures and the iron cylinder 
([Fe2L3]
4+
) was established.  
The experiment, herein, was designed around an S1, S2 and S3 three way junction 
in which only the S3* strand is labelled. Increasing concentrations of the iron cylinder 
were added to the solution in the presence of different competitor DNAs. The competitor 
DNAs were selected to have the same charge (number of bases) as the three way junction 
to minimise electrostatic effects. Alternatively, the experiment could be designed to add 
increased concentrations of competitor into a fixed concentration of complex and DNA 
three way junction.  
 
Figure 3.19 Sequences of competitors. A) G-quartet (left) and its G-quadruplex scaffold (right). B) C-C 
base pair (left) and its i-motif structure (right). Taken from the ref.
32
 C) Double stranded DNA. D) Double 
stranded with a loop containing ten thymines. 
 
Chapter 3 
 154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20 Autoradiogram of a competitive assay of a DNA three way junction and the other DNA 
structures to the iron cylinder [Fe2L3]
4+
. The competitiors used for this experiments were double stranded 
DNA (dsDNA, B), double strand with loop (dsDNA_L, C), G-quadruplex (D) and i-motif (E). The 
concentration of a DNA three way junction and competitor were constant at 0.2 µM. The ratio of complex 
to DNA three way junction to competitor increased from 0.25:1:1, 0.5:1:1, 1:1:1, 2:1:1 to 10:1:1, 
corresponding to 0.05, 0.1, 0.2, 0.4 and 2 µM of complex.  
 
A
. 
B. C. 
D. E. 
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Our assumption is that the competitors bind preferentially to the iron cylinder then less 
three way junction will be stabilised when the cylinder is added. The competitors used in 
this experiment were a double strand DNA (dsDNA), a double strand DNA with 10 loops 
(dsDNA_L), a G-quadruplex structure and an i-motif structure as shown in Figure 3.19.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Top: A plot illustrating percentage of three way junction versus concentration of iron cylinder 
(µM) in the presence of competitors. The ratio of complex: DNA three way junction: competitor increased 
from 0.25:1:1, 0.5:1:1, 1:1:1, 2:1:1 to 10:1:1, respectively. Bottom: A plot the top graph focusing the ratio 
of complex: DNA three way junction: competitor increased from 0.25: 1: 1, 0.5: 1: 1, 1: 1: 1, respectively 
corresponding to 0.05, 0.1, 0.2, 0.4 and 2 µM of complex. The trend lines were drawn for clarity. The 
experiments were conducted in triplicate and the error bars representing SD value. 
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The gel electrophoresis results shown in Figure 3.20 were later evaluated and compared 
among the DNA structures.  
The gel quantification represented as a graph in Figure 3.21 shows that if we 
consider low concentration of the cylinder (0 – 0.2 µM) it shows that double stranded 
DNA and double stranded DNA with loop are good competitors.  
G-quadruplex and i-motif DNA structures do not seem to compete for binding. 
These two structures are pre-formed in the solution so the fact that the cylinder can 
assemble the three way junction structure in their presence indicates a much stronger 
binding constant to the three way junction. This finding raises question marks over the 
validity of Yu’s recent report.
30
 Yu’s experiments based on DNA melting experiments 
conducted at temperature above the stability of the cylinder and may therefore be 
reporting on a cylinder component (such as the iron centre) rather than the cylinder. It 
should be aware that the i-motif structure probably did not form because pH, used in the 
experiment, was not low enough (required ~ 5.5) for the protonation of cytosine bases in 
the i-motif structure. 
The double stranded and double stranded with loop DNAs are clearly competitors 
though the precise preference is hard to quantify in the experiment as both the double 
stranded and double stranded with loop DNAs will be preformed in solution while with 
three way junction is only formed in presence of the cylinder. The loop point represents a 
Y-shaped junction and the double stranded DNA is likely to denature at the ends 
(providing Y-shaped forks). 
From studies with a palindromic DNA, it is known that cylinder binds to three 
way junction over double stranded DNA, with a strong preference, with no double 
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stranded DNA observed in these experiments either at low or high cylinder loading. The 
sensitivity of this competition binding assay is shown by the fact that at 1:1:1 ratio of 
cylinder: three way junction: double stranded DNA, ~60% is bound to the three way 
junction and 40% to the double stranded DNA. This reinforces just how great the 
preference for three way junction over G-quadruplex is.   
The looped DNA, which contains the form at loop point, is bound in preference to 
double stranded DNA. This may indicate that the competition comes not from major 
groove binding but from Y-shaped junction binding. 
However, to elucidate the recognition of the iron cylinder to the DNA structures, 
i.e. DNA three way junction, G-quadruplex and i-motif structure, further experiments 
will be required to support this preliminary testing experiment. The binding constant of 
the iron cylinder to the DNA three way junction, G-quadruplex and i-motif DNA 
structure must be determined and the mechanism of the iron cylinder exhibiting cell 
growth and leading to apoptosis elucidated by cell testing.  
 
3.3 Conclusions  
In summary, gel electrophoresis with radiolabelling is a powerful technique 
offering high sensitivity in the study of the recognition of the metallo supramolecular 
cylinder to a DNA three way junction. In the rational drug design of new analogues, 
consideration of the size, shape, metal centre, the conjugation of functional groups are 
crucial in retaining the DNA recognition of the parent drug. The results herein show that 
only an iron cylinder with a certain size and shape allows three way junction formation. 
Results also show that changing the metal ion centre of the metallo cylinder from iron to 
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ruthenium does not alter the recognition of the complex to DNA three way junction. The 
selectivity and recognition of the iron cylinder to the DNA three way junction can be 
increased by conjugating amino acids to the ligand. Moreover, the competition assay of 
several DNA structures shows that the iron cylinder binds to three way junction 
preferentially over G-quadruplex structure but binding to other Y-shaped junctions is a 
possible competition. 
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3.4 Experimental 
All chemicals were purchased from Fisher, Sigma-Aldrich and Fluka otherwise the 
source will be specified. 
Radioactive labelling: A reaction mixture of 10 µl in 1.5 ml eppendrof containing 4.8 µl 
of MilliQ water, 1 µl of 10x bacteriophage T4 polynucleotide kinase buffer, 1.2 µl of 100 
µM oligonucleotide (S3), 1µl of bacteriophage T4 polynucleotide kinase (New England 
Biolab) 2 µl of γ-
32
P ATP (6000 Ci/mmol) from Perkin Elmer were well mixed and 
incubated for 40 min at 37 °C. Then the mixture was heated at 80 °C for 3 minutes to 
inactivate the polynucleotide kinase. For cleanup of radioactive DNA fragments from 
unincorporated ATP A QIAquick nucleotide removal kit (QIAGEN) was used. Briefly, 
10 volumes of Buffer PN were added to 1 volume of the reaction sample. Then the 
mixture was transferred onto spin column and centrifuged column at 6000 rpm for 1 
minute.  The supernatant was discarded. The column was transferred into a new elution 
tube and buffer PE was added 500 µl. The flow-through was discarded and the wash was 
repeated with another 500 µl of Buffer PE. The column was centrifuged again at 13,000 
rpm for 1 minute to discard the residual buffer. The column was transferred into a 1.5 ml 
eppendrof. 30 µl of milliQ water was added to the column and allowed to stand for 5 
minutes before being centrifuged at 13,000 rpm for 2 minutes to obtain 8 µM of stock 
radiolabeled DNA.  
Polyacrylamide gel preparation: 15% native polyacrylamide gel solution containing 10 
ml of 10x TB buffer pH 8.3 (890 mM tris(hydroxymethy) amino methane, 890 mM boric 
acid), 37.5 ml of 40% acrylamide (29:1) from Geneflow, 52.5 ml of milliQ water, 500µl 
of 10%(w/v) ammonium persulfate and 75 µl TEMED, was poured onto a set of glass 
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plates. The wells of the polymerised gel were thoroughly washed with a running buffer 
(TB buffer) before use. Note that pre-running of the gel at 200 volts for 5 minutes is 
required before the experiment is performed. 
Purity checking by 18% denaturing polyacrylamide gel electrophoresis: 18% 
denaturing polyacrylamide gel solution containing 10 ml of 10x TBE buffer pH 8.3 (890 
mM tris(hydroxymethy) amino methane, 890 mM boric acid and 2 mM Na2EDTA) from 
National Diagnostics, 45 ml of 40% acrylamide (29:1) from Geneflow, 42 g of urea, top 
the milli Q water up to 100 ml. The solution was mixed very well until all components 
became a homogenous solution. Then 500µl of 10%(w/v) ammonium persulfate and 75 
µl TEMED were added to the solution. Subsequently, the solution was poured onto a set 
of glass plates. The wells of the polymerised gel were thoroughly washed with a running 
buffer (TB buffer) before use. Note that prerunning of the gel at 200 volts for 5 minutes is 
required before the experiment is performed. The labelled strand was loaded onto the 
well and run for 2 hours. The gel was then taken out from the glass plate and exposed to 
the phosphorimager for 10 min, then the image was developed. 
Gel electrophoresis experiment: The highly pure oligonucleotides 
(S1:CGGAACGGCACTCG, S2: CGAGTGCAGCGTGG, S3: CCACGCTCGTTCCG) 
were bought from Eurofins, Germany. Stoichiometric amounts of the oligonucleotides 
(0.4 µM, related to strand) were mixed with complexes in the TBN buffer pH 8.3 
containing 89 mM tris(hydroxymethy) amino methane, 89 mM boric acid and 100 µM 
NaCl. The solutions were incubated at room temperature for 1 hour and on ice for 15 
minutes. The samples were loaded onto 15% polyacrylamide gel electrophoresis and run 
for 4 hours at 120 volts using Gel System (Thermo Scientific, UK). Then, the gel was 
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exposed on a phosphor plate for an hour. The image was obtained from Molecular imager 
FX (Bio-Rad). The quantification was operated by Quantity one (Bio-Rad). 
Competition assay of DNA 3WJ and other DNA structures: the solution of labelled 
DNA 3WJ (0.2 µM) in TBN buffer was incubated with the iron cylinder for an hour at 
room temperature. DNA (per strand):complex ratios 3:0.25, 3:0.5, 3:1, 3:2 and 3:10. The 
concentration of the cylinder, corresponded to those ratios are 0.05, 0.1, 0.2, 0.4 and 2 
µM. Then the same amount of a solution of non-labelled competitor (0.2 µM) was added 
in to each ratio. The solutions were incubated for 1 hour at room temperature. The 
samples were loaded, run and quantified using the same method as described previously. 
The sequences of competitor are shown below. 
 
Competitor Abbreviation Sequences (5’-3’) 
G-quadruplex
30
 G-quadruplex AGG GTT AGG GTT AGG 
GTT AGG G 
i-motif DNA
30
 i-motif CCC TAA CCC TAA CCC 
TAA CCC T 
Double stranded DNA dsDNA CCT TCA CGC GAA CGT 
AAT CCT, AGG ATT ACG 
TTC GCG TGA AGG 
Double strand DNA with 
loop 
dsDNA_L TTC ACG CGT TTT TTT 
TTT AAC GTA AT, ATT 
ACG TTC GCG TGA A 
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Chapter 4 
 
 
 
The application of the metallosupramolecular cylinder to DNA 
nanotechnology 
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4.1 Introduction 
DNA polyhedra are prepared for a wide range of applications such as for the 
encapsulation and release of drugs, regulation of protein folding and activity, and the 
assembly of 3D networks for catalysis and biomolecule crystallisation.
1-3
 The first DNA 
nanostructure, the cube-like DNA, was constructed by Nadrian Seeman and co-workers.
4
 
In the procedure described, two quadrilaterals were annealed to form a belt-like object 
that was then purified, reconstituted, cylised and ligated to produce an assembly of six 
interconnected cyclic DNA strands as a cube like object, in less than 1% yield. The 
synthetic route is shown in Figure 4.1. 
 
Figure 4.1 Synthetic scheme
4
 for cube-like DNA nanostructure. 
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 Later, the same group modified the method by utilising a solid-phase synthesis to 
combine individual polygons and polygonal clusters into a truncated DNA octahedron
5
 
containing 14 faces (six squares and eight hexagons), 24 vertices, and 36 edges. The 
DNA octahedron
6
 was later constructed from a mixture of a 1,669 base nucleotides, 
defined as the heavy chain, and five 40 base nucleotides, the light chains, by a simple 
denaturation–renaturation procedure. These constructions were complicated and required 
several sequences for the construction. However, Turberfield and co-workers 
subsequently synthesised a DNA tetrahedron designed from a single step synthesis.
7, 8
 
The tetrahedron was assembled from four strands each comprising a 55 base 
oligonucleotides. Each strand contains three 17 base sub-sequences, separated by two- 
base hinges. The unhybrided hinges are designed to ensure that the structure has 
sufficient flexibility to achieve an angle of 60° between adjacent edges. The ease of the 
synthesis and the rigidity make this DNA nanostructure promising as a DNA cargo 
vessel. The application of this design was then demonstrated by the same group. 
Turberfield and co-workers encapsulated the protein, cytochrome c, into a DNA 
tetrahedron by conjugating it to the inner surface of the DNA tetrahedron.
9
 Moreover, the 
rigidity of the DNA tetrahedron is beneficial for the binding of fluorescent dyes to the 
nanostructure. Armitage et al. showed that the DNA tetrahedron provides a protective 
medium for the fluorophores, YOYO-1 (Figure 4.2), resulting in their improved 
photostability and increased resistance to nuclease digestion.
10
 This is an example of 
ultilising the DNA tetrahedron to enhance the stability of the intercalating dye.  
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Figure 4.2 Chemical structure of YOYO-1. 
 
The triple stranded supramolecular cylinder, [Fe2L3]
4+
, is formed from three bis-
pyridylimine ligands wrapped around two iron metal centres
11
 and is cylindrical in shape. 
This cylinder has been shown to bind in the major groove of DNA and causes remarkable 
intramolecular coiling of DNA.
12, 13
 It can also bind to DNA three way junction.
14
 
However, the interaction between this cylinder and a three dimensional DNA construct 
has never been established. 
  Herein, the interaction between the iron cylinder and the DNA tetradron was 
demonstrated by CD and gel electrophoresis. The change in topology was illustrated by 
AFM, and later the stability of the iron cylinder and the DNA structure was probed by 
melting temperature experiment.  
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Figure 4.3 A) Synthetic scheme of DNA tetrahedron. B) A side view (left) and top view (right) of a 
spacefilling representation
8
 of tetrahedron. Each face of tetrahedron is illustrated by a single color. C) The 
structure of the iron cylinder
12
 [Fe2L3
]4+
 which has ~2 nm in length and ~1 nm in diameter. 
 
 
4.2 Results and discussion 
4.2.1 CD binding study of the iron cylinder and the DNA tetrahedron 
CD spectroscopy is a useful technique to analyze changes in DNA morphology by 
the interaction of DNA with small molecules. The changes in CD signal of DNA 
observed on interaction with drugs may often be assigned to the corresponding changes in 
DNA structure. To confirm that the iron cylinder interacts with the DNA tetrahedron, 
circular dichroism (CD) was utilised to probe the interaction. The iron cylinder was 
titrated into the DNA tetrahedron solution in cacodylate buffer. In addition, the 
concentration of the DNA tetrahedron was kept constant during the titration. The ratio of 
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the DNA tetrahedron (bases) to the cylinder started from 60:1, 30:1, 15:1, 8:1, 6:1 to 4:1. 
The concentrations of the iron cylinder corresponding to these ratios are 0.17, 0.33, 0.67, 
1.25, 1.67 and 2.5 µM, respectively.  
The results (Figure 4.4) show that the B-form DNA was still retained, due to a 
characteristic pattern from 220 nm to 300 nm. The unique pattern remained during the 
titration, revealing that the iron cylinder does not perturb the conformation of the DNA. 
Also the recorded UV-Vis spectra during the titration indicate that the iron cylinder 
retained its structure. Interestingly, an induced CD (ICD) was not observed during the 
titration. It is possible that the DNA tetrahedron contains two enantiomers
7
 as does the 
iron cylinder
15, 16
. Therefore, any ICDs cancelled each other out and no signal was 
detected.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 CD spectra (left) and UV-Vis spectra (right) from 1 cm pathlength cuvette containing 10 µM 
DNA tetrahedron in 20 mM NaCl and 1 mM cacodylate buffer with increasing concentration of [Fe2L3
]4+.
 
The DNA in bases:[Fe2L3
]4+
 ratios are 60:1, 30:1, 15:1, 8:1, 6:1 and 4:1. The concentration of the cylinder 
corresponding to these ratios are 0.17, 0.33, 0.67, 1.25, 1.67 and 2.5 µM, respectively. 
 
Chapter 4 
 171 
4.2.2 Gel electrophoresis studies 
To probe any potential binding in more detail, gel electrophoresis was introduced 
to investigate the effect of the iron cylinder on the DNA nanostructure. The experiment 
was designed to have a control, the DNA tetrahedron synthesised by hybridising four 
strands of DNA as mentioned in the literature.
7
 Then, the DNA tetrahedron was treated 
with the iron cylinder at increasing ratios (DNA tetrahedron:cylinder) from  1:0.5, 1:1, 
1:2, 1:4, 1:8 to 1:16. The concentration of the cylinder corresponding to these ratios are 
0.5, 1, 2, 4, 8, 16 µM.  
The results (Figure 4.5) show that the DNA nanostructure was formed with 
migration of the hybridised four strands, the DNA tetrahedron, being slower than the 
three strands, double strands and a single strand ,respectively (on 10% PAGE). In the 
presence of the iron cylinder, [Fe2L3]
4+
, the migration of the DNA nanostructure was 
accelerated starting from 1:1. In addition, the migration was significantly accelerated at 
higher concentration of the cylinder. A possible explanation for this observation is that 
the iron cylinder binds to the DNA nanostructure and causes DNA bending, thus the 
DNA nanostructure becomes more compact and migrates though the gel network faster 
than the one of that has less cylinder. A trace of precipitation, shown as a band on the 
well, was detected at 1:4 ratio and more dramatically observed at 1:8 and 1:16 
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Figure 4.5 Autoradiogram illustrating the interaction between the DNA tetrahedron and the iron cylinder 
on 10% non-denaturing polyacrylamide gel electrophoresis. Lanes 1-3: Control containing T1, T1+T2, 
T1+T2+T3. Lane 4: Control consisting of strand 1, 2, 3 and 4, (T1+T2+T3+T4), forming DNA tetrahedron 
(1 µM). Lanes 5-10: Sample containing a DNA tetrahedron in the presence of the iron cylinder, [Fe2L3]
4+
. 
The ratio of DNA tetrahedron to the iron cylinder started from 1:0.5, 1:1, 1:2, 1:4, 1:8 to 1:16 respectively. 
The concentrations of the cylinder corresponding to these ratios are 0.5, 1, 2 ,4, 8, 16 µM. All the samples 
were carried out in TM buffer (10 mM Tris, 1 mM 20 mM MgCl2, pH 8.0). 
 
It is known that the DNA tetrahedron has a rigid structure. However, the iron 
cylinder appears to have a high affinity for interacting with the structure and in fact alters 
the structure, however the B-DNA configuration is retained. To study this further, 
ethidium bromide, a representative intercalator was used to compare its interaction and 
effects with these of the iron cylinder.  
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Figure 4.6 Autoradiogram illustrating the interaction between DNA tetrahedron and ethidium bromide on 
10% non-denaturing polyacrylamide gel electrophoresis. Lanes 1-3: Control containing T1, T1+T2 and 
T1+T2+T3 respectively. Lane 4: Control containing strand 1, 2, 3 and 4, (T1+T2+T3+T4), forming a 
control, DNA tetrahedron (1 µM). Lanes 5-10: Sample containing a DNA tetrahedron in the presence of 
ethidium bromide. The ratio of DNA tetrahedron in base pairs to ethidium bromide started from 220:1, 
220:2, 220:4, 220:8, 220:16, 220:32, 220:55, 220:110 to 220:220 respectively. The concentrations of 
ethidium bromide corresponding to these ratios are 1, 2, 4, 8, 16, 32, 55, 110 and 220 µM. All the samples 
were carried out in TM buffer (10 mM Tris, 1 mM 20 mM MgCl2, pH 8.0) 
 
The results (Figure 4.6) demonstrate that increasing the concentration of ethidium 
bromide causes a slight retardation of the migration of the DNA tetrahedron. This result 
is the converse of what we observed using the iron cylinder. It is possible that ethidium 
bromide intercalated between base pairs will stiffen the DNA arms leading to a more 
rigid slower moving tetrahedron. Alternatively, this nanostructure could be unwinded and 
stiffened by ethidium bromide resulting in the twisting away of the DNA nanostructure. 
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Moreover, in the presence of ethidium bromide, the band has shifted only a small amount 
compared to shifts observed with the iron cylinder. This implies that the DNA bending 
effect of the iron cylinder on the DNA tetrahedron is more powerful than the stiffening 
effect of ethidium bromide. Nevertheless, both clearly interact differently with the DNA 
nanostructure.  
 
4.2.3 Atomic Force Microscopy (AFM) 
 Gel electrophoresis experiments show the change of DNA nanostructure resulting 
in the accelerated migration. However, imaging and measuring the dimensions of the 
tetrahedron would be intriguing for monitoring the interaction of the iron cylinder with 
the DNA nanostructure. Herein, AFM was carried out to image the effect of the iron 
cylinder on the DNA tetrahedron. In addition, the dimensions of the tetrahedron in the 
presence and absence of the iron cylinder will be presented. This work was performed in 
the laboratories of Professor Richard E. Palmer, School of Physics, The University of 
Birmingham.  
The DNA tetrahedron was designed to have six of 17 base pair (bp) edges 
meeting at one vertex. Consequently, only one orientation giving a height of ~ 6.2 nm is 
expected on the surface.
8
 The three dimensional plot reveals that the height of the DNA 
tetrahedron is ~ 6-8 nm, corresponding to that observed in the literature. However, the 
images were not well resolved due to the tip radius. The radius of the tip was 6 nm which 
is bigger than the nanostructure (~ 6.2 nm) thus resulting in the image appearing as a dot 
(Figure 4.7).  
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Figure 4.7 AFM images of the DNA tetrahedron. Top left: AFM image showing the DNA tetrahedron 
deposited on a mica surface. Top right: Enlargement of the top left image. Bottom: A three dimensional 
plot of the top right image showing the height of the DNA tetrahedron and the scanning area. 
 
In the presence of the iron cylinder (Figure 4.8), the plot reveals that the dimension of 
the DNA tetrahedron was altered. The height of the structure was reduced from ~ 6.2 nm 
to 2 nm i.e. to a collapsed structure from the bending which corresponds to the gel 
electrophoresis results. This plot confirms that the iron cylinder interacts with the DNA 
tetrahedron resulting in a structural change.  
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Figure 4.8 AFM images of the DNA tetrahedron treated with iron cylinder. Top left: AFM image showing 
the DNA tetrahedron treated with iron cylinder. Top right: Enlargement of the top left image. Bottom: 
Three dimensional plot of the top right image showing the height of the DNA tetrahedron and scanning 
area. The ratio of tetrahedron:iron cylinder is 1:2. 
 
4.2.4 DNA thermal denaturation studies 
It is known that when a solution of DNA is heated enough, the non covalent 
forces that hold the two strands together are not sufficiently strong enough and the bonds 
will break. When this happens, the two strands come apart in a process known as DNA 
melting or DNA denaturation. The temperature at which the DNA strands are half 
denatured is called the melting temperature or Tm. Plotting absorbance, at 260 nm, against 
temperature is known as a melting curve.
17
 Tm is usually used to indicate the stability of 
the double helix DNA. The interaction of synthetic agent and DNA may alter Tm by 
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stabilising (increase of Tm) or destabilising (decrease of Tm) effect. Therefore, the melting 
curve experiment was established to monitor the stability of the iron cylinder and DNA 
tetrahedron adduct.  
 
Figure 4.9 Melting curve of the DNA tetrahedron (10 µM) in the presence of the iron cylinder ([Fe2L3]
4+
; 
10 µM)) at ratio 1:1 (DNA tetrahedron:complex) and ethidium bromide (EtBr; 1.1 mM) at ratio 2:1 
(DNA(bases):ethidium bromide). All samples were carried out in TM buffer (10 mM Tris, 5 mM MgCl2, 
pH 8.0) 
 
On the addition of ethidium bromide
 
to the DNA solution, the DNA melting 
temperature was found to increase from 64 °C to 66 °C at the ratio of DNA tetrahedron 
base pair:ethidium bromide of 2:1. This shows that the stability of the DNA tetrahedron is 
increased by ethidium bromide. Note that at lower ratios (less than 2:1) no change in the 
melting temperature was observed. Monitoring at higher ratios of the DNA base pair to 
ethidium bromide was not achievable due to the overlap of absorbance, from ethidium 
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bromide, with the DNA at 260 nm. Interestingly, the melting temperature significantly 
increased from 64 °C to 69 °C in the presence of [Fe2L3]
4+
 at a ratio of DNA 
tetrahedron:[Fe2L3]
4+
, 1:1. Just as for ethidium bromide, at higher concentration of the 
cylinder, overlapping spectroscopy was an issue and at lower concentration, no change 
was found. These results show that the iron cylinder ([Fe2L3]
4+
) has a greater ability in 
stabilising the DNA tetrahedron than ethidium bromide, used as a control.  
 
4.3 Conclusions 
Herein, it is shown that the iron cylinder interacts with the DNA tetrahedron, 
known to have a rigid structure confirmed by a number of techniques. Firstly the CD 
experiment suggests that the cylinder and DNA B-structure are not affected by their 
interactions. Gel electrophoresis demonstrates that the structure of the DNA tetrahedron 
changes in the presence of the iron cylinder, shown by the migration of the bands. The 
topological information obtained from AFM demonstrates that the dimensions of the 
structure are altered. Additionally, the dimensional measurements carried out support the 
topological change. AFM images reveal that the height of the tetrahedron in the presence 
of the iron cylinder is reduced from 6.2 nm to 2 nm. Finally, a thermal denaturation 
experiment indicates that the stability of the DNA tetrahedron treated with the iron 
cylinder is greater than the one without the iron cylinder. The studies in this chapter were 
mainly focused on how the iron cylinder and ethidium bromide interact with the 
nanostructure. It would be interesting to carry out the experiment in which the 
nanostructure was assembled in the presence of ligand e.g. T1+ligand, T1+T2+ligand, 
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T1+T2+T3+ligand and T1+T2+T3+T4+ligand. It could be possible that the binding of 
the ligand to the preformed DNA may change the topology of the final nanostructure. 
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4.4 Experimental 
Assembly of Tetrahedra.
7
 To form the tetrahedral, equimolar quantities (10 µM) of 
oligonucleotides 1 to 4 were combined in TM buffer (10 mM Tris, 5 mM MgCl2, pH 8.0), 
heated to 95°C for 2 minutes and then cooled to 4°C over 30 seconds using a PCR 
machine (Eppendorf Mastercycler). All oligonucleotides were supplied by MWG Eurofin 
(Germany). Strand T1: ACA TTC CTA AGT CTG AAA CAT TAC AGC TTG CTA 
CAC GAG AAG AGC CGC CAT AGT A. Strand T2: TAT CAC CAG GCA GTT GAC 
AGT GTA GCA AGC TGT AAT AGA TGC GAG GGT CCA ATA C. Strand T3: TCA 
ACT GCC TGG TGA TAA AAC GAC ACT ACG TGG GAA TCT ACT ATG GCG 
GCT CTT C. Strand T4: TTC AGA CTT AGG AAT GTG CTT CCC ACG TAG TGT 
CGT TTG TAT TGG ACC CTC GCA T 
Circular Dichroism (CD): A spectropolarimeter (JASCO) was used for CD 
measurements. The parameters used are as follows; 100 mdeg; data pitch, 0.5 nm; 
scanning mode, continuous; scanning speed, 200 nm per min; response, 0.1 seconds; 
bandwidth, 1.0; accumulation, 12. The experiments were performed at 25 °C with 1 cm 
path length cuvette (Strana) for measuring at 200-750 nm. Before the measurement, the 
DNA tetrahedron was formed as described above. 250 µl of the DNA tetrahedron (10 
µM) in buffers of 0.89 mM Na-cacodylate ( pH 7.0 ) and 20 mM NaCl were titrated with 
complex (250 µM). The concentration of the DNA tetrahedron (bases):complex ratios are 
60:1, 30:1, 15:1, 8:1, 6:1 and 4:1. During the titration UV-Vis spectra (Cary 5000) were 
recorded. 
Gel electrophoresis: 
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Polyacrylamide gel preparation: 10% native polyacrylamide gel solution containing 20 
ml of 10x TB buffer pH 8.3 (890 mM tris(hydroxymethy) amino methane, 890 mM boric 
acid), 50 ml of 40% acrylamide (29:1) from Geneflow, 130 ml of milliQ water, 1ml of 
10%(w/v) ammonium persulfate and 100 µl TEMED, was poured onto a set of glass 
plates. The wells of the polymerised gel were thoroughly washed with a running buffer 
(TB buffer) before use. Note that prerunning of the gel at 200 volts for 5 minutes is 
required before the experiment is performed. 
Gel electrophoresis experiment: 20 µl of the samples in 1.5 ml Eppendorf tubes were 
prepared by mixing the tetrahedra assembled (1 µM as final concentration) with the iron 
cylinder [Fe2L3]
4+
 in TM buffer. Ratios of the DNA tetrahedron (bases) to complex were 
220:0.5, 220:1, 220:2, 220:4, 220:8 and 220:16 respectively while ratios of the DNA 
tetrahedron (bases) to ethidium bromide were 220:1, 220:2, 220:4, 220:8, 220:16, 220:32, 
220:55, 220:110 and 220:220. The samples were incubated at room temperature for 1 
hour and then on ice for 20 min. 10 µl of 30% glycerol was added to each sample to 
increase the density of the sample to be able to sink into a well. All samples then were 
loaded into 10% polyacrylamide gel. Note that loading dye (5x GelPilot DNA Loading 
Dye, QIAGEN) was separately loaded into the first and the last well to mark where the 
DNA migrates to. The gel was run at 120 volt for 2.50 hours then the gel was placed in 
between a sheet of 3MM whatman paper and Saran wrap. The film (Kodak, Sigma-
aldrich) was exposed on the gel overnight at -80°C. The film was developed by Curix60 
processor (AGFA).  
AFM imaging: samples were prepared for AFM by placing a drop containing 
10 µl of 10 nM tetrahedron or tetrahedron treated with metal complex (ratio tetrahedron : 
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complex ; 1:2) in TM buffer (10 mM Tris, 15 mM MgCl2, pH 8.0) and 2 µl of 10 mM 
NiCl2
18
 on freshly cleaved mica (1 cm × 1 cm) by the adhesive tape. After incubating for 
30 minutes, the samples were rinsed for 5 seconds in a jet of deionised water directed 
onto the surface with a squeeze bottle. The samples were blow dried with compressed 
nitrogen gas and imaged using a Dimension 3100 scanning probe microscope and 
Nanoscope IIIa controller (Veeco, California), operation in tapping mode in air at a scan 
rate of 1-2 Hz. The AFM probes were 125 µm-long cantilever made of single crystal 
silicon with pyramidal shaped Si tips (VISTAprobes), with an average resonance 
frequency of 300 kHz and spring constant K = 40 N/m. The tip radius given by the 
supplier (Vistaprobes T300) is <10 nm. The images were obtained at room temperature 
(T = 23 ± 2 °C). The samples were imaged in several places and many times 
DNA melting curve: The experiment was run simultaneously in the cuvettes of 1.2 mL 
volume using a thermostatic cell-changer UV-Vis spectrophotometer on a Cary 5000 
spectrophotometer. Solution of a DNA tetrahedron, a DNA tetrahedron-metal complex 
consisting of DNA (bases):complex in a ratio of 220:1 and a DNA tetrahedron-ethidium 
bromide solution of DNA (base):ethidium bromide; 220:110 were prepared. The 
solutions were prepared independently and all contained the same DNA nanostructure 
concentration (10 µM) as well as buffer (TM buffer; 10 mM Tris, 5 mM MgCl2, pH 8.0). 
Before and after running the melting curves, UV spectra of the solutions were recorded. 
Cary 5000 UV-Visible Parameters: wavelength: 260 nm; signal band width: 1.0 nm; 
average time: 10.0s; data interval: 0.2°C; temperature scan: 10−95°C; ramp rate: 
0.2°C/min; hold time: 10.0. 
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Chapter 5 
 
 
 
The determination of the binding constant of the iron cylinder 
to oligonucleotide by Surface Plasmon Resonance (SPR) 
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5.1 Introduction 
The determination of a binding constant from an experiment is important for 
investigating interaction of a drug and its target. There are several methods facilitating 
calculation of the binding constant between the DNA binding drug and target DNA such 
as UV-Vis absorption spectroscopy
1-3
 DNA footprinting
4
, circular dichroism (CD)
5
 and 
fluorescence quenching
6
. However, these techniques can have drawbacks, for example 
absorption spectroscopy requires hypochromism of absorption band while radiolabelling 
is desired for DNA footprinting. CD experiments can be time consuming. Quenching in 
fluorescence by ethidium bromide displacement is an indirect approach to determine the 
binding constant, defined as apparent binding constant. Therefore, the alternative 
techniques for the determination of the binding constant which are reliable, detect the 
interaction in real time and do not involve labelling are desirable.  
Surface plasmon resonance (SPR) potentially fulfills all these requirements. This 
biosensor technology has recently become an established method of measuring a variety 
of biomolecular interactions (principally involving proteins), e.g. kinetics and equilibrium 
constants, in real time and characterising binding reactions in the absence of any labelling 
requirements.
7-13
 The principle of SPR-based instruments (Figure 5.1) is to measure the 
refractive index near a sensor surface. In order to detect an interaction, the receptor which 
might be either DNA or protein is immobilised onto the sensor surface. The analyte 
(molecule of interest) is injected in aqueous solution through the flow cell, under 
continuous flow.  
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When the analyte and the receptor interact to form a complex, the SPR detector records 
changes in refractive index near the sensor surface in real time. These changes are 
proportional to the mass of molecules binding to the surface. The result, plotted as 
response in resonance unit (RU) versus time (second), is known as a sensorgram. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 A) Schematic diagram of basic components for SPR biosensor: Light passes through the prism 
and slide, reflects off the gold film and passes back through the prism to a detector. Changes in reflectivity 
versus angle give a signal that is proportional to the amount of complex bound near the surface. B) 
Schematic sensogram, showing association, dissociation and regeneration phases: (1) Association of 
analyte with DNA during sample injection; (2) Dissociation of analyte from the surface during the buffer 
flow; (3) Regeneration of the complex to allow surface to be re-used many times. Taken from ref. 
14
 
 
 
SPR based biosensor technology is widely exploited to determinate the binding constant 
and stoichiometry of binding as shown in Table 5.1 
 
 
A B 
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Table 5.1 Studies of the interaction between DNA-binding drugs and target DNA sequences facilitated by 
SPR technique. Taken from ref. 
15
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It is know that the triple stranded iron cylinder interacts with DNA by binding in 
the major groove and causes intramolecular coiling and also binds to the hollow cavity of 
a DNA three way junction.
16, 17
 As mentioned above, the binding constant of the DNA 
and DNA binding drug is important for the design of new anticancer drugs in terms of 
preferential binding of the drug to a particular DNA site. Pebedery et al. initially 
determined the binding constant of the iron cylinder and calf thymus DNA by ethidium 
bromide displacement assay.
6
 The principle of this technique is based on fluorescent 
quenching. The experiment is carried out by adding iron cylinder [Fe2L3]
4+
 to a solution 
of DNA with sufficient ethidium bromide. The fluorescence dramatically increases when 
ethidium bromide binds to DNA. The principle of ethidium bromide displacement is 
based on the fact that the iron cylinder which has a high positive charge (4+), serving as a 
stronger binder, will displace ethidium bromide bound DNA resulting in decreasing 
fluorescent intensity due to the displacement. The binding constants determined from the 
ethidium bromide displacement experiment are 6 x 10
7
, 7x10
7 
and 7x10
7 
M
-1 
for the iron 
cylinder in racemic mixture and the M and the P enantiomers, respectively, to calf 
thymus DNA. However, two criteria are needed to be considered: 1) the quenching of 
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fluorescence could either originate from the displacement of ethidium bromide, bound to 
DNA, by the cylinder or the cylinder interacting with the ethidium bromide without 
displacement occurring. 2) the binding mode of ethidium bromide and the cylinder is 
different. Ethidium bromide is known as an intercalator while the cylinder is a major 
groove binder.
16
 These criteria show that this technique should be used with caution for 
determining the binding constant of the iron cylinder to DNA. 
To try to more accurately determine the binding constant and the kinetic 
behaviour of the iron cylinder, and its enantiomers, with DNA. SPR based technique is 
explored herein.  
 
5.2 Results and discussion 
5.2.1 Streptavidin immobilisation 
To introduce the SPR technique, an overview of the principle steps of a SPR 
experiment are described as follows (Figure 5.2).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Overview of SPR experiment. A) Sensor surface. B) Carboxyl group (red spheres) conjugated 
with streptavidin (green). C) The binding of biotinylated oligonucleotide (blue) to streptavidin. D)  The 
binding of the iron cylinder (purple) to oligonucleotide. 
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Firstly, the correct sensor chip is chosen for the experiment. Secondly, the 
functional group on the sensor surface needs to be activated to be able to conjugate a 
ligand (DNA) to the chip surface. Then, analyte (the iron cylinder) is injected over the 
flow cells containing immobilised ligands. Finally, the binding constant is calculated 
from the results of the experiment using a mathematical equation. 
 In our studies, a CM5 sensor chip was chosen for the experiment due to its 
versatility and popularity for the direct immobilisation of the ligand (oligonucleotide). 
The CM5 surface is shown in Figure 5.3. 
 
 
 
 
 
 
 
 
 
Figure 5.3 Schematic drawing illustrating the carboxymethylated dextran covalently attached to the gold 
surface of CM5 chip. Taken from ref.
18
 
 
To immobilise the oligonucleotide to the sensor surface, the chip was treated with 
streptavidin providing a functional group to bind to the biotinylated oligonucleotide via 
the streptavidin-biotin interaction. The sensorgram of streptavidin immobilisation over 
four flow cells is shown in Figure 5.4. 
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Figure 5.4 Sensorgram for streptavidin immobilisation on the CM5 chip. 
 
The sensorgram in Figure 5.4 is a plot between response (RU) in Y axis and time 
(s) in X axis. The outstanding three peaks, marked A, B and C on the sensorgram are the 
result of the refractive index changing due to the binding of injected chemicals to the 
surface. The matrix of this CM5 chip is carboxymethylated dextran covalently attached to 
a gold surface; this group is suitable for covalently coupling target molecules to the 
sensor surface via amine, thiol, aldehyde or carboxyl groups. The first peak (peak A) 
corresponds to injection of an EDC-NHS mixture. The NHS (N-hydroxysuccinimide) 
activates the carboxymethyl groups on the surface, thus creating a highly reactive 
succinimide ester which will react with an amine group on streptavidin in the next step. 
The second peak (peak B) corresponds to the streptavidin immobilisation on the surface. 
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To block the remaining activated carboxymethyl groups, ethanolamine was injected to 
quench and elute a non-covalent bound material as shown in peak C. The amine coupling 
via reactive esters is demonstrated in Figure 5.5. The amount of streptavidin immobilised 
on the surface was calculated by subtracting response (RU) at the end of injection from 
response (RU) at the beginning of injection as labelled D in Figure 5.4. The streptavidin 
was immobilised at similar loading (1895.9, 2002.1, 1986.4 and 1896.4 response unit in 
flow cell 1, 2, 3 and 4 respectively).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Streptavidin immobilisation. Left: A simple schematic drawing of streptavidin immobilisation. 
The red spheres represent carboxyl group on dextran (black line). The green cartoons illustrate streptavidin  
Right: Reaction scheme of carboxyl (COOH) activation with EDC/NHS. 
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5.2.2 Oligonucleotide immobilisation 
The hairpin oligonucleotide labelled with biotin at 5´end (5´ 5GC ATC GTT TTC 
GAT GC 3´; 5 is biotin) was injected over three flow cells (1, 2 and 3) with streptavidin 
coated surfaces. Flow cell 4 was left as a control. A time-dependent, stable 
immobilisation of DNA was observed (Figure 5.5) on the streptavidin surface.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Sensorgram of the biotinylated oligonucleotide bound to surface treated with streptavidin.  
 
The sensorgram in Figure 5.5 shows the large change in refractive index during 
immobilisation due to the binding of biotinylated oligonucleotide and streptavidin 
immobilised on the surface. The response (RU) of oligonucleotide immobilisation were 
214.2, 280.4, 293.6 RU in flow cell 1, 2 and 3 respectively. Flow cell 4 was a reference 
cell so the response (RU) was zero. 
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5.2.3 Affinity binding study of the iron cylinder to the oligonucleotide   
The binding of the iron cylinder to the oligonucleotide was carried out in 
cacodylate buffer containing 150 mM NaCl, pH 7.95. These conditions were established 
to give reproducible results and minimise the non specific binding of the cylinder to the 
sensor surface. Different concentrations of the iron cylinder, [Fe2L3]
4+
, increasing from 
0.117 to 15 µM were injected across the four flow cells. The sensorgram of [Fe2L3]
4+
 
binding to immobilised oligonucleotide is shown in Figure 5.6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Overlay plot sensorgrams of the iron cylinder [Fe2L3]
4+
 binding to oligonucleotide of flow cell 
1, 2 and 3 in 150mM NaCl and 100 mM cacodylate buffer, pH 7.95. 
 
Each peak in the sensorgram represents the binding of [Fe2L3]
4+
 to the oligonucleotide in 
each injection carried out from low to high concentration of [Fe2L3]
4+
. The sensorgram in 
Figure 5.6 demonstrates that each peak corresponding to refractive index increases 
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rapidly and then levels off to an equilibrium in a short time (approximately 105 seconds). 
This indicates that [Fe2L3]
4+
 binds strongly to the immobilised oligonucleotide. Although 
most of the iron cylinder ([Fe2L3]
4+
) was dramatically dissociated from oligonucleotide in 
15 min, some small quantities of [Fe2L3]
4+
 remained on the chip, as the level of 
sensorgram before and after the injection was not at the same level. In addition the 
remaining iron cylinder on the surface was apparently increased at high concentration of 
the injected iron cylinder. However, the remaining [Fe2L3]
4+
 on the sensor chip was not 
significant compared to the huge binding signal achieved. The sharp spikes in flow cell 1 
suggest that air bubbles blocked the flow cell during injection. Therefore, this flow cell 
was not taken into account for the binding constant determination. Surprisingly, there 
were small signals in flow cell 4 which was a control, presumably indicating some weak 
adhesions of the cylinder to streptavidin. However, these signals are considerably smaller 
than the responses in the other three cells. Nevertheless, the response from flow cell 4, 
reference cell, will be subtracted from flow cells 2 and 3 to obtain the corrected 
equilibrium response. The overlay of the concentrations in flow cell 2 and 3 is illustrated 
in Figure 5.7. It can be seen that the dissociation of the iron cylinder from the 
oligonucleotide, started from ~ 235 seconds, was rapidly decreased (in few second) then 
it took long time (~ 400 seconds) to be completely dissociated. This clearly suggests that 
the iron cylinder exhibits biphasic dissociation kinetics to oligonucleotide. 
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Figure 5.7 Overlay plot sensorgrams of the iron cylinder [Fe2L3]
4+
 binding to the oligonucleotide. The 
concentration of the cylinder was increased from 0.117 µM (bottom curve) to 15 µM (top curve). Left: 
Flow cell 2. Right: Flow cell 3. The blue arrow represents the initial RU value before the iron cylinder is 
injected onto the surface while the red arrow marks the point that DNA-[Fe2L3]
4+
complex is in the 
equilibrium phase. 
 
 
5.2.3.1 Equilibrium analysis 
The formation of the analyte-ligand complex (AB) can be defined as shown in 
Equation 1. 
                                                    (1)                      
 
Where ka and kd are the rate constants for the association and dissociation respectively of 
DNA-drug complex. A is analyte, [Fe2L3]
4+
. B is the ligand, DNA. Therefore, the rate of 
complex formation is demonstrated below. 
)2(][])[]]([[
][
0 ABkABBAk
dt
ABd
da −−=
 
A + B AB
ka
kd
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where [AB] is the amount of bound analyte, [A] is the amount of a free analyte  ,[B]0 is 
the total amount of ligand on the sensor surface. The binding constant can be calculated 
by the method as described below.  
If the total amount of ligand [B]0 is represented in terms of the maximum analyte binding 
capacity of the surface ,i.e., the total amount of DNA binding sites on the sensor surface, 
then the concentration term is equal to and can be changed to SPR response signal, R. 
The binding can be expressed as shown below. 
                                         )3()( max RkRRCk
dt
dR
da −−=  
where dR/dt is the rate of change of the SPR response signal. R is the response signal 
directly measured from the binding. Rmax is the maximum response signal at the 
saturation surface binding site. This can be determined as described below. C is the 
injected concentration of the drug analyte (M). ka is the association rate constant (M
-1
s
-1
) 
and kd is the dissociation rate constant (s
-1
). The binding constant, i.e., association 
constant, KA, may be calculated as KA = ka / kd (M
-1
). At equilibrium, dR/dt = 0 and 
Equation 3 can be rewritten. 
                                          )4(max eqAA
eq
RKRK
C
R
−=  
Therefore, the steady state association constant KA can be obtained from the slope of a 
plot of Req /C versus Req and the dissociation constant KD can be calculated as 1/KA as 
illustrated in Figure 5.8. This plot is called a Scatchard plot.
19
 Although the data is 
frequently represented in a Scatchard plot ( Req/C vs Req) as a straight line, large errors 
can occur in the plot, especially at low concentration.
20
 Therefore a non-linear regression 
shown in Equation 5 is selected for the binding constant calculation. 
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Figure 5.8 Top: Simulated sensorgram illustrating affinity and kinetic measurement of DNA-drug 
interaction according to Equation (3). Bottom: A plot of Req/C against Req at different drug concentration 
according to Equation (4) thus giving a straight line from which Rmax and KA can be calculated. Taken from 
ref.
15
 
 
From Equation 3, at equilibrium, dR/dt = 0, 
                            0      =     kaC (Rmax-Req) – kdReq                                                         (5) 
   kdReq    =      RmaxkaC – ReqkaC                                                                (6) 
Divided by kd on both side and KA = ka / kd                              
                             Req    =      RmaxKAC – ReqKAC                                                            (7) 
            Req+ ReqKAC    =      RmaxKAC                                                                             (8) 
            Req(1+ KAC)     =      RmaxKAC                                                                             (9) 
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C)K (1
CKR
   R 
A
Amax
eq
+
=                                                         (10) 
 
 
Figure 5.9 A binding curve of the steady state binding response Req versus drug concentration C according 
to Equation (10). Taken from ref.
15
 
 
The maximum response (Rmax) can be obtained from the plot of SPR response in 
resonance units (RU) against the concentration of the analyte. Furthermore, the 
equilibrium binding constant can be obtained from the inverted concentration of the 
analyte (1/KA) corresponding to half of the maximum binding response (Rmax/2) as shown 
in Figure 5.9. It should be noted that binding constants in this chapter are calculated by 
non linear regression. All curves are fitted by using “Origin Pro8”. 
To calculate the equilibrium binding constant of the iron cylinder to the 
oligonucleotide, the response (RU) of each iron cylinder concentration, shown in Figure 
5.7, were plotted against the concentration of [Fe2L3]
4+
 in order to obtain a non-linear 
curve. In addition, binding of the iron cylinder to DNA was background subtracted using 
a blank flow cell i.e. flow cell 4. In addition flow cell 4 was treated in the same way as 
flow cells 1, 2 and 3 apart from oligonucleotide immobilisation step omitted.  
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The “Origin Pro8” software was used to determined Rmax and KA by fitting the 
data to the model (Equation 10). Note that KA and Keq are the same which is the 
equilibrium binding constant. Keq will be used for this entire chapter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Response (RU) at equilibrium versus concentration of the iron cylinder binding to 16 bp DNA 
surface. The concentration of the iron cylinder ranged from 0.12 to 15 µM. Graph representing non-linear 
fitting by hyperbolic equation of the mean of three individual experiments ± SD (n = 3) 
 
 
 
The results show that the equilibrium binding constant (Keq) calculated from the 
fitting of the non linear regression is 1.6 ± 1.1 x 10
5
 M
-1
 and the maximum response at 
saturation surface binding (Rmax) is 480 ± 36.9 RUs.  
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5.2.3.2 Maximum binding ratio (mbr) 
Beside the binding constant (Keq) and the maximum binding response (Rmax), a 
maximum binding ratio (mbr) can be determined from the experiment. The correlation of 
the measured SPR response in resonance units (RUs) to the surface concentration of 
immobilised target DNA and drug bound is assumed by using the estimate 1 RU ≈ 1 
pg.mm
-2
. This value has been used for proteins and oligonucleotides.
11
 Therefore, the 
Rmax value calculated from the previous section can be used to calculate a maximum 
binding ratio (mbr) (mol drug bound/ mol DNA immobilised), assuming one set of 
independent non-interacting binding sites, using the following equation
21
: 
                             
 
 
Where RDNA is the amount of surface immobilised DNA (RUs) and n is the number of 
bases of the target DNA. MW DNA and MW drug are the molecular weight of the 
immobilised DNA and of the drug respectively. Rmax is the maximum response at the 
saturation of surface binding sites and can be determined by the method described above.  
To determine the maximum binding ratio of the iron cylinder to DNA, all the parameters 
shown in Equation 11 must be known. The maximum binding response was obtained 
from section 5.2.3.1 and is 480 RUs, as well as the immobilised DNA on the surface 
(section 5.2.2) which is 574 RUs. The molecular weight of DNA and drug are 4863.2 and 
1382.86 RU respectively. In addition, the number of bases of the oligonucleotide is 16.  
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Consequently, the maximum binding ratio (mbr) of the iron cylinder [Fe2L3]
4+
 to 
the oligonucleotide was 0.18 ≈ 1 drug/ 5 bp. This value corresponds to expected ratio of 
0.2 ≈ 1 drug/ 5 bp as it has been shown that the iron cylinder binds to DNA in the major 
groove across 5 bp.
22, 23
  
 
5.2.4 Affinity binding study of the enantiomers of the iron cylinder ([Fe2L3]
4+
) to the 
oligonucleotide 
The supramolecular cylinder, [Fe2L3]
4+
, is a helical molecule and comprises of 
two enantiomeric forms defined as M and P for left and right handed helicates, 
respectively.
24, 25
 Both enantiomers interact differently with DNA; M has a stronger 
binding affinity to DNA than the P enantiomer.
26-28
 Moreover, the binding mode for the 
enantiomers is believed to be different; the M enantiomer binds to the DNA major groove 
while phosphate backbone binding is expected for the P.
27
  However, the binding constant 
of the enantiomers to DNA has never been determined. To achieve these values, SPR 
experiments were introduced.  
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1
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5.2.4.1 M enantiomer 
The two fold dilution of the M enantiomer starting from 15 µM to 0.117 µM was 
dissolved in cacodyate buffer containing 150 mM NaCl, pH 7.95 and injected over four 
flow cells containing immobilised oligonucleotide. The sensorgrams of the M enantiomer 
binding to the oligonucleotide are depicted in Figure 5.10. Interestingly, the biphasic 
dissociation kinetics was also observed in the M enantiomer to the oligonucleotide.   
 
 
 
 
 
 
  
 
 
 
Figure 5.10 Overlay plot of sensorgram of M enantiomer binding to oligonucleotide. The concentrations of 
M enantiomer range from 0.117 µM in the lowest curve to the 15 µM in the top curve. Cacodylate buffer 
pH 7.95 with 150 mM NaCl was used in the SPR experiment. The red arrow marks the points in which the 
sensorgram reaches a steady state. 
                      
To determine the binding constant (Keq) for the M enantiomer to the 
oligonucleotide the plot of response (RU) from the steady-state region of the SPR 
sensorgrams versus the concentration of the enantiomer was plotted. The graph is shown 
in Figure 5.11.  
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Figure 5.11 Equilibrium binding response versus concentration of  M enantiomer binding to 16 bp DNA 
surface. The concentrations of M enantiomer ranged from 0.117 to 15 µM. The DNA surface 
immobilisation level of three flowcells (1, 2, 3) were 158, 150.5 and 145 RUs, respectively. Graph 
representing non-linear fitting by hyperbolic equation of the mean of three individual experiments ± SD (n 
= 3) 
 
 
The non linear regression function from Origin Pro8 was employed to fit the 
curve in Figure 5.11. The maximum binding response (Rmax) was 217.6 ± 17 RUs and the 
binding constant (Keq) was 6.0 ± 0.4 x 10
5 
M
-1
.  
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5.2.4.2 P enantiomer 
To compare the kinetic values, i.e. Rmax and Keq, with the M enantiomer, the SPR 
experiment with the P enantiomer was carried out. The same procedure was repeated in 
which two folded dilution of the P enantiomer from 15 µM to 0.117 µM dissolved in 
cacodylate buffer containing 150 mM NaCl pH 7.95 was injected over four flowcells 
containing 16 bases immobilised oligonucleotide. The sensorgrams of the P enantiomer 
binding to the oligonucleotide are illustrated in Figure 5.12. The plot of sensorgrams of 
the P enantiomer binding to oligonucleotide reveals that the dissociation of the P 
enantiomer from the oligonucleotide is biphasic kinetics. The first phase can be seen in 
few seconds after dissociation as the graph is rapidly decreased. The slow dissociation of 
the P enantiomer from oligonucleotide is demonstrated in the second phase.  
 
                                                                      
 
 
 
 
 
Figure 5.12 Overlay plot sensorgrams of P enantiomer binding to oligonucleotide of flow cells 1, 2 and 3 
from left to right respectively. The concentrations of P enantiomer in cacodylate buffer with 150 mM NaCl 
range from 0.117 µM in the lowest curve to 15 µM in the top curve. The red arrows mark the points in 
which the sensorgram reaches to an equilibrium phase. 
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To calculate the binding constant (Keq) for the P enantiomer to the 
oligonucleotide, the plot of RU values from the steady-state region of the SPR 
sensorgrams versus the concentration of the P enantiomer was required. The graph is 
shown in Figure 5.13.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 Equilibrium binding response (RU) versus concentration for P enantiomer binding to the 16 
bases DNA surface. The concentrations of P enantiomer ranged from 0.117 to 15 µM. The DNA surface 
immobilisation level among three flow cells (1, 2 and 3) were 196.2, 176.1 and 221.7 RUs respectively. 
Graph representing non-linear fitting by hyperbolic equation of the mean of three individual experiments ± 
SD (n = 3) 
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The data (Figure 5.13) was curve fitted by non linear regression function using 
Origin Pro8. The maximum binding response (Rmax) was 309.3 ± 15.9 RUs and the 
binding constant (Keq) was 2.0 ± 0.6 x 10
5 
M
-1
. Regarding the previous section 5.2.4.1 the 
Rmax and Kmax of the M enantiomer were 217.6 ± 17 RUs and 6.0 ± 0.4 x 10
5
 M
-1
. The 
results show that the binding constant (Keq) of the M enantiomer (6.0 ± 0.4 x 10
5
 M
-1
) is 
higher than that of the P enantiomer (2.0 ± 0.6 x 10
5 
M
-1
). This implies that the binding 
affinity of the M enantiomer to the oligonucleotide is higher than that of the P 
enantiomer. Surprisingly the iron cylinder [Fe2L3]
4+ 
was found to have the same 
maximum binding ratio, which was 5 bases per drug as shown in the literature.
23
 The 
summary of Rmax of [Fe2L3]
4+
, the M enantiomer and the P enantiomer is shown in Table 
5.2. 
 
Table 5.2 Summary of equilibrium parameters obtained from the SPR experiments.  
 
 Keq (M
-1
) Rmax (RUs) 
[Fe2L3]
4+ 
1.6 ± 1.1 x 10
5
 480 ± 36.9 
M enantiomer 6.0 ± 0.4 x 10
5
 217.6 ± 17 
P enantiomer 2.0 ± 0.6 x 10
5
 309.3 ± 15.9 
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5.3 Conclusions 
SPR is a powerful technique for the investigation of small molecule binding to 
DNA due to its high sensitivity which can detect a small refractive index change in the 
range of 10-100 RUs. Herein, the results demonstrate that SPR can detect and quantify 
binding of the iron cylinder [Fe2L3]
4+ 
to DNA as well as its enantiomers. It reveals that 
the M enantiomer has a higher binding affinity ( Keq = 6.0 ± 0.4 x10
5
 M
-1
) than the P 
enantiomer (Keq = 2.0 ± 0.6 x 10
5 
M
-1
). In addition, the dissociation of the iron cylinder 
and its enantiomers from oligonucleotide is a biphasic kinetics which consists of an initial 
rapid dissociation and follows by a slow dissociation. Moreover, the maximum binding 
ratio of the [Fe2L3]
4+ 
cylinder is 5 bases per drug. This methodology is very useful for 
determining novel quantitative kinetic data and the equilibrium constant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
 210 
5.4 Experimental 
The machine setup procedure. The CM5 chip (Biacore, GE Healthcare) was inserted 
into the appropriate socket. Then, HBS-EP (0.01 HEPES pH 7.4, 0.15 M NaCl, 3 mM 
EDTA, 0.005% v/v Surfactant P20, Biacore) was placed on the machine. To prime the 
machine, 0.5 ml of BIAnormalising solution (Biacore) was injected over the chip’s 
surface.  150 mM NaCl, 100mM cacodylate buffer pH 7.95 was placed on the machine. 
Streptavidin immobilisation. To immobilise streptavidin on the surface, the following 
reagents were employed: 150 µl of EDC (0.4 M) mixed 1:1 with NHS (0.1 M) made up 
before coupling, 120 µl of 0.5mg/ml streptavidin in 10mM Na Acetate pH 5.5, 120 µl of 
1.0 M ethanolamine-HCl pH 8.5 and 500 µl of 10 mM glycine-HCl pH 2.5. Each reagent 
separately contained in a plastic tube, was placed on the right position in the machine in 
which the reagents were injected in order. The buffer used during the immobilisation was 
HBS-EP as it was used for the machine setup.   
Oligonucleotide immobilisation. Biotinylated oligonucleotide (5´ 5GC ATC GTT TTC 
GAT GC 3´; 5 is biotin) which can form a hairpin was supplied by AltaBioscience. The 
machine was firstly primed with 100 mM cacodylate buffer pH 7.95 containing 150 mM 
NaCl before the oligonucleotide was immobilised to get rid of the negative signal caused 
from changing buffer.  Then the oligonucleotide was diluted to 1 µg/ml in 150 mM NaCl, 
100 mM cacodylate buffer pH 7.95 and separately injected over flow cells 1, 2 and 3 at 
the rate of injection 5 µl/min by using quick injection mode. Flow cell 4 was left as 
control. 
Affinity binding of the iron cylinder [Fe2L3]
4+
 to immobilised oligonucleotide. Two-
fold dilution of [Fe2L3]
4+
 in 150mM NaCl and 100 mM cacodylate buffer pH 7.95 carried 
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out from 15 µM to 0.117 µM were injected over four flow cells from low to high 
concentration with kinject injection mode.  
Affinity binding of the enantiomers of the iron cylinder [Fe2L3]
4+
 to immobilised 
oligonucleotide. Two-fold dilution of M and P enantiomers in 150mM NaCl and 100 
mM cacodylate buffer pH 7.95 carried out from 15 µM to 0.117 µM were injected over 
four flow cells from low to high concentration with kinject injection mode.  
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6.1 Conclusions 
The majority of the work described in this thesis has shown how well a 
metallosupramolecular cylinder can recognize and interact specifically with a range of 
nucleic acids. The biophysical experiments herein were performed to elucidate the 
preferential interaction of the cylinder to nucleic acids including DNA, RNA and a three 
dimensional DNA nanostructure.  
In Chapters 2 and 3, gel electrophoresis was the main technique employed to 
investigate the recognition and stabilisation of three way junction nucleic acids by a 
metallosupramolecular cylinder. 
Chapter 2 focused on the recognition and stabilisation of RNA three way 
junctions by a metallosupramolecular triple stranded helicate. This experiment was 
designed to answer the question that also arises for cisplatin, a well known anticancer 
drug, since that drug can potentially also bind not only DNA but also RNA. The 
polyacrylamide gel electrophoresis studies demonstrated that the iron cylinder can 
recognise and stabilise RNA three way junctions with both perfect base pairing and 
mismatched base pairing. Additionally, this binding does not perturb the A-form structure 
of the RNA arms as confirmed by circular dichroism. Moreover, the specific combination 
of the DNA-RNA hybrid was shown to be preferentially recognized by the iron cylinder.  
The effect of enantiomers of the iron cylinder on the recognition of RNA three 
way junction was examined. The result revealed that the M is obviously more effective 
than the P enantiomer for the binding at high RNA concentration. The corresponding 
result from the recent crystal structure, grown from the solution of RNA three way 
junction and the racemic mixture of the iron cylinder, shows that only the M is sitting at 
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the core cavity of the RNA three way junction. Interestingly, the M is also more effective 
than the P in the recognition of DNA three way junction. 
 Besides the iron cylinder, the ruthenium cylinder which has an identical size and 
shape but different metal centre was investigated for the recognition of RNA three way 
junction. Slightly higher stabilisation efficiency was observed with the ruthenium 
cylinder. It might be possible that the difference in the stabilisation of the two cylinders 
to the RNA three way junction could be related to the difference in cytotoxicity of the 
cylinders: the iron cylinder is active against ovarian cancer cell lines while the ruthenium 
cylinder is not.  
The competition assay of nucleic acids to the cylinder revealed that the iron 
cylinder may preferentially bind to RNA three way junction rather than the DNA. 
However, this is not certain because the equilibrium being studied is not the simple 
competition but rather more complicated as shown in Figure 2.25.  It is worth noting that 
increasing RNA concentration in all experiments can promote three way junction 
formation.  
 In Chapter 3, the size and shape of metallosupramolecular cylinder were shown to 
be the key factors for the recognition and stabilisation of the DNA three way junction by 
the cylinder. Several cylinder derivatives were tested for the recogniton. Among those 
complexes, the iron cylinder conjugated a peptide showed the highest promotion of three 
way junction (compared to the parent cylinder) due to a high positive charge of the 
compound from the amino acid attached. Moreover, the preferential binding of the iron 
cylinder to the other DNA structures was examined. The result shows that the three way 
junction structure is the most favourite structure for the binding of the cylinder compared 
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to G-quadruplex and i-motif structures but other Y-shaped junctions i.e. a double 
stranded DNA and a double stranded DNA with loop can compete for binding.  
The recent emergence of DNA nanotechnology initiated the idea of combining 
concept of supramolecular chemistry and DNA nanotechnology by utilising the 
supramolecular chemistry as an approach to synthesise the metallosupramolecular 
cylinder that enables to recognise and control the three dimensional DNA nanostructure. 
To demonstrate the powerful methodology, supramolecular chemistry, for modulating a 
DNA nanostructure, the experiments in Chapter 4 were undertaken. Gel electrophoresis, 
AFM and thermal denaturation indicated that the iron cylinder can bind and alter a very 
rigid DNA nanostructure, DNA tetrahedron. The ability to recognise and (reversibly) 
modify the morphology of a DNA nanostructure could be a very powerful tool indeed 
and opens up new possibilities in the field of DNA nanotechnology.  
In Chapter 2, 3 and 4, it has been shown that the cylinder recognises and binds to 
nucleic acids. To have a closer quantitative look, SPR was established and exploited to 
determine the binding affinity of the iron cylinder to DNA. Detection in real time and 
precisely providing kinetic parameters are the advantages of this method. 
This thesis has established that the cylinder can bind to a range of nucleic acids. 
This takes the work beyond the original DNA binding of the cylinder, recognized at the 
outset, and shows that its biological targets may be wider than envisaged and that its 
applications may also extend into nanotechnology. Within the binding to DNA, the thesis 
has demonstrated that the three way junction is the preferred DNA structural target over a 
range of other DNA motifs, but that other Y-shaped DNA structures can also be bound. 
The apparent preferential recognition of DNA-RNA hybrid structure demonstrated in this 
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thesis is intriguing and was not predicted. This could be exciting as DNA-RNA Y-shaped 
hybrids are present when DNA is transcribed. It is also noteworthy that siRNA are a 
current area of research and powerful application involving DNA-RNA hybrid structure. 
The thesis has also confirmed the importance of the size, shape and chirality of the 
cylinder in its nucleic acid recognition.  
 
6.2 Future work 
The work herein provides much information about the recognition of nucleic 
acids by the cylinder and it enables and indicates exciting work that can be developed in 
the future.  
As described in the thesis, the technique exploited to probe the recognition of the 
stabilisation of RNA three way junction by a metallosupramolecular cylinder was mainly 
polyacrylamide gel electrophoresis (PAGE). The other techniques should be now 
introduced for probing this such as an NMR study of the interaction of RNA three way 
junction with the cylinder. This technique will provide more detail about how exactly the 
cylinder interacts with the RNA three way junction in the solution. The information 
gained from this study will be useful for the design of the novel metallosupramolecular 
cylinders which might selectively recognise RNA recognitions. In addition, the 
competition assay of DNA three way junction and other DNA structures shown in this 
thesis would need further experiments to confirm the apparent results. Possible 
experiments would be to exploit SPR technique (mentioned in Chapter 5) to determine 
the binding constant of the iron cylinder to the other DNA structures then compare the 
binding constant among the structures. The result from this experiment would support the 
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result from the competition assay from the gel experiment. Another exciting future 
experiment is a synthesis of the iron cylinder conjugated with a gold nanoparticle for 
investigating the preferential binding of DNA three way junction over double stranded 
DNA. The idea is to conjugate the gold nanoparticle to a capped iron cylinder which will 
allow only a particle to be anchored at the end of the cylinder instead of six as seen with 
the peptides. The different size of gold nanoparticle from the cylinder will be positioned 
on the arms of the junction or its heart depending on the location of the cylinder. In 
addition, each DNA strand can be labelled with a different size of metal particle for 
example gold nanoparticle. The result of the binding will be shown by Transmission 
Electron Microscopy (TEM). In TEM, if the cylinder prefers to bind to the heart of the 
three way junction it will show the arrangement of the dots representing gold 
nanoparticle labeling on the three way junction in a triangle shape with a single dot in the 
middle of triangle. However, if the single dot is not in the middle it means that the iron 
cylinder prefers to bind to the double stranded DNA as it binds to the arm of the three 
way junction. The schematic drawing is shown in Figure 6.1. 
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Figure 6.1 Schematic drawing depicted the idea of using conjugated gold nanoparticle cylinder to probe 
the preferential binding of the cylinder to the double stranded DNA and the three way junction. 
 
 
+ 
TEM 
Prefer to DNA three way junction Prefer to double strand DNA 
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Besides biophysical investigations, molecular biology and biological experiment are 
required to monitor the effect of the cylinder on the biological function of a cell line in 
order to find the specific gene that response to the iron cylinder treatment and whether 
the regulation of that specific gene in response to the iron cylinder treatment is crucial to 
the antitumor activity. This would be an exciting experiment which should be done in the 
future. The experiment that mentioned in the future work will drive the research going 
and it might be a quick driving force to launch the cylinder in the clinical trial.  
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Scintillator Counting 
The specific activity is specified as of the calibration date. This must be taken into 
consideration when calculating concentration in mass-dependent applications. The 
specific activity on any day prior to the calibration date can be calculated using the 
formula: 
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The specific activity on any day after the calibration date can be calculated using the 
formula: 
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where: 
SA = Specific Activity expressed as Ci/mmol 
SA cal. = Specific Activity on the calibration date. 
DF = Fraction of current radioactivity that will remain on the calibration date (from the 
decay table) For example, for a date 8 days prior to the calibration date DF = 0.678. 
SA Theo = 9120 Ci/mmol for the theoretical specific activity of carrier free 
32
P. 
 
 
 
 
 
 225 
Table A.1 The decay table of phosphorus 32 
 
To use the decay table above, find the number of days in the top and left hand 
columns of the chart, then find the corresponding decay factor. To obtain a precalibration 
number, divide by the decay factor. For a postcalibration number, multiply by the decay 
factor. 
